



Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 29, 2019
Production of steviol glycosides in recombinant hosts




Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Douchin, V., Mikkelsen, M. D., & Møller-Hansen, I. (2016). IPC No. C07H1/08; C12N15/81. Production of steviol
glycosides in recombinant hosts (Patent No. WO2016023844.)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)
(19) World Intellectual Property
Organization I
International Bureau (10) International Publication Number
(43) International Publication Date WO 2016/023844 Al
18 February 2016 (18.02.2016) PO P C T
(51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY,
A23L 1/236 (2006.01) C07H 1/08 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM,
C12N 15/81 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT,
HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR,(21) International Application Number: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG,
PCT/EP20 15/0683 14 MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM,
(22) International Filing Date: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC,
7 August 2015 (07.08.2015) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN,
TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
(25) Filing Language: English
(84) Designated States (unless otherwise indicated, for every
(26) Publication Language: English kind of regional protection available): ARIPO (BW, GH,
(30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ,
62/035,902 11 August 2014 ( 11.08.2014) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU,
TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE,
(71) Applicant: EVOLVA SA [CH/CH]; Duggingerstrasse 23, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU,
CH-4153 Reinach (CH). LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK,
SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ,(72) Inventors: DOUCHIN, Veronique; Aurikelvej 2, 4th, GW, KM, ML, MR, NE, SN, TD, TG).2000 Frederiksberg (DK). MIKKELSEN, Michael Dal-
gaard; Bregnevej 1, 3500 Vaerlose (DK). M0LLER- Published:
HANSEN, Iben; Worsaaesvej 16, 5. Tv, 1972 Frederiks
— with international search report (Art. 21(3))berg (DK).
— before the expiration of the time limit for amending the(74) Agent: SMAGGASGALE, Gillian Helen; 55 Drury Lane, claims and to be republished in the event of receipt of
London WC2B 5SQ (GB). amendments (Rule 48.2(h))
(81) Designated States (unless otherwise indicated, for every
— with sequence listing part of description (Rule 5.2(a))
kind of national protection available): AE, AG, AL, AM,
(54) Title: PRODUCTION OF STEVIOL GLYCOSIDES IN RECOMBINANT HOSTS
Figure 1
(57) Abstract: The invention relates to recombinant microorganisms and methods for producing steviol glycosides and steviol glyc-
oside precursors.
PRODUCTION OF STEVSOL GLYCOSIDES IN RECOMBINANT HOSTS
BACKGROUND OF THE INVENTION
Field of the Invention
[0001] This disclosure relates generally to the recombinant production of steviol
glycosides such as rebaudioside A (RebA), rebaudioside B (RebB), rebaudioside D (RebD),
and rebaudioside M (RebM) by recombinant hosts such as recombinant microorganisms and
isolation methods thereof. In particular, this disclosure relates to modifications to transport
systems in a recombinant host to increase production of such steviol glycosides and/or
transport of such steviol glycosides into the culture medium.
Description of Related Art
[0002] Sweeteners are well known as ingredients used most commonly in the food,
beverage, or confectionary industries. The sweetener can either be incorporated into a final
food product during production or for stand-alone use, when appropriately diluted, as a
tabletop sweetener or an at-home replacement for sugars in baking. Sweeteners include
natural sweeteners such as sucrose, high fructose corn syrup, molasses, maple syrup, and
honey and artificial sweeteners such as aspartame, saccharine, and sucralose. Stevia
extract is a natural sweetener that can be isolated and extracted from a perennial shrub,
Stevia rebaudiana. Stevia is commonly grown in South America and Asia for commercial
production of stevia extract. Stevia extract, purified to various degrees, is used commercially
as a high intensity sweetener in foods and in blends or alone as a tabletop sweetener.
[0003] Chemical structures for several steviol glycosides are shown in Figure 1,
including the diterpene steviol and various steviol glycosides. Extracts of the Stevia plant
generally comprise rebaudiosides and other steviol glycosides that contribute to the sweet
flavor, although the amount of each steviol glycoside often varies, inter alia, among different
production batches.
[0004] As recovery and purification of steviol glycosides from the Stevia plant have
proven to be labor intensive and inefficient, there remains a need for a recombinant
production system that can produce high yields of desired steviol glycosides, such as RebD
and RebM.
SUMMARY OF THE INVENTION
[0005] It is against the above background that the present invention provides certain
advantages and advancements over the prior art.
[0006] In particular, the invention provides a recombinant host capable of synthesizing a
steviol glycoside, comprising a gene encoding a transporter polypeptide and/or a gene
encoding a transcription factor polypeptide that regulates expression of at least one
transporter gene; wherein expression of the gene encoding the transporter polypeptide
and/or the gene encoding the transcription factor polypeptide that regulates expression of at
least one transporter gene is modified and the recombinant host transports at least a portion
of the synthesized steviol glycoside from the host into a culture medium.
[0007] In some aspects of the recombinant host disclosed herein, the gene encoding the
transporter polypeptide is an endogenous gene.
[0008] In some aspects of the recombinant host disclosed herein, the transporter
polypeptide comprises an ATP-binding cassette (ABC) transporter, a major facilitator
superfamily (MFS) transporter, an amino acid/auxin permease (AAAP) family transporter,
ATPase transporter, a sulfate permease (SulP) family transporter, a lysosomal cystine
transporter (LCT) family transporter, a Ca2+:cation antiporter (CaCA) family transporter, an
amino acid-polyamine-organocation (APC) superfamily transporter, a
multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) transporter, a ZRT/IRT-like protein
(ZIP) metal transporter family transporter, a mitochondrial protein translocase (MPT) family
transporter, a voltage-gated ion channel (VIC) family transporter, a monovalent cation:proton
antiporter-2 (CPA2) family transporter, a ThrE family of putative transmembrane amino acid
efflux transporter, an oligopeptide transporter (OPT) family transporter, a K+ transporter (Trk)
family transporter, a bile acid:Na symporter (BASS) family transporter, a drug/metabolite
transporter (DMT) superfamily transporter, a mitochondrial carrier (MC) family transporter,
an auxin efflux carrier (AEC) family transporter, an ammonia channel transporter (Amt)
family transporter, a metal ion (Mn +-iron) transporter (Nramp) family transporter, a transient
receptor potential Ca + channel (TRP-CC) family transporter, an arsenical resistance-3
(ACR3) family transporter, a nucleobase:cation symporter- (NCS1) family transporter, an
inorganic phosphate transporter (PiT) family transporter, an arsenite-antimonite (ArsAB)
efflux family transporter, an IISP family of transporter, a glycerol uptake (GUP) family
transporter, a metal ion transport (MIT) family transporter, a copper transport (Ctr) family or
a cation diffusion facilitator (CDF) family transporter.
[0009] In some aspects of the recombinant host disclosed herein, the modified
expression comprises modified expression comprises:
(a) overexpressing the gene encoding the transporter polypeptide and/or
the gene encoding the transcription factor polypeptide; or
(b) deleting the gene encoding the transporter polypeptide and/or the
gene encoding the transcription factor polypeptide.
[0010] In some aspects of the recombinant host disclosed herein, the gene encoding the
transporter polypeptide and/or the gene encoding the transcription factor polypeptide has an
activity that is increased.
[0011] In some aspects of the recombinant host disclosed herein, one or more of the
genes encoding the transporter polypeptide and/or one or more of the genes encoding the
transcription factor polypeptide are overexpressed.
[0012] In some aspects of the recombinant host disclosed herein, the transporter
polypeptide and/or transcription polypeptide comprise YAL067C set forth in SEQ D NO: 14,
YBL089W set forth in SEQ ID NO: 15, YBL099W set forth in SEQ ID NO: 16, YBR008C set
forth in SEQ ID NO:86, YBR021W set forth in SEQ ID NO:87, YBR043C set forth in SEQ ID
NO:88, YBR180W set forth in SEQ ID NO: 13, YBR241C set forth in SEQ ID NO: 17,
YBR287W set forth in SEQ ID NO:89, YBR294W set forth in SEQ D NO: 18, YBR295W set
forth in SEQ ID NO:90, YBR296C set forth in SEQ D NO:91 , YCL038C set forth in SEQ ID
NO:92, YCL069W set forth in SEQ ID NO: 19, YCR01 1C set forth in SEQ ID NO:93,
YCR028C set forth in SEQ ID NO:20, YCR075C set forth in SEQ ID NO:21, YDL054C set
forth in SEQ ID NO:94, YDL100C set forth in SEQ ID NO:95, YDL128W set forth in SEQ ID
NO:22, YDL185W set forth in SEQ ID NO:23, YDL194W set forth in SEQ ID NO:24,
YDL210W set forth in SEQ ID NO:25, YDL245C set forth in SEQ ID NO:96, YDL247W set
forth in SEQ ID NO:97, YDR01 1W set forth in SEQ ID NO:98, YDR061W set forth in SEQ ID
NO:26, YDR093W set forth in SEQ ID NO:27, YDR292C set forth in SEQ ID NO:99,
YDR338C set forth in SEQ ID NO:28, YDR406W set forth in SEQ ID NO:29, YDR497C set
forth in SEQ ID NO:100, YDR536W set forth in SEQ ID NO:30, YEL006W set forth in SEQ
ID NO:101, YEL027W set forth in SEQ ID NO:102, YEL031W set forth in SEQ ID NO:31,
YEL065W set forth in SEQ ID NO:103, YER019C-A set forth in SEQ ID NO: 104, YER053C
set forth in SEQ D NO: 105, YER1 19C set forth in SEQ ID NO: 106, YER166W set forth in
SEQ ID NO:32, YFL01 1W set forth in SEQ ID NO:33, YFL028C set forth in SEQ ID NO: 107,
YFR045W set forth in SEQ D NO.108, YGL006W set forth in SEQ ID NO:34, YGL013C set
forth in SEQ ID NO:35, YGL084C set forth in SEQ ID NO: 109, YGL104C set forth in SEQ ID
NO: 110, YGL1 14W set forth in SEQ ID NO:1 11, YGL167C set forth in SEQ ID NO:1 12,
YGL255W set forth in SEQ ID NO:36, YGR125W set forth in SEQ ID NO:37, YGR181W set
forth in SEQ D NO:38, YGR217W set forth in SEQ ID NO:39, YGR224W set forth in SEQ D
NO:40, YGR257C set forth in SEQ D NO: 113, YGR281W set forth in SEQ D NO:41,
YHL016C set forth in SEQ D NO:42, YHL035C set forth in SEQ ID NO: 114, YHL036W set
forth in SEQ ID NO:1 15, YHR002W set forth in SEQ D NO:1 16, YHR096C set forth in SEQ
ID NO:1 17, YIL006W set forth in SEQ ID NO:1 18, YIL088C set forth in SEQ ID NO:43,
YIL120W set forth in SEQ ID NO: 119, YIL121W set forth in SEQ ID NO:120, YIL166C set
forth in SEQ D NO: 121 , YJL093C set forth in SEQ D NO:44, YJL094C set forth in SEQ ID
NO:45, YJL108C set forth in SEQ ID NO:46, YJL133W set forth in SEQ ID NO: 122,
YJL212C set forth in SEQ ID NO:47, YJL219W set forth in SEQ ID NO: 123, YJR106W set
forth in SEQ D NO:48, YJR160C set forth in SEQ ID NO:49, YKL016C set forth in SEQ D
NO:124, YKL050C set forth in SEQ ID NO:125, YKL064W set forth in SEQ ID NO:50,
YKL120W set forth in SEQ ID NO:126, YKL146W set forth in SEQ D NO:127, YKL209C set
forth in SEQ ID NO: 128, YKR039W set forth in SEQ ID NO: 129, YKR050W set forth in SEQ
D NO:51, YKR105C set forth in SEQ D NO:52, YKR106W set forth in SEQ ID NO:53,
YLR41 1W set forth in SEQ ID NO: 130, YLR447C set forth in SEQ ID NO:54, YML038C set
forth in SEQ ID NO:131 , YML1 16W set forth in SEQ ID NO:55, YMR034C set forth in SEQ
D NO:56, YMR056C set forth in SEQ D NO:57, YMR166C set forth in SEQ ID NO: 132,
YMR253C set forth in SEQ D NO:58, YMR279C set forth in SEQ ID NO: 133, YNL003C set
forth in SEQ ID NO: 134, YNL065W set forth in SEQ D NO:59, YNL070W set forth in SEQ
D NO:60, YNL083W set forth in SEQ ID NO:61, YNL095C set forth in SEQ D NO:62,
YNL121C set forth in SEQ D NO:63, YNL142W set forth in SEQ ID NO:64, YNL268W set
forth in SEQ ID NO: 135, YNR055C set forth in SEQ ID NO: 136, YOL020W set forth in SEQ
D NO:65, YOL075C set forth in SEQ ID NO:66, YOL077W-A set forth in SEQ ID NO:67,
YOL122C set forth in SEQ ID NO:68, YOL158C set forth in SEQ ID NO:137, YOR079C set
forth in SEQ ID NO:69, YOR087W set forth in SEQ ID NO:70, YOR092W set forth in SEQ D
NO:71, YOR100C set forth in SEQ ID NO:138, YOR130C set forth in SEQ D NO:72,
YOR153W set forth in SEQ ID NO: 139, YOR222W set forth in SEQ ID NO:73, YOR271C set
forth in SEQ ID NO: 140, YOR273C set forth in SEQ ID NO:141, YOR291W set forth in SEQ
ID NO:74, YOR306C set forth in SEQ ID NO:75, YOR307C set forth in SEQ D NO: 142,
YOR316C set forth in SEQ ID NO:76, YOR332W set forth in SEQ ID NO:143, YOR334W set
forth in SEQ ID NO:77, YOR348C set forth in SEQ ID NO: 144, YPL036W set forth in SEQ
D NO:145, YPL078C set forth in SEQ D NO:78, YPL270W set forth in SEQ ID NO:79,
YPL274W set forth in SEQ D NO:80, YPR003C set forth in SEQ ID NO:81 , YPR01 1C set
forth in SEQ D NO:82, YPR058W set forth in SEQ D NO:83, YPR128C set forth in SEQ ID
NO:84, or YPR201W set forth in SEQ D NO:85.
[0013] In some aspects of the recombinant host disclosed herein, YBR043C set forth in
SEQ ID NO:88, YDL100C set forth in SEQ ID NO:95, YDL054C set forth in SEQ ID NO:94,
YDL128W set forth in SEQ D NO:22, YDL198C set forth in SEQ ID NO: 146, YDR061W set
forth in SEQ D NO:26, YDR536W set forth in SEQ ID NO:30, YEL027W set forth in SEQ ID
NO: 102, YFL054C set forth in SEQ ID NO:147, YGL167C set forth in SEQ ID NO:1 12,
YGR181W set forth in SEQ D NO:38, YHL016C set forth in SEQ ID NO:42, YIL166C set
forth in SEQ ID NO: 121, YJL093C set forth in SEQ D NO:44, YJR106W set forth in SEQ ID
NO:48, YKL120W set forth in SEQ ID NO: 126, YKL146W set forth in SEQ D NO: 127,
YKR039W set forth in SEQ ID NO:129, YMR034C set forth in SEQ ID NO:56, YMR166C set
forth in SEQ ID NO: 132, YOL122C set forth in SEQ ID NO:68, YOR079C set forth in SEQ D
NO:69, YPL270W set forth in SEQ D NO:79, and/or YPR01 1C set forth in SEQ ID NO:82
are overexpressed.
[0014] In some aspects, the recombinant host further comprises:
(a) one or more genes encoding a sucrose transporter and a sucrose
synthase;
(b) a gene encoding a geranylgeranyl diphosphate synthase (GGPPS)
polypeptide;
(c) a gene encoding an ent-copalyl diphosphate synthase (CDPS)
polypeptide;
(d) a gene encoding a kaurene synthase (KS) polypeptide;
(e) a gene encoding a kaurene oxidase (KO) polypeptide;
(f) a gene encoding a steviol synthase (KAH) polypeptide;
(g) a gene encoding a cytochrome P450 reductase (CPR)
polypeptide;
(h) a gene encoding a UGT85C2 polypeptide;
(i) a gene encoding a UGT76G1 polypeptide;
(k) a gene encoding a UGT91 D2 functional homolog; and/or
(I) a gene encoding a EUGT1 1 polypeptide;
wherein at least one of the genes is a recombinant gene; and
wherein the host is capable of producing one or more of RebA, RebB, RebD
and/or Reb .
[0015] In some aspects of the recombinant host disclosed herein, at least one of the
genes is codon optimized for expression in the host.
[0016] In some aspects of the recombinant host disclosed herein,at least one of the
genes is codon optimized for expression in Saccharomyces cerevisiae.
[0017] In some aspects of the recombinant host disclosed herein,
(a) the GGPPS polypeptide comprises a polypeptide having at least 70%
identity to an amino acid sequence set forth in SEQ ID NO: 149;
(b) the CDPS polypeptide comprises a polypeptide having at least 70%
identity to an amino acid sequence set forth in SEQ ID NO:150;
(c) the KO polypeptide comprises a polypeptide having at least 70%
identity to an amino acid sequence set forth in SEQ ID NO: 152;
(d) the KS polypeptide comprises a polypeptide having at least 40%
identity to an amino acid sequence set forth in SEQ D NO: 151;
(e) the KAH polypeptide comprises a polypeptide having at least 60%
identity to an amino acid sequence set forth in SEQ ID NO: 154;
(f) the CPR polypeptide comprises a polypeptide having at least 70%
identity to an amino acid sequence set forth in SEQ ID NO: 153 and/or
a polypeptide having at least 65% identity to an amino acid sequence
set forth in SEQ ID NO: 155;
(g) the UGT85C2 polypeptide comprises a polypeptide having at least
55% identity to an amino acid sequence set forth in SEQ ID NO: 156;
(h) the UGT76G1 polypeptide comprises a polypeptide having at least
50% identity to an amino acid sequence set forth in SEQ ID NO: 158;
(i) the UGT74G1 polypeptide comprises a polypeptide having at least
55% identity to an amino acid sequence set forth in SEQ ID NO: 157;
(j) the a UGT91D2 functional homolog comprises a UGT91D2e-b
polypeptide having at least 90% identity to the amino acid sequence
set forth in SEQ ID NO: 159; and
(k) the EUGT1 1 polypeptide comprises a polypeptide having at least 65%
identity to an amino acid sequence set forth in SEQ D NO: 148.
[0018] In some aspects, the recombinant host disclosed herein comprises a
microorganism that is a plant cell, a mammalian cell, an insect cell, a fungal cell, or a
bacterial cell.
[0019] In some aspects, the bacterial cell comprises Escherichia bacteria cells,
Lactobacillus bacteria cells, Lactococcus bacteria cells, Cornebacterium bacteria cells,
Acetobacter bacteria cells, Acinetobacter bacteria cells, or Pseudomonas bacterial cells.
[0020] In some aspects, the fungal cell is a yeast cell.
[0021] In some aspects, the yeast cell is a cell from Saccharomyces cerevisiae,
Schizosaccharomyces pombe, Yarrowia lipolytica, Candida glabrata, Ashbya gossypii,
Cyberlindnera jadinii, Pichia pastoris, Kluyveromyces lactis, Hansenula polymorpha,
Candida boidinii, Arxula adeninivorans, Xanthophyllomyces dendrorhous, or Candida
albicans species.
[0022] In some aspects, the yeast cell is a Saccharomycete.
[0023] In some aspects, the yeast cell is a ceil from the Saccharomyces cerevisiae
species.
[0024] The invention further provides a method of producing a steviol glycoside,
comprising:
(a) growing the recombinant host disclosed herein in a culture medium, under
conditions in which the genes comprising recombinant host disclosed herein
are expressed,
wherein the steviol glycoside is synthesized by the host; and
(b) optionally isolating the steviol glycoside.
[0025] In some aspects of the methods disclosed herein, the steviol glycoside is RebA,
RebB, RebD, and/or Reb , and wherein:
(a) RebA is capable of being synthesized in the recombinant host disclosed
herein expressing UGT85C2, UGT76G1, UGT74G1, and UGT91D2;
(b) RebB is capable of being synthesized in the recombinant host disclosed
herein expressing UGT85C2, UGT76G1, and UGT91D2;
(c) RebD is capable of being synthesized in the recombinant host disclosed
herein expressing UGT85C2, UGT76G1, UGT74G1 , and UGT91D2 and/or
EUGT1 1; and
(d) RebM is capable of being synthesized in the recombinant host disclosed
herein expressing UGT85C2, UGT76G1 , UGT74G1 , and UGT91D2 and/or
EUGT1 1.
[0026] In some aspects of the methods disclosed herein a gene encoding YBR043C set
forth in SEQ ID NO:88, YDL100C set forth in SEQ ID NO:95, YDL054C set forth in SEQ ID
NO:94, YDL128W set forth in SEQ ID NO:22, YDL198C set forth in SEQ ID NO: 146,
YDR061W set forth in SEQ D NO:26, YDR536W set forth in SEQ ID NO:30, YEL027W set
forth in SEQ ID NO:102, YFL054C set forth in SEQ ID NO: 147, YGL167C set forth in SEQ
ID NO: 1 2 , YGR181W set forth in SEQ ID NO:38, YHL016C set forth in SEQ ID NO:42,
YIL166C set forth in SEQ D NO: 121 , YJL093C set forth in SEQ D NO:44, YJR106W set
forth in SEQ ID NO:48, YKL120W set forth in SEQ ID NO: 126, YKL146W set forth in SEQ ID
NO:127, YKR039W set forth in SEQ D NO:129, YMR034C set forth in SEQ ID NO:56,
YMR166C set forth in SEQ ID NO: 132, YOL122C set forth in SEQ D NO:68. YOR079C set
forth in SEQ ID NO:69, YPL270W set forth in SEQ ID NO:79, and/or YPR011C set forth in
SEQ ID NO:82 is overexpressed.
[0027] In some aspects of the methods disclosed herein the steviol glycoside is
produced at a concentration of between about 500 mg/L to about 10,000 mg/L.
[0028] The invention further provides a method of increasing production or transport of a
steviol glycoside into a culture medium, comprising:
(a) growing the recombinant host disclosed herein in a culture medium, under
conditions in which the genes comprising the host disclosed herein are
expressed,
wherein the steviol glycoside is synthesized by the host; and
(b) optionally isolating the steviol glycoside.
[0029] In some aspects of the methods disclosed herein, the steviol glycoside is RebA,
RebB, RebD, and/or RebM.
[0030] The invention further provides a method increasing production of steviol or a
steviol glycoside in a recombinant host, comprising modifying expression of a gene encoding
a transporter polypeptide and/or a gene encoding a transcription that regulates expression of
at least one transporter gene, wherein the host is capable of transporting at least a portion of
the produced steviol or a steviol glycoside from the host into a culture medium.
[0031] These and other features and advantages of the present invention will be more
fully understood from the following detailed description of the invention taken together with
the accompanying claims. It is noted that the scope of the claims is defined by the recitations
therein and not by the specific discussion of features and advantages set forth in the present
description.
DESCRIPTION OF DRAWINGS
[0032] Figure 1 shows the chemical structures and synthesis pathways for various
steviol glycosides.
[0033] Figure 2 is a bar graph of the amount (µΜ) of RebA, RebB, RebD, or Reb in the
supernatant of a steviol glycoside-producing strain overexpressing transporter genes
YGR181W (SEQ D NO:38) or YDR061W (SEQ ID NO:26), compared to a control steviol
glycoside-producing strain. See Example 4 .
[0034] Figure 3A and Figure 3B are bar graphs of the amount (mg/L) of RebA, RebD, or
RebM in the supernatant (Figure 3A) or total culture (Figure 3B) of a YGR181W (SEQ ID
NO:38) or YDR061W (SEQ ID NO:26) overexpressing strain, compared to a control steviol
glycoside-producing strain. See Example 4.
[0035] Figure 4A shows levels of 13-SMG (total levels and supernatant levels;
µ Οϋ ο), Figure 4B shows levels of RebA (total levels and supernatant levels; M/OD 0o),
Figure 4C shows levels of RebB (total levels and supernatant levels; M/OD60 ) , Figure 4D
shows levels of RebD (total levels and supernatant levels; µΜ/Ο 60 ) , and Figure 4E shows
levels of RebM (total levels and supernatant levels; µ /00 0ο) in a steviol glycoside-
producing S. cerevisiae strain with a genomically integrated transporter gene. The
genomically integrated transporter genes of Figures 4A-E are YBR043C (SEQ ID NO:88),
YEL027W (SEQ ID NO:102), YJL093C (SEQ ID NO:44), YJR106W (SEQ ID NO:48),
YMR166C (SEQ D NO: 132), YIL166C (SEQ ID NO: 121), YKL120W (SEQ ID NO: 126),
YDL054C (SEQ ID NO:94), YDL128W (SEQ ID NO:22), YDR536W (SEQ ID NO:30),
YGL167C (SEQ ID NO: 12), YKL146W (SEQ ID NO:127), YKR039W (SEQ ID NO: 129),
YOL122C (SEQ ID NO:68), and YPR01 1C (SEQ ID NO:82). See Example 6.
[0036] Figure 5A shows supernatant levels of RebA, RebB, RebD, and RebM (in
µΜ/ODeoo) of a steviol glycoside-producing strain overexpressing YMR166C (SEQ ID
NO: 132), YEL027W (SEQ ID NO: 102), YKL120W (SEQ ID NO: 126), YIL166C (SEQ ID
NO:121), YJR106W (SEQ ID NO:48), YJL093C (SEQ ID NO:44), and YBR043C (SEQ ID
NO:88) by the USER cloning system. Figure 5B shows total levels of RebA, RebB, RebD,
and RebM (in µΜ/Ο 60ο) of a steviol glycoside-producing strain overexpressing YMR166C
(SEQ ID NO: 132), YEL027W (SEQ ID NO: 102), YKL120W (SEQ ID NO: 126), YIL166C
(SEQ ID NO: 121), YJR106W (SEQ ID NO:48), YJL093C (SEQ ID NO:44), and YBR043C
(SEQ ID NO:88) by the USER cloning system.
DETAILED DESCRIPTION
[0037] All publications, patents and patent applications cited herein are hereby expressly
incorporated by reference in their entirety for all purposes.
[0038] Before describing the present invention in detail, a number of terms will be
defined. As used herein, the singular forms "a," "an," and "the" include plural referents unless
the context clearly dictates otherwise. For example, reference to "a nucleic acid" means one
or more nucleic acids.
[0039] It is noted that terms like "preferably," "commonly," and "typically" are not utilized
herein to limit the scope of the claimed invention or to imply that certain features are critical,
essential, or even important to the structure or function of the claimed invention. Rather,
these terms are merely intended to highlight alternative or additional features that can or
cannot be utilized in a particular embodiment of the present invention.
[0040] For the purposes of describing and defining the present invention it is noted that
the term "substantially" is utilized herein to represent the inherent degree of uncertainty that
can be attributed to any quantitative comparison, value, measurement, or other
representation. The term "substantially" is also utilized herein to represent the degree by
which a quantitative representation can vary from a stated reference without resulting in a
change in the basic function of the subject matter at issue.
[0001] Methods well known to those skilled in the art can be used to construct genetic
expression constructs and recombinant cells according to this invention. These methods
include in vitro recombinant DNA techniques, synthetic techniques, in vivo recombination
techniques, and polymerase chain reaction (PGR) techniques. See, for example, techniques
as described in Green & Sambrook, 2012, MOLECULAR CLONING: A LABORATORY
MANUAL, Fourth Edition, Cold Spring Harbor Laboratory, New York; Ausubel e a/., 1989,
CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, Greene Publishing Associates and
Wiley Interscience, New York, and PGR Protocols: A Guide to Methods and Applications
(Innis et a!., 1990, Academic Press, San Diego, CA).
[0041] As used herein, the terms "polynucleotide," "nucleotide," "oligonucleotide," and
"nucleic acid" can be used interchangeably to refer to nucleic acid comprising DNA, RNA,
derivatives thereof, or combinations thereof.
[0042] As used herein, the terms "microorganism," "microorganism host,"
"microorganism host cell," "host cell," "recombinant host," "recombinant microorganism host,"
and "recombinant host cell" can be used interchangeably. As used herein, the term
"recombinant host" is intended to refer to a host, the genome of which has been augmented
by at least one DNA sequence. Such DNA sequences include but are not limited to genes
that are not naturally present, DNA sequences that are not normally transcribed into RNA or
translated into a protein ("expressed"), and other genes or DNA sequences which one
desires to introduce into the non-recombinant host. It will be appreciated that typically the
genome of a recombinant host described herein is augmented through stable introduction of
one or more recombinant genes. Generally, introduced DNA is not originally resident in the
host that is the recipient of the DNA, but it is within the scope of this disclosure to isolate a
DNA segment from a given host, and to subsequently introduce one or more additional
copies of that DNA into the same host, e.g., to enhance production of the product of a gene
or alter the expression pattern of a gene. In some instances, the introduced DNA will modify
or even replace an endogenous gene or DNA sequence by, e.g., homologous recombination
or site-directed mutagenesis. Suitable recombinant hosts include microorganisms.
[0043] As used herein, the term "recombinant gene" refers to a gene or DNA sequence
that is introduced into a recipient host, regardless of whether the same or a similar gene or
DNA sequence may already be present in such a host. "Introduced," or "augmented" in this
context, is known in the art to mean introduced or augmented by the hand of man. Thus, a
recombinant gene can be a DNA sequence from another species or can be a DNA sequence
that originated from or is present in the same species but has been incorporated into a host
by recombinant methods to form a recombinant host. It will be appreciated that a
recombinant gene that is introduced into a host can be identical to a DNA sequence that is
normally present in the host being transformed and is introduced to provide one or more
additional copies of the DNA to thereby permit overexpression or modified expression of the
gene product of that DNA. Said recombinant genes are particularly encoded by cDNA.
[0044] As used herein, the term "engineered biosynthetic pathway" refers to a
biosynthetic pathway that occurs in a recombinant host, as described herein, and does not
naturally occur in the host.
[0045] As used herein, the term "endogenous" gene refers to a gene that originates from
and is produced or synthesized within a particular organism, tissue, or cell. In some
embodiments, the endogenous gene is a yeast transporter. In some embodiments, the
transporter is endogenous to S. cerevisiae, including, but not limited to S. cerevisiae strain
S288C. In some embodiments, an endogenous yeast transporter gene is overexpressed.
As used herein, the term "overexpress" is used to refer to the expression of a gene in an
organism at levels higher than the level of gene expression in a wild type organism. See,
e.g., Prelich, 2012, Genetics 190:841-54. In some embodiments, an endogenous yeast
transporter gene is deleted. See, e.g., Giaever & Nislow, 2014, Genetics 197(2):451-65. As
used herein, the terms "deletion," "deleted," "knockout," and "knocked out" can be used
interchangeably to refer to an endogenous gene that has been manipulated to no longer be
expressed in an organism, including, but not limited to, S. cerevisiae. In some
embodiments, a deleted/knocked out gene is a transporter gene or a transcription factor
gene that regulates expression of a transporter gene.
[0046] As used herein, the terms "heterologous sequence" and "heterologous coding
sequence" are used to describe a sequence derived from a species other than the
recombinant host. In some embodiments, the recombinant host is an S. cerevisiae cell, and
a heterologous sequence is derived from an organism other than S. cerevisiae. A
heterologous coding sequence, for example, can be from a prokaryotic microorganism, a
eukaryotic microorganism, a plant, an animal, an insect, or a fungus different than the
recombinant host expressing the heterologous sequence. In some embodiments, a coding
sequence is a sequence that is native to the host.
[0047] A "selectable marker" can be one of any number of genes that complement host
cell auxotrophy, provide antibiotic resistance, or result in a color change. Linearized DNA
fragments of the gene replacement vector then are introduced into the cells using methods
well known in the art (see below). Integration of the linear fragments into the genome and
the disruption of the gene can be determined based on the selection marker and can be
verified by, for example, PGR or Southern blot analysis. Subsequent to its use in selection,
a selectable marker can be removed from the genome of the host cell by, e.g., Cre-LoxP
systems (see, e.g., Gossen et a/., 2002, Ann. Rev. Genetics 36:153-173 and U.S.
2006/0014264). Alternatively, a gene replacement vector can be constructed in such a way
as to include a portion of the gene to be disrupted, where the portion is devoid of any
endogenous gene promoter sequence and encodes none, or an inactive fragment of, the
coding sequence of the gene.
[0048] As used herein, the terms "variant" and "mutant" are used to describe a protein
sequence that has been modified at one or more amino acids, compared to the wild type
sequence of a particular protein.
[0049] As used herein, the term "inactive fragment" is a fragment of the gene that
encodes a protein having, e.g., less than about 0% {e.g., less than about 9%, less than
about 8%, less than about 7%, less than about 6%, less than about 5%, less than about 4%,
less than about 3%, less than about 2%, less than about 1%, or 0%) of the activity of the
protein produced from the full-length coding sequence of the gene. Such a portion of a gene
is inserted in a vector in such a way that no known promoter sequence is operably linked to
the gene sequence, but that a stop codon and a transcription termination sequence are
operably linked to the portion of the gene sequence. This vector can be subsequently
linearized in the portion of the gene sequence and transformed into a cell. By way of single
homologous recombination, this linearized vector is then integrated in the endogenous
counterpart of the gene with inactivation thereof.
[0050] As used herein, the term "steviol glycoside" refers to Rebaudioside A (RebA)
(CAS # 58543-16-1), Rebaudioside B (RebB) (CAS # 58543-17-2), Rebaudioside C (RebC)
(CAS # 63550-99-2), Rebaudioside D (RebD) (CAS # 63279-13-0), Rebaudioside E (RebE)
(CAS # 63279-14-1 ), Rebaudioside F (RebF) (CAS # 438045-89-7), Rebaudioside M
(RebM) (CAS # 1220616-44-3), Rubusoside (CAS # 63849-39-4), Duicoside A (CAS #
64432-06-0), Rebaudioside I (Rebl) (MassBank Record: FU000332), Rebaudioside Q
(RebQ), 1,2-Stevioside (CAS # 57817-89-7), 1,3-Stevioside (RebG), 1,2-Bioside (MassBank
Record: FU000299), 1,3-Bioside, Steviol-13-O-glucoside (13-SMG), Steviol-19-O-glucoside
(19-SMG), a tri-glucosylated steviol glycoside, a tetra-glycosylated steviol glycoside, a
penta-glucosylated steviol glycoside, a hexa-glucosylated steviol glycoside, a hepta-
glucosylated steviol glycoside, di-glucosylated kaurenoic acid, tri-glucosylated kaurenoic
acid, di-glucosylated kaurenol, tri-glucosylated kaurenol, and isomers thereof.
[0051] Recombinant steviol glycoside-producing Saccharomyces cerevisiae (S.
cerevisiae) strains are described in WO 201 1/153378, WO 2013/022989, WO 2014/122227,
and WO 2014/122328, each of which has been incorporated by reference herein in its
entirety. See, also, Example 2 . Methods of producing steviol glycosides in recombinant
hosts, by whole cell bio-conversion, and in vitro are also described in WO 2011/153378, WO
2013/022989, WO 2014/122227, and WO 2014/122328.
[0052] In some embodiments, steviol glycosides and/or steviol glycoside precursors are
produced in vivo through expression of one or more enzymes involved in the steviol
glycoside biosynthetic pathway in a recombinant host. For example, a steviol-producing
recombinant host expressing one or more of a gene encoding a geranylgeranyl diphosphate
synthase (GGPPS) polypeptide, a gene encoding an ent-copalyl diphosphate synthase
(CDPS) polypeptide, a gene encoding a kaurene synthase (KS) polypeptide, a gene
encoding a kaurene oxidase polypeptide (KO), a gene encoding a steviol synthase (KAH)
polypeptide, a gene encoding a cytochrome P450 reductase (CPR) polypeptide, and a gene
encoding a UGT polypeptide can produce a steviol glycoside and/or steviol glycoside
precursors in vivo. See Example 2.
[0053] In some embodiments, a recombinant host comprises a nucleic acid encoding a
UGT85C2 polypeptide, a nucleic acid encoding a UGT76G1 polypeptide, a nucleic acid
encoding a UGT74G1 polypeptide, a nucleic acid encoding a UGT91D2 polypeptide, and/or
a nucleic acid encoding a EUGT1 1 polypeptide. The skilled worker will appreciate that
expression of these genes may be necessary to produce a particular steviol glycoside but
that one or more of these genes can be endogenous to the host provided that at least one
(and in some embodiments, all) of these genes is a recombinant gene introduced into the
microorganism. In a particular embodiment, a steviol-producing recombinant microorganism
comprises exogenous nucleic acids encoding UGT85C2, UGT76G1, or UGT91D2
polypeptides. In another particular embodiment, a steviol-producing recombinant
microorganism comprises exogenous nucleic acids encoding UGT85C2, UGT76G1,
UGT74G1, and UGT91D2 polypeptides. In yet another particular embodiment, a steviol-
producing recombinant microorganism comprises exogenous nucleic acids encoding
UGT85C2, UGT76G1, UGT74G1, and EUGT1 polypeptides. In yet another particular
embodiment, a steviol-producing recombinant microorganism comprises the exogenous
nucleic acids encoding UGT85C2, UGT76G1 , UGT74G1, UGT91D2 (including inter alia
91D2e, 91D2m, 91D2e-b, and functional homologs thereof), and EUGT1 polypeptides.
See Example 2.
[0054] In certain embodiments, the steviol glycoside is RebA, RebB, RebD, and/or
RebM. RebA can be synthesized in a steviol-producing recombinant microorganism
expressing UGT85C2, UGT76G1 , UGT74G1, and UGT91D2. RebB can be synthesized in a
steviol-producing recombinant microorganism expressing UGT85C2, UGT76G1, and
UGT91D2. RebD can be synthesized in a steviol-producing recombinant microorganism
expressing UGT85C2, UGT76G1 UGT74G1, and UGT91D2 and/or EUGT1 1. RebM can be
synthesized in a steviol-producing recombinant microorganism expressing UGT85C2,
UGT76G1, UGT74G1 , and UGT91D2 and/or EUGT1 1 (see Figure 1, Example 2).
[0055] In some embodiments, steviol glycosides and/or steviol glycoside precursors are
produced through contact of a steviol glycoside precursor with one or more enzymes
involved in the steviol glycoside pathway in vitro. For example, contacting steviol with a
UGT polypeptide can result in production of a steviol glycoside in vitro. In some
embodiments, a steviol glycoside precursor is produced through contact of an upstream
steviol glycoside precursor with one or more enzymes involved in the steviol glycoside
pathway in vitro. For example, contacting ent-kaurenoic acid with a KAH enzyme can result
in production of steviol in vitro.
[0056] In some embodiments, a steviol glycoside or steviol glycoside precursor is
produced by whole cell bioconversion. For whole cell bioconversion to occur, a host cell
expressing one or more enzymes involved in the steviol glycoside pathway takes up and
modifies a steviol glycoside precursor in the cell; following modification in vivo, a steviol
glycoside remains in the cell and/or is excreted into the culture medium. For example, a
host cell expressing a gene encoding a UGT polypeptide can take up steviol and glycosylate
steviol in the ceil; following glycosylation in vivo, a steviol glycoside can be excreted into the
culture medium. In some embodiments, the cell is permeabilized to take up a substrate to
be modified or to excrete a modified product.
[0057] In some embodiments, a steviol glycoside or steviol glycoside precursor
composition produced in vivo, in vitro, or by whole cell bioconversion comprises less
contaminants than a stevia extract from, inter alia, a stevia plant. Contaminants include
plant-derived compounds that contribute to off-flavors. Potential contaminants include
pigments, lipids, proteins, phenolics, saccharides, spathulenol and other sesquiterpenes,
labdane diterpenes, monoterpenes, decanoic acid, 8,1 1,14-eicosatrienoic acid, 2-
methyloctadecane, pentacosane, octacosane, tetracosane, octadecanol, stigmastero!, β-
sitosterol, a - and β-amyrin, iupeo!, β-amryin acetate, pentacyclic triterpenes, centauredin,
quercitin, epi-alpha-cadinol, carophylienes and derivatives, beta-pinene, beta-sitosterol, and
gibberellin.
[0058] As used herein, the ter s "detectable amount," "detectable concentration,"
"measurable amount," and "measurable concentration" refer to a level of steviol glycosides
measured in AUC, µΜ/ODeoo. mg/L, µΜ, or m . Steviol glycoside production (i.e., total,
supernatant, and/or intracellular steviol glycoside levels) can be detected and/or analyzed by
techniques generally available to one skilled in the art, for example, but not limited to, liquid
chromatography-mass spectrometry (LC-MS), thin layer chromatography (TLC), high-
performance liquid chromatography (HPLC), ultraviolet-visible spectroscopy/
spectrophotometry (UV-Vis), mass spectrometry (MS), and nuclear magnetic resonance
spectroscopy (NMR).
[0059] As used herein, the terms "or" and "and/or" is utilized to describe multiple
components in combination or exclusive of one another. For example, "x, y, and/or z" can
refer to "x" alone, "y" alone, "z" alone, "x, y, and z," "(x and y) or z," "x or (y and z)," or "x or y
or z." In some embodiments, "and/or" is used to refer to the exogenous nucleic acids that a
recombinant cell comprises, wherein a recombinant ceil comprises one or more exogenous
nucleic acids selected from a group. In some embodiments, "and/or" is used to refer to
production of steviol glycosides and/or steviol glycoside precursors. In some embodiments,
"and/or" is used to refer to production of steviol glycosides, wherein one or more steviol
glycosides are produced. In some embodiments, "and/or" is used to refer to production of
steviol glycosides, wherein one or more steviol glycosides are produced through one or
more of the following steps: culturing a recombinant microorganism, synthesizing one or
more steviol glycosides in a recombinant microorganism, and/or isolating one or more steviol
glycosides.
Transporters a d Transcription Factor Expression
[0060] This document describes reagents and methods that can be used to efficiently
produce steviol glycoside compositions. Modification of transport systems in a recombinant
host that are involved in transport of steviol glycosides into culture medium can allow more
effective production of steviol glycosides in recombinant hosts.
[0061] As set forth herein, recombinant cells having modifications to cellular transport
are capable of producing steviol. Recombinant hosts described herein can produce steviol
and have altered expression of at least one endogenous transporter gene. Recombinant
hosts described herein can produce steviol and have altered expression of a transcription
factor that regulates expression of at least one endogenous transporter gene. Altering
expression of endogenous transporter genes can be useful for increasing production of
steviol and/or excretion of steviol into the culture medium.
[0062] As set forth herein, recombinant cells having modifications to cellular transport
are capable of producing at least one steviol glycoside, including, but not limited to, RebA,
RebB, RebD, and/or RebM. Recombinant hosts described herein can produce at least one
steviol glycoside such as RebA, RebB, RebD, and/or RebM and have altered expression of
at least one endogenous transporter gene. Recombinant hosts described herein can
produce at least one steviol glycoside such as RebA, RebB, RebD, and/or RebM and have
altered expression of a transcription factor that regulates expression of at least one
endogenous transporter gene. Recombinant hosts described herein can produce at least
one steviol glycoside such as RebA, RebB, RebD, and/or RebM and have altered
expression of a plurality of endogenous transporter genes and/or of a plurality of
transcription factor genes that regulate expression of a a plurality of endogenous transporter
genes. Altering expression of endogenous transporter genes and/or transcription factors
regulating expression of at least one transporter gene can be useful for increasing
production of steviol glycosides and/or excretion of steviol glycosides into the culture
medium.
[0063] Recombinant hosts disclosed herein can include one or more biosynthesis
genes, such as one or more genes encoding a sucrose transporter and a sucrose synthase;
a gene encoding a geranylgeranyl diphosphate synthase (GGPPS) polypeptide; a gene
encoding an ent-copalyl diphosphate synthase (CDPS) polypeptide; a gene encoding a
kaurene synthase (KS) polypeptide; a gene encoding a kaurene oxidase (KO) polypeptide; a
gene encoding a steviol synthase (KAH) polypeptide; a gene encoding a cytochrome P450
reductase (CPR) polypeptide; a gene encoding a UGT85C2 polypeptide; a gene encoding a
UGT76G1 polypeptide; a gene encoding a UGT74G1 polypeptide; a gene encoding a a
UGT91D2 functional homolog; and/or a gene encoding a EUGT1 polypeptide; wherein
experession of one or more of these genes results in production of steviol steviol glycosides
such as RebA, RebB, RebD, and/or RebM.
[0064] As used herein, the terms "transport of a steviol glycoside," "steviol glycoside
transport," "excretion of a steviol glycoside," and "steviol glycoside excretion" can be used
interchangeably.
[0065] As used herein, the term "transporter" (also referred to as a membrane transport
protein) refers to a membrane protein involved in the movement of small molecules,
macromolecules (such as carbohydrates), and ions across a biological membrane.
Transporters span the membrane in which they are localized and across which they
transport substances. Transporter proteins can assist in the movement (i.e., transport or
excretion) of a substance from the intracellular space to the culture medium. Transporters
are known to function as passive transport systems, carrying molecules down their
concentration gradient, or as active transport systems, using energy to carry molecules uphill
against their concentration gradient. Active transport is mediated by carriers which couple
transport directly to the use of energy derived from hydrolysis of an ATP molecule or by
carriers which make use of a pre-established electrochemical ion gradient to drive co-
transport of the nutrient molecule and a co-transported ion. The latter category comprises
symporters and antiporters, which carry the ion in the same or opposite direction,
respectively, as the transported substrate.
[0066] Transport proteins have been classified according to various criteria at the
Transporter Classification Database (on the world wide web at tcdb.org). See, Saier Jr. et
a/., Nucl. Acids Res., 42(1 ):D251 -258 (2014). Non-!imiting examples thereof include, among
others, the family of Multiple Drug Resistance (MDR) plasma membrane transporters that is
thought to be ubiquitous among living organisms. The MDR transporter superfamily can be
further subdivided according to the mode of operation by which the substrate is transported
from one side of the membrane to the other. Transporters can operate to move substances
across membranes in response to chemiosmotic ion gradients or by active transport. ATP-
binding cassette transporters (ABC transporters) are transmembrane proteins that utilize the
energy of adenosine triphosphate (ATP) hydrolysis to carry out translocation of various
substrates across membranes. They can transport a wide variety of substrates across the
plasma membrane and intracellular membranes, including metabolic products, lipids and
sterols, and drugs. Particular non-limiting examples of endogenous ABC transporter genes
include PDR5, YDR061W, PDR15, SNQ2, YOR1, YOL075C, MDL2, ADP1, CAF16, VMR1
and STE6 (or a functional homolog thereof). In some aspects, ABC transporters transport
steviol glycosides.
[0067] A second group of MDRs is further subdivided based on the nature of the
chemiosmotic gradient that facilitates the transport. Saier, Jr. et a/., J. Mol. Microbiol.
Biotechnoi. 1:257-279 (1999). In some aspects, MDR transporters transport steviol
glycosides.
[0068] Another transporter family, the Major Facilitator Superfamily (MFS) transporters
are monomeric polypeptides that can transport small solutes in response to proton gradients.
The MFS transporter family is sometimes referred to as the uniporter-symporter-antiporter
family. MFS transporters function in, inter alia, in sugar uptake and drug efflux systems.
MFS transporters typically comprise conserved MFS-specific motifs. Non-limiting examples
of endogenous MFS transporter genes include DTR1, SE01, YBR241C, VBA3, FEN2,
SNF3, STL1, HXT10, AZR1, MPH3, VBA5, GEX2, SNQ1 , AQR1 , MCH1 , MCH5, ATG22,
HXT15, MPH2, ITR1, SIT1, VPS73, HXT5, QDR1 , QDR2, QDR3, SOA1, HXT9, YMR279C,
YIL166C, HOL1, ENB1 , TP04 and FLR1 (or a functional homolog thereof). In some
aspects, MFS transporters transport steviol glycosides.
[0069] Other transporter families include the SMR (small multidrug resistant) family,
RND (Resistance-Nodulation-Cell Division) family, and the MATE (multidrug and toxic
compound extrusion) family. The SMR family members are integral membrane proteins
characterized by four alpha-helical transmembrane strands that confer resistance to a broad
range of antiseptics, lipophilic quaternary ammonium compounds (QAC), and
aminoglycoside resistance in bacteria. See, Bay & Turner, 2009, BMC Evol Biol., 9:140. In
some aspects, SMR transporters transport steviol glycosides.
[0070] The MATE family members comprise 12 transmembrane (TM) domains.
Members of the MATE family have been identified in prokaryotes, yeast such as S.
cerevisiae and Schizosaccharomyces pombe, and plants. See Diener et a/., 2001, Plant
Cell. 13(7): 1625-8. The MATE family members are sodium or proton antiporters. In some
aspects, MATE transporters transport steviol glycosides.
[0071] Additional transporter families include the amino acid/auxin permease (AAAP)
family (for example, YKL146W/AVT3, YBL089W/AVT5, YER1 19C/AVT6 and
YIL088C/AVT7), the ATPase family (for example, YBL099W/ATP1, YDL185W/VMA1 ,
YLR447C/VMA6, YOL077W/ATP19, YPL078C/ATP4, YEL027W/VMA3, YKL016C/ATP7,
and YOR332W7VMA4), the sulfate permease (SulP) family (for example, YBR294W/SUL1 ,
YGR125W and YPR003C), the lysosomal cystine transporter (LCT) family (for example,
YCR075C/ERS1), the Ca2+:cation antiporter (CaCA) family (for example, YDL128W/VCX1
and YJR106W/ECM27), the amino acid-polyamine-organocation (APC) superfamily (for
example, YDL210W/UGA4, YOL020W/TAT2, YPL274W/SAM3, YNL268W/LYP1,
YHL036W/MUP3, YKR039W/GAP1 and YOR348C/PUT4), multidrug/oligosaccharidyi-
lipid/polysaccharide (MOP) (for example, YDR338C), the ZRT/IRT-like protein (ZIP) metal
transporter family (for example, YGL225W/ZRT1 and YOR079C/ATX2), the mitochondrial
protein translocase (MPT) family (for example, YGR181W/TIM13, YNL070W/TOM7,
YNL121C/TOM70, the voltage-gated ion channel (VIC) family (for example,
YGR217W/CCH1 and YJL093C/TOK1), the monovalent cation:proton antiporter-2 (CPA2)
family (for example, YJL094C/KHA1), the ThrE family of putative transmembrane amino acid
efflux transporters (for example, YJL108C/PRM10), the oligopeptide transporter (OPT)
family (for example, YJL212C/OPT1 and YGL1 14W), the K+ transporter (Trk) family (for
example, TKR050W/TRK2), the bile acid:Na symporter (BASS) family (for example,
YMR034C), the drug/metabolite transporter (DMT) superfamily (for example, YMR253C,
YML038C/ YMD8, and YOR307C/SLY41 ) , the mitochondrial carrier (MC) family (for
example, YMR056C/AAC1 , YNL083W/SAL1 , YOR130C/ORT1, YOR222W/ODC2,
YPR01 1C, YPR058W/YMC1 , YPR128C/ANT1 , YEL006W/YEA6, YER053C/PIC2,
YFR045W, YGR257C/MTM1 , YHR002W/LEU5, YIL006W/YIA6, YJL133W/MRS3,
YKL120W/OAC1, YMR166C, YNL003C/PET8 and YOR100C/CRC1), the auxin efflux carrier
(AEC) family (for example, YNL095C, YOR092W/ECM3 and YBR287W), the ammonia
channel transporter (Amt) family (for example, YNL142W/MEP2), the metal ion (Mn +-iron)
transporter (Nramp) family (for example, YOL122C/SMF1), the transient receptor potential
Ca + channel (TRP-CC) family (for example, YOR087W/YVC1), the arsenical resistance-3
(ACR3) family (for example, YPR201W/ARR3), the nucieobasexation symporter-1 (NCS1 )
family (for example, YBR021W/FUR4), the inorganic phosphate transporter (PiT) family (for
example, YBR296C/PH089), the arsenite-antimonite (ArsAB) efflux family (for example,
YDL100C/GET3), the MSP family of transporters, the glycerol uptake (GUP) family (for
example, YGL084C/GUP1), the metal ion transport (MIT) family (for example,
YKL064W/MNR2, YKL050C and YOR334W/MRS2), the copper transport (Ctr) family (for
example, YLR41 1W/CTR3) and the cation diffusion facilitator (CDF) family (for example,
YOR316C/COT1). Particular members of any of these transporter families are included
within the scope of the disclosed invention to the extent that altered expression in a cell
capable of producing steviol glycoside increases production of said steviol glycoside from
the cell; exemplary members are disclosed above and in Tables 5 , 6 , and 14.
[0072] As used herein, the term "transcription factor" refers to a DNA-binding protein that
regulates gene expression. Preferably, the transcription factor regulates expression of at
least one transporter gene.
[0073] Methods for identifying a gene affecting production or transport of steviol
glycosides and steviol glycoside pathway intermediates are disclosed herein. Such methods
can involve inactivating at least one endogenous transporter gene or modifying expression
of at least one transporter gene. Typically, a library of mutant microorganisms is prepared,
each mutant in the library having a different endogenous transporter gene inactivated.
Methods of inactivating genes and determining their effect in a microorganims are known to
a person having ordinary skill in the art; additional methods are disclosed in W O
2014/122328, the disclosure of which is incorporated by reference in its entirety. The mutant
microorganisms comprising one or more steviol glycoside pathway genes are cultured in a
medium under conditions in which steviol or a steviol glycoside is synthesized, and the
amount of total, supernatant, and/or intracellular steviol glycosides produced by the
microorganism is measured (e.g., using LC-MS) as described herein.
[0074] The disclosure is directed to recombinant host cells in which expression of
endogenous transporter or transcription factor genes is modified. In some embodiments, the
transporter or transcription factor gene is endogenous to S. cerevisiae, including, but not
limited to S. cerevisiae strain S288C. In some embodiments, expression of an endogenous
transporter or transcription factor can be modified by repiacing the endogenous promoter
with a different promoter that results in increased expression of the transporter protein (e.g.,
at least a 5% increase in expression, such as at least a 10%, 15%, 20%, 25%, 30%, 35%,
40%, 45%, or 50%, 100%, 200% increase or more in expression). For example, an
endogenous promoter can be replaced with a constitutive or inducible promoter that results
in increased expression of the transporter. Homologous recombination can be used to
replace the promoter of an endogenous gene with a different promoter that results in
increased expression of the transporter. In other embodiments, the inducible or constitutive
promoter and endogenous transporter or transcription factor can be integrated into another
locus of the genome using homologous recombination. In other embodiments, the
transporter or transcription factor gene can be introduced into a microorganism using
exogenous plasmids with a promoter that results in overexpression of the transporter or
transcription factor in the microorganim. In yet another embodiment, the exogenous
plasmids may also comprise multiple copies of the transporter or transcription factor gene.
In a further embodiment, the endogenous transporter or transcription factor can be induced
to be overexpressed using native mechanisms to the recombinant microorganism (e.g. heat
shock, stress, heavy metal, or antibiotic exposure). In yet a further embodiment, the activity
of an endogenous gene product is enhanced or increased (for example, by mutation). In yet
another embodiment, a homologous or orthologous gene of an endogenous yeast
transporter or transcription factor gene is overexpressed.
[0075] In certain other embodiments, modified expression of a target gene in a
recombinant mircroorganism comprises overexpressing a transporter gene and/or a
transcription factor gene involved in expression of said transporter gene. In yet other
embodiments, a plurality of endogenous transporter genes or transcription factor genes is
overexpressed in said recombinant microorganism.
[0076] Modification of transcription factor expression can be used to increase transporter
expression. For example, yeast transcriptions factor PDR1 regulates expression of the
genes encoding ABC transporters PDR5, SNQ2 and YOR1. Therefore, in some
embodiments, promoters for the endogenous PDR1 locus can be replaced with a different
promoter that results in increased expression of the transcription factors, which can increase
production of endogenous transporters.
[0077] In some embodiments, the transporter gene or transcription factor gene is (using
Uniprot Ordered Locus Name for each): YAL067C, YBL089W, YBL099W, YBR008C,
YBR021W, YBR043C, YBR180W, YBR241C, YBR287W, YBR294W, YBR295W, YBR296C,
YCL038C, YCL069W, YCR01 1C, YCR028C, YCR075C, YDL054C, YDL100C, YDL128W,
YDL185W, YDL194W, YDL210W, YDL245C, YDL247W, YDR01 1W, YDR061W, YDR093W,
YDR292C, YDR338C, YDR406W, YDR497C, YDR536W, YEL006W, YEL027W, YEL031W,
YEL065W, YER019C-A, YER053C, YER1 19C, YER166W, YFL01 1W, YFL028C, YFR045W,
YGL006W, YGL013C, YGL084C, YGL104C, YGL1 14W, YGL167C, YGL255W, YGR125W,
YGR181W, YGR217W, YGR224W, YGR257C, YGR281W, YHL016C, YHL035C,
YHL036W, YHR002W, YHR096C, YIL006W, YIL088C, YIL120W, YIL121W, YIL166C,
YJL093C, YJL094C, YJL108C, YJL133W, YJL212C, YJL219W, YJR106W, YJR160C,
YKL016C, YKL050C, YKL064W, YKL120W, YKL146W, YKL209C, YKR039W, YKR050W,
YKR105C, YKR106W, YLR41 1W, YLR447C, YML038C, YML1 16W, YMR034C, YMR056C,
YMR166C, YMR253C, YMR279C, YNL003C, YNL065W, YNL070W, YNL083W, YNL095C,
YNL121C, YNL142W, YNL268W, YNR055C, YOL020W, YOL075C, YOL077W-A,
YOL122C, YOL158C, YOR079C, YOR087W, YOR092W, YOR100C, YOR130C, YOR153W,
YOR222W, YOR271C, YOR273C, YOR291W, YOR306C, YOR307C, YOR316C,
YOR332W, YOR334W, YOR348C, YPL036W, YPL078C, YPL270W, YPL274W, YPR003C,
YPR01 1C, YPR058W, YPR128C, and/or YPR201W. SEQ ID NOs, Uniprot Accession
Numbers, and gene names for each Ordered Locus can be found in Tables 5 , 6 , and 14. In
some embodiments, the above transporter genes and transcription factor genes regulate
excretion of steviol glycosides.
[0078] In some embodiments, deletion in a steviol glycoside-producing strain of
YDL128W (SEQ ID NO:22), YDL194W (SEQ ID NO:24), YDL210W (SEQ ID NO:25),
YDR536W (SEQ ID NO:30), YFL01 1W (SEQ ID NO:33), YGL006W (SEQ ID NO:34),
YGL013C (SEQ D NO:35), YGL255W (SEQ ID NO:36), YGR181W (SEQ D NO:38),
YGR217W (SEQ ID NO:39), YHL016C (SEQ ID NO:42), Y1L088C (SEQ ID NO:43),
YJL094C (SEQ ID NO:45), YJR106W (SEQ ID NO:48), YKR050W (SEQ ID N0:51 ) ,
YNL065W (SEQ ID NO:59), YNL083W (SEQ ID N0:61), YNL121C (SEQ ID NO:63),
YNL142W (SEQ ID NO:64), YOR291W (SEQ ID NO:74), YOR306C (SEQ D NO:75),
YOR334W (SEQ ID NO:77), YPL270W (SEQ ID NO:79), YPR01 1C (SEQ D NO:82),
YPR128C (SEQ ID NO:84) results in a measurable decrease of RebD excreted into the
culture medium, indicating that each plays a role in RebD excretion. See Example 3 and
Tables 7-10.
[0079] In some embodiments, deletion in a steviol glycoside-producing strain of
YBR180W (SEQ ID NO: 13), YAL067C (SEQ D NO: 14), YBR241C (SEQ ID NO: 17),
YCL069W (SEQ ID NO: 19), YCR075C (SEQ ID NO:21 ) , YDL128W (SEQ ID NO:22),
YDL194W (SEQ ID NO:24), YDR093W (SEQ ID NO:27), YDR338C (SEQ ID NO:28),
YDR406W (SEQ ID NO:29), YER166W (SEQ ID NO:32), YFL01 1W (SEQ ID NO:33),
YGL006W (SEQ ID NO:34), YGL013C (SEQ ID NO:35), YGL255W (SEQ D NO:36),
YGR217W (SEQ ID NO:39), YHL016C (SEQ ID NO:42), YJL094C (SEQ ID NO:45),
YJL212C (SEQ ID NO:47), YJR106W (SEQ ID NO:48), YJR160C (SEQ ID NO:49),
YKR050W (SEQ ID NO:51), YKR106W (SEQ ID NO:53), YML1 16W (SEQ ID NO:55),
YMR034C (SEQ ID NO:56), YMR056C (SEQ ID NO:57), YMR253C (SEQ ID NO:58),
YNL070W (SEQ ID NO:60), YNL083W (SEQ ID NO:61 ) , YNL095C (SEQ ID NO:62),
YNL121C (SEQ ID NO:63), YOL075C (SEQ ID NO:66), YOL122C (SEQ ID NO:68),
YOR087W (SEQ ID NO:70), YOR222W (SEQ ID NO:73), YOR291W (SEQ ID NO:74),
YOR306C (SEQ ID NO:75), YPL274W (SEQ ID NO:80), YPR003C (SEQ ID NO:81 ) ,
YPR01 1C (SEQ ID NO:82), or YPR201W (SEQ ID NO:85) results in a measurable decrease
of RebM, indicating that each plays a role in RebM excretion. See Example 3 and Tables 7-
10.
[0080] In some embodiments, overexpression of YGR181W (SEQ D NO:38) or
YDR061W (SEQ ID NO:26) improves RebD and RebM transport into the culture medium by
approximately 2-fold (-400-500 mg/L of supernatant RebD and RebM in YGR181W (SEQ ID
NO:38) and YDR061W (SEQ ID NO:26) overexpression strains versus -250 mg/L of
supernatant RebD and RebM in a control steviol glycoside-producing strain). See Example
4 , Figure 2 , and Figure 3.
[0081] In some embodiments, overexpression of a transporter of Table 11 increases
excretion of RebA, RebB, RebD, and/or RebM by at least 20%. In some embodiments,
overexpression of a transporter of Table 12 increases production of RebA, RebB, RebD,
and/or RebM by at least 40%. See Example 5.
[0082] In some embodiments, a transporter gene is integrated into the genome of a
steviol glycoside-producing host. In some embodiments, the integrated transporter is
YBR043C (SEQ ID NO:88), YEL027W (SEQ ID NO:102), YJL093C (SEQ ID NO:44),
YJR106W (SEQ D NO:48), YMR166C (SEQ ID NO:132), YIL166C (SEQ ID NO:121),
YKL120W (SEQ ID NO: 126), YDL054C (SEQ ID NO:94), YDL128W (SEQ ID NO:22),
YDR536W (SEQ D NO:30), YGL167C (SEQ ID NO:1 12), YKL146W (SEQ ID NO:127),
YKR039W (SEQ ID NO:129), YOL122C (SEQ ID NO:68), or YPR01 1C (SEQ ID NO:82). In
some embodiments, integration of YBR043C (SEQ ID NO:88), YEL027W (SEQ ID NO:102),
YJL093C (SEQ ID NO:44), YJR106W (SEQ ID NO:48), YKL120W (SEQ ID NO: 126), or
YMR166C (SEQ ID NO: 132) improves excretion and/or totai production of 13-SMG. In
some embodiments, integration of YBR043C (SEQ ID NO:88), YEL027W (SEQ ID NO:102),
or YMR166C (SEQ D NO: 132) improves excretion and/or total production of RebA. In some
embodiments, integration of YBR043C (SEQ ID NO:88), YEL027W (SEQ ID NO: 102), or
YMR166C (SEQ ID NO: 132) improves excretion and/or total production of RebB. In some
embodiments, integration of YBR043C of SEQ ID NO:88, YEL027W of SEQ ID NO: 102,
YJL093C of SEQ ID NO:44, YJR106W of SEQ ID NO:48, and YMR166C of SEQ ID NO: 132
improves excretion and/or total production of RebD, and YBR043C of SEQ ID NO:88,
YEL027W of SEQ ID NO:102, YIL166C (SEQ ID NO:121), YJL093C of SEQ ID NO:44,
YJR106W of SEQ ID NO:48, and YMR166C of SEQ ID NO: 132 improves excretion and/or
totai production of RebM, as measured by an increase in RebD and RebM levels in the
supernatant compared to a control steviol glycoside-producing strain. See Example 6 .
[0083] In some embodiments, steviol glycoside-producing S. cerevisiae strains
overexpressing YJL093C (SEQ ID NO:44) or YBR043C (SEQ ID NO:88) produce higher
levels of RebD + RebM, compared to a steviol glycoside-producing S. cerevisiae strain that
does not overexpress YJL093C or YBR043C. See Example 7 .
[0084] In some embodiments, a transporter that is knocked out can also have specificity
for transport of larger molecular weight steviol glycosides (for example, RebD and the
knockout of YGR181W of SEQ ID NO:38 or YOR291W of SEQ ID NO:74), and therefore,
can be useful to overexpress in strains where transport of RebD into the culture medium is
desired. With appropriate balancing of the rate of glycosylation activity through expression
of pathway UGTs, smaller molecular weight steviol glycosides are further glycosylated
before they are transported into the culture medium. For example, higher expression levels
of a UGT76G1 and UGT91D2e and/or EUGT1 1, as compared to the UGT74G1 and
UGT85C2 enzymes, can prevent accumulation of the steviol monoglucosides that are
transported more readily. If the UGT activity level is higher (so the glycosylation rate is
faster) than the rate of transport, then greater amounts of larger molecular weight steviol
glycosides will be produced.
Steviol a d Steviol Glycoside Biosynthesis Nucleic Acids
[0085] A recombinant gene encoding a polypeptide described herein comprises the
coding sequence for that polypeptide, operably linked in sense orientation to one or more
regulatory regions suitable for expressing the polypeptide. Because many microorganisms
are capable of expressing multiple gene products from a polycistronic mRNA, multiple
polypeptides can be expressed under the control of a single regulatory region for those
microorganisms, if desired. A coding sequence and a regulatory region are considered to be
operably linked when the regulatory region and coding sequence are positioned so that the
regulatory region is effective for regulating transcription or translation of the sequence.
Typically, the translation initiation site of the translational reading frame of the coding
sequence is positioned between one and about fifty nucleotides downstream of the
regulatory region for a monocistronic gene.
[0086] In many cases, the coding sequence for a polypeptide described herein is
identified in a species other than the recombinant host, i.e., is a heterologous nucleic acid.
Thus, if the recombinant host is a microorganism, the coding sequence can be from other
prokaryotic or eukaryotic microorganisms, from plants or from animals. In some case,
however, the coding sequence is a sequence that is native to the host and is being
reintroduced into that organism. A native sequence can often be distinguished from the
naturally occurring sequence by the presence of non-natural sequences linked to the
exogenous nucleic acid, e.g., non-native regulatory sequences flanking a native sequence in
a recombinant nucleic acid construct. In addition, stably transformed exogenous nucleic
acids typically are integrated at positions other than the position where the native sequence
is found. "Regulatory region" refers to a nucleic acid having nucleotide sequences that
influence transcription or translation initiation and rate, and stability and/or mobility of a
transcription or translation product. Regulatory regions include, without limitation, promoter
sequences, enhancer sequences, response elements, protein recognition sites, inducible
elements, protein binding sequences, 5 ' and 3 ' untranslated regions (UTRs), transcriptional
start sites, termination sequences, polyadenylation sequences, introns, and combinations
thereof. A regulatory region typically comprises at least a core (basal) promoter. A
regulatory region also may include at least one control element, such as an enhancer
sequence, a n upstream element or an upstream activation region (UAR). A regulatory region
is operably linked to a coding sequence by positioning the regulatory region and the coding
sequence so that the regulatory region is effective for regulating transcription or translation
of the sequence. For example, to operably link a coding sequence and a promoter
sequence, the translation initiation site of the translational reading frame of the coding
sequence is typically positioned between one and about fifty nucleotides downstream of the
promoter. A regulatory region can, however, be positioned as much as about 5,000
nucleotides upstream of the translation initiation site, or about 2,000 nucleotides upstream of
the transcription start site.
[0087] The choice of regulatory regions to be included depends upon several factors,
including, but not limited to, efficiency, selectability, inducibility, desired expression level, and
preferential expression during certain culture stages. It is a routine matter for one of skill in
the art to modulate the expression of a coding sequence by appropriately selecting and
positioning regulatory regions relative to the coding sequence. It will be understood that
more than one regulatory region may be present, e.g., introns, enhancers, upstream
activation regions, transcription terminators, and inducible elements.
[0088] One or more genes can be combined in a recombinant nucleic acid construct in
"modules" useful for a discrete aspect of steviol and/or steviol glycoside production.
Combining a plurality of genes in a module, particularly a polycistronic module, facilitates the
use of the module in a variety of species. For example, a steviol biosynthesis gene cluster,
or a UGT gene cluster, can be combined in a polycistronic module such that, after insertion
of a suitable regulatory region, the module can be introduced into a wide variety of species.
As another example, a UGT gene cluster can be combined such that each UGT coding
sequence is operably linked to a separate regulatory region, to form a UGT module. Such a
module can be used in those species for which monocistronic expression is necessary or
desirable. In addition to genes useful for steviol or steviol glycoside production, a
recombinant construct typically also comprises an origin of replication, and one or more
selectable markers for maintenance of the construct in appropriate species.
[0089] It will be appreciated that because of the degeneracy of the genetic code, a
number of nucleic acids can encode a particular polypeptide; i.e., for many amino acids,
there is more than one nucleotide triplet that serves as the codon for the amino acid. Thus,
codons in the coding sequence for a given polypeptide can be modified such that optimal
expression in a particular host is obtained, using appropriate codon bias tables for that host
(e.g., microorganism). As isolated nucleic acids, these modified sequences can exist as
purified molecules and can be incorporated into a vector or a virus for use in constructing
modules for recombinant nucleic acid constructs.
[0090] In some cases, it is desirable to inhibit one or more functions of an endogenous
polypeptide in order to divert metabolic intermediates towards steviol or steviol glycoside
biosynthesis. For example, it may be desirable to downregulate synthesis of sterols in a
strain in order to further increase steviol or steviol glycoside production, e.g., by
downregulating squalene epoxidase. As another example, it may be desirable to inhibit
degradative functions of certain endogenous gene products, e.g., glycohydrolases that
remove glucose moieties from secondary metabolites or phosphatases as discussed herein.
As another example, expression of membrane transporters involved in transport of steviol
glycosides can be activated, such that transportation of steviol glycosides is increased.
Such regulation can be beneficial in that transportation of steviol glycosides can be
increased for a desired period of time during culture of the microorganism, thereby
increasing the yield of glycoside product(s) at harvest. In such cases, a nucleic acid that
overexpresses the polypeptide or gene product may be included in a recombinant construct
that is transformed into the strain. Alternatively, mutagenesis can be used to generate
mutants in genes for which it is desired to increase or enhance function.
Recombinant Hosts
[0091] Recombinant hosts can be used to express polypeptides for the producing steviol
glycosides, including mammalian, insect, plant, and algal cells. A number of prokaryotes
and eukaryotes are also suitable for use in constructing the recombinant microorganisms
described herein, e.g., gram-negative bacteria, yeast, and fungi. A species and strain
selected for use as a steviol glycoside production strain is first analyzed to determine which
production genes are endogenous to the strain and which genes are not present. Genes for
which an endogenous counterpart is not present in the strain are advantageously assembled
in one or more recombinant constructs, which are then transformed into the strain in order to
supply the missing function(s).
[0092] Typically, the recombinant microorganism is grown in a fermenter at a defined
temperature(s) for a desired period of time. The constructed and genetically engineered
microorganisms provided by the invention can be cultivated using conventional fermentation
processes, including, inter alia, chemostat, batch, fed-batch cultivations, semi-continuous
fermentations such as draw and fill, continuous perfusion fermentation, and continuous
perfusion cell culture. Depending on the particular microorganism used in the method, other
recombinant genes such as isopentenyl biosynthesis genes and terpene synthase and
cyclase genes may also be present and expressed. Levels of substrates and intermediates,
e.g., isopentenyl diphosphate, dimethylallyl diphosphate, GGPP, kaurene and kaurenoic
acid, can be determined by extracting samples from culture media for analysis according to
published methods.
[0093] Carbon sources of use in the instant method include any molecule that can be
metabolized by the recombinant host cell to facilitate growth and/or production of the steviol
glycosides. Examples of suitable carbon sources include, but are not limited to, sucrose
(e.g., as found in molasses), fructose, xylose, ethanol, glycerol, glucose, cellulose, starch,
cellobiose or other glucose-comprising polymer. In embodiments employing yeast as a host,
for example, carbon sources such as sucrose, fructose, xylose, ethanol, glycerol, and
glucose are suitable. The carbon source can be provided to the host organism throughout
the cultivation period or alternatively, the organism can be grown for a period of time in the
presence of another energy source, e.g., protein, and then provided with a source of carbon
only during the fed-batch phase.
[0094] After the recombinant microorganism has been grown in culture for the desired
period of time, steviol and/or one or more steviol glycosides can then be recovered from the
culture using various techniques known in the art. In some embodiments, a permeabilizing
agent can be added to aid the feedstock entering into the host and product getting out. For
example, a crude lysate of the cultured microorganism can be centrifuged to obtain a
supernatant. The resulting supernatant can then be applied to a chromatography column,
e.g., a C-18 column, and washed with water to remove hydrophilic compounds, followed by
elution of the compound(s) of interest with a solvent such as methanol. The compound(s)
can then be further purified by preparative HPLC. See also, WO 2009/140394.
[0095] it will be appreciated that the various genes and modules discussed herein can
be present in two or more recombinant hosts rather than a single host. When a plurality of
recombinant hosts is used, they can be grown in a mixed culture to produce steviol and/or
steviol glycosides.
[0096] Alternatively, the two or more hosts each can be grown in a separate culture
medium and the product of the first culture medium, e.g., steviol, can be introduced into
second culture medium to be converted into a subsequent intermediate, or into an end
product such as, for example, RebA. The product produced by the second, or final host is
then recovered. It will also be appreciated that in some embodiments, a recombinant host is
grown using nutrient sources other than a culture medium and utilizing a system other than a
fermenter.
[0097] Exemplary prokaryotic and eukaryotic species are described in more detail
below. However, it will be appreciated that other species can be suitable. For example,
suitable species can be in a genus such as Agaricus, Aspergillus, Bacillus, Candida,
Corynebacterium, Eremothecium, Escherichia, Fusarium/Gibberella , Kluyveromyces,
Laetiporus, Lentinus, Phaffia, Phanerochaete, Pichia, Physcomitreila, Rhodoturula,
Saccharomyces, Schizosaccharomyces, Sphaceloma, Xanthophyilomyces or Yarrowia.
Exemplary species from such genera include Lentinus tigrinus, Laetiporus sulphureus,
Phanerochaete chrysosporium, Pichia pastoris, Cyberlindnera jadinii, Physcomitreila patens,
Rhodoturula giutinis, Rhodoturula mucilaginosa, Phaffia rhodozyma, Xanthophyilomyces
dendrorhous, Fusarium fujikuroi/Gibberella fujikuroi, Candida utilis, Candida glabrata,
Candida albicans, and Yarrowia lipolytica.
[0098] In some embodiments, a microorganism can be a prokaryote such as Escherichia
coli.
[0099] In some embodiments, a microorganism can be an Ascomycete such as
Gibberella fujikuroi, Kluyveromyces lactis, Schizosaccharomyces pombe, Aspergillus niger,
Yarrowia lipolytica, Ashbya gossypii, or S. cerevisiae.
[00100] In some embodiments, a microorganism can be an algal cell such as Blakeslea
trispora, Dunaliella salina, Haematococcus pluvialis, Chlorella sp., Undaria pinnatifida,
Sargassum, Laminaria japonica, Scenedesmus almeriensis species.
[001 01] In some embodiments, a microorganism can be a cyanobacterial cell such as
Blakeslea trispora, Dunaliella salina, Haematococcus pluvialis, Chlorella sp., Undaria
pinnatifida, Sargassum, Laminaria japonica, Scenedesmus almeriensis.
Saccharomyces spp.
[001 02] Saccharomyces is a widely used chassis organism in synthetic biology, and can
be used as the recombinant microorganism platform. For example, there are libraries of
mutants, plasmids, detailed computer models of metabolism and other information available
for S. cerevisiae, allowing for rational design of various modules to enhance product yield.
Methods are known for making recombinant microorganisms.
Aspergillus spp.
[00103] Aspergillus species such as A. oryzae, A. niger and A. sojae are widely used
microorganisms in food production and can also be used as the recombinant microorganism
platform. Nucleotide sequences are available for genomes of A. nidulans, A. fumigatus, A.
oryzae, A. clavatus, A. flavus, A. niger, and A. terreus, allowing rational design and
modification of endogenous pathways to enhance flux and increase product yield. Metabolic
models have been developed for Aspergillus, as well as transcriptomic studies and
proteomics studies. A. niger is cultured for the industrial production of a number of food
ingredients such as citric acid and gluconic acid, and thus species such as A. niger are
generally suitable for producing steviol glycosides.
E. coli
[00104] E. coli, another widely used platform organism in synthetic biology, can also be
used as the recombinant microorganism platform. Similar to Saccharomyces, there are
libraries of mutants, plasmids, detailed computer models of metabolism and other
information available for E. coli, allowing for rational design of various modules to enhance
product yield. Methods similar to those described above for Saccharomyces can be used to
make recombinant E. coli microorganisms.
[00105] Agaricus, Gibberella. and Phanerochaete spp.
[00106] Agaricus, Gibberella, and Phanerochaete spp. can be useful because they are
known to produce large amounts of isoprenoids in culture. Thus, the terpene precursors for
producing large amounts of steviol glycosides are already produced by endogenous genes.
Thus, modules comprising recombinant genes for steviol glycoside biosynthesis
polypeptides can be introduced into species from such genera without the necessity of
introducing mevalonate or MEP pathway genes.
Arxula adeninivorans (Blastobotrvs adeninivorans)
[00107] Arxula adeninivorans is dimorphic yeast (it grows as budding yeast like the
baker's yeast up to a temperature of 42°C, above this threshold it grows in a filamentous
form) with unusual biochemical characteristics. It can grow on a wide range of substrates
and can assimilate nitrate. It has successfully been applied to the generation of strains that
can produce natural plastics or the development of a biosensor for estrogens in
environmental samples.
Yarrowia lipolvtica
[00108] Yarrowia lipolytica is dimorphic yeast (see Arxula adeninivorans) and belongs to
the family Hemiascomycetes. The entire genome of Yarrowia lipolytica is known. Yarrowia
species is aerobic and considered to be non-pathogenic. Yarrowia is efficient in using
hydrophobic substrates (e.g. alkanes, fatty acids, oils) and can grow on sugars. It has a high
potential for industrial applications and is an oleaginous microorgamism. Yarrowia lipolyptica
can accumulate lipid content to approximately 40% of its dry cell weight and is a model
organism for lipid accumulation and remobilization. See e.g., Nicaud, 2012, Yeast
29(10):409-18; Beopoulos et al., 2009, Biohimie 91(6):692-6; Bankar et al., 2009, Appl
Microbiol Biotechnol. 84(5):847-65.
Rhodotorula sp.
[00109] Rhodotorula is unicellular, pigmented yeast. The oleaginous red yeast,
Rhodotorula glutinis, has been shown to produce lipids and carotenoids from crude glycerol
(Saenge et al., 201 , Process Biochemistry 46(1 ):21 0-8). Rhodotorula toruloides strains
have been shown to be an efficient fed-batch fermentation system for improved biomass and
lipid productivity (Li et a!., 2007, Enzyme and Microbial Technology 4 1:312-7).
Rhodosporidium toruloides
[00110] Rhodosporidium toruloides is oleaginous yeast and useful for engineering lipid-
production pathways (See e.g. Zhu et a/., 2013, Nature Commun. 3:1 112; Ageitos er a/.,
201 1, Applied Microbiology and Biotechnology 90(4): 1219-27).
Candida boidinii
[00111] Candida boidinii is methylotrophic yeast (it can grow on methanol). Like other
methylotrophic species such as Hansenula polymorpha and Pichia pastoris, it provides an
excellent platform for producing heterologous proteins. Yields in a multigram range of a
secreted foreign protein have been reported. A computational method, IPRO, recently
predicted mutations that experimentally switched the cofactor specificity of Candida boidinii
xylose reductase from NADPH to NADH. See, e.g., Mattanovich et al., 2012, Methods Mol
Biol. 824:329-58; Khoury et al., 2009, Protein Sci. 18(1 0):21 25-38.
Hansenula polymorpha (Pichia angusta)
[00112] Hansenula polymorpha is methylotrophic yeast (see Candida boidinii). It can
furthermore grow on a wide range of other substrates; it is thermo-tolerant and can
assimilate nitrate (see also Kluyveromyces lactis). It has been applied to producing hepatitis
B vaccines, insulin and interferon alpha-2a for the treatment of hepatitis C, furthermore to a
range of technical enzymes. See, e.g., Xu et al., 2014, Virol Sin. 29(6):403-9.
Kluyveromyces lactis
[00113] Kluyveromyces lactis is yeast regularly applied to the production of kefir. It can
grow on several sugars, most importantly on lactose which is present in milk and whey. It
has successfully been applied among others for producing chymosin (an enzyme that is
usually present in the stomach of calves) for producing cheese. Production takes place in
fermenters on a 40,000 L scale. See, e.g., van Ooyen et al., 2006, FEMS Yeast Res.
6(3):381-92.
Pichia pastoris
[00114] Pichia pastoris is methylotrophic yeast (see Candida boidinii and Hansenula
polymorpha). It provides an efficient platform for producing foreign proteins. Platform
elements are available as a kit and it is worldwide used in academia for producing proteins.
Strains have been engineered that can produce complex human N-glycan (yeast glycans are
similar but not identical to those found in humans). See, e.g., Piirainen et al., 2014, N
Biotechnol. 31(6):532-7.
Physcomitrella S D.
[00115] Physcomitrella mosses, when grown in suspension culture, have characteristics
similar to yeast or other fungal cultures. This genera can be used for producing plant
secondary metabolites, which can be difficult to produce in other types of cells.
Steviol Glycoside Compositions
[00116] Steviol glycosides do not necessarily have equivalent performance in different
food systems. It is therefore desirable to have the ability to direct the synthesis to steviol
glycoside compositions of choice. Recombinant hosts described herein can produce
compositions that are selectively enriched for specific steviol glycosides (e.g., RebD) and
have a consistent taste profile. Thus, the recombinant hosts described herein can facilitate
the production of compositions that are tailored to meet the sweetening profile desired for a
given food product and that have a proportion of each steviol glycoside that is consistent
from batch to batch. Hosts described herein do not produce the undesired plant by-products
found in Stevia extracts. Thus, steviol glycoside compositions produced by the recombinant
hosts described herein are distinguishable from compositions derived from Stevia plants.
[00117] The amount of an individual steviol glycoside (e.g., RebA, RebB, RebD, or RebM)
produced can be from about 1 mg/L to about 2,800 mg/L, e.g., about 1 to about 10 mg/L,
about 3 to about 10 mg/L, about 5 to about 20 mg/L, about 10 to about 50 mg/L, about 10 to
about 100 mg/L, about 25 to about 500 mg/L, about 100 to about 1,500 mg/L, or about 200
to about 1,000 mg/L, at least about 1,000 mg/L, at least about 1,200 mg/L, at least about at
least 1,400 mg/L, at least about 1,600 mg/L, at least about 1,800 mg/L, or at least about
2,800 mg/L. In some aspects, the amount of an individual steviol glycoside can exceed
2,800 mg/L. The amount of a combination of steviol glycosides (e.g., RebA, RebB, RebD, or
RebM) produced can be from about 1 mg/L to about 6,000 mg/L, e.g., about 200 to about
,500, at least about 2,000 mg/L, at least about 3,000 mg/L, at least about 4,000 mg/L, at
least about 5,000 mg/L, or at least about 6,000 mg/L. In some aspects, the amount of a
combination of steviol glycosides can exceed 6,000 mg/L. In general, longer culture times
will lead to greater amounts of product. Thus, the recombinant microorganism can be
cultured for from 1 day to 7 days, from 1 day to 5 days, from 3 days to 5 days, about 3 days,
about 4 days, or about 5 days.
[00 8] It will be appreciated that the various genes and modules discussed herein can
be present in two or more recombinant microorganisms rather than a single microorganism.
When a plurality of recombinant microorganisms is used, they can be grown in a mixed
culture to produce stevioi and/or stevioi glycosides. For example, a first microorganism can
comprise one or more biosynthesis genes for producing stevioi and null mutations in a first
group of endogenous transporters, while a second microorganism comprises stevioi
glycoside biosynthesis genes and null mutations in a second group of endogenous
transporters. The product produced by the second, or final microorganism is then
recovered, it will also be appreciated that in some embodiments, a recombinant
microorganism is grown using nutrient sources other than a culture medium and utilizing a
system other than a fermenter.
[00119] Alternatively, the two or more microorganisms each can be grown in a separate
culture medium and the product of the first culture medium, e.g., stevioi, can be introduced
into second culture medium to be converted into a subsequent intermediate, or into an end
product such as RebA. The product produced by the second, or final microorganism is then
recovered. The microorganisms can have the same or a different group of mutations in
endogenous transporters. It will also be appreciated that in some embodiments, a
recombinant microorganism is grown using nutrient sources other than a culture medium
and utilizing a system other than a fermenter.
[00120] Stevioi glycosides do not necessarily have equivalent performance in different
food systems. It is therefore desirable to have the ability to direct the synthesis to stevioi
glycoside compositions of choice. Recombinant hosts described herein can produce
compositions that are selectively enriched for specific stevioi glycosides (e.g., RebD) and
have a consistent taste profile. Thus, the recombinant microorganisms described herein can
facilitate the production of compositions that are tailored to meet the sweetening profile
desired for a given food product and that have a proportion of each stevioi glycoside that is
consistent from batch to batch. Microorganisms described herein do not produce the
undesired plant byproducts found in Stevia extracts. Thus, stevioi glycoside compositions
produced by the recombinant microorganisms described herein are distinguishable from
compositions derived from Stevia plants.
[00121] Stevioi glycosides and compositions obtained by the methods disclosed herein
can be used to make food products, dietary supplements and sweetener compositions. See,
e.g., WO 201 1/153378, WO 2013/022989, WO 2014/122227, and WO 2014/122328, each of
which has been incorporated by reference in its entirety.
[00122] For example, substantially pure steviol or steviol glycoside such as RebM or
RebD can be included in food products such as ice cream, carbonated beverages, fruit
juices, yogurts, baked goods, chewing gums, hard and soft candies, and sauces.
Substantially pure steviol or steviol glycoside can also be included in non-food products such
as pharmaceutical products, medicinal products, dietary supplements and nutritional
supplements. Substantially pure steviol or steviol glycosides may also be included in animal
feed products for both the agriculture industry and the companion animal industry.
Alternatively, a mixture of steviol and/or steviol glycosides can be made by culturing
recombinant microorganisms separately, each producing a specific steviol or steviol
glycoside, recovering the steviol or steviol glycoside in substantially pure form from each
microorganism and then combining the compounds to obtain a mixture comprising each
compound in the desired proportion. The recombinant microorganisms described herein
permit more precise and consistent mixtures to be obtained compared to current Stevia
products. For example, recombinant microorganisms described herein can express
transporters specific for transport of a particular rebaudioside into the culture medium.
When a transporter is specific for a particular rebaudioside it will enrich the concentration of
that compound in the fermentation broth, preventing it from being further reacted to a
different compound, and by selectively transporting the rebaudioside into the fermentation
broth it will make it easier to recover from the other rebaudiosides and therefore making the
process more efficient.
[00123] In another alternative, a substantially pure steviol or steviol glycoside can be
incorporated into a food product along with other sweeteners, e.g. saccharin, dextrose,
sucrose, fructose, erythritol, aspartame, sucralose, monatin, or acesulfame potassium. The
weight ratio of steviol or steviol glycoside relative to other sweeteners can be varied as
desired to achieve a satisfactory taste in the final food product. See, e.g. , U.S.
2007/01 2831 1. In some embodiments, the steviol or steviol glycoside may be provided with
a flavor (e.g., citrus) as a flavor modulator.
[00124] Compositions produced by a recombinant microorganism described herein can
be incorporated into food products. For example, a steviol glycoside composition produced
by a recombinant microorganism can be incorporated into a food product in an amount
ranging from about 20 mg steviol glycoside/kg food product to about 800 mg steviol
glycoside/kg food product on a dry weight basis, depending on the type of steviol glycoside
and food product. For example, a steviol glycoside composition produced by a recombinant
microorganism can be incorporated into a dessert, cold confectionary (e.g., ice cream), dairy
product (e.g., yogurt), or beverage (e.g. , a carbonated beverage) such that the food product
has a maximum of 500 mg steviol glycoside/kg food on a dry weight basis. A steviol
glycoside composition produced by a recombinant microorganism can be incorporated into a
baked good (e.g., a biscuit) such that the food product has a maximum of 300 mg steviol
glycoside/kg food on a dry weight basis. A steviol glycoside composition produced by a
recombinant microorganism can be incorporated into a sauce (e.g., chocolate syrup) or
vegetable product (e.g., pickles) such that the food product has a maximum of 1000 mg
steviol glycoside/kg food on a dry weight basis. A steviol glycoside composition produced by
a recombinant microorganism can be incorporated into a bread such that the food product
has a maximum of 160 mg steviol glycoside/kg food on a dry weight basis. A steviol
glycoside composition produced by a recombinant microorganism, plant, or plant cell can be
incorporated into a hard or soft candy such that the food product has a maximum of 600 mg
steviol glycoside/kg food on a dry weight basis. A steviol glycoside composition produced by
a recombinant microorganism, plant, or plant cell can be incorporated into a processed fruit
product (e.g., fruit juices, fruit filling, jams, and jellies) such that the food product has a
maximum of 1000 mg steviol glycoside/kg food on a dry weight basis.
[00125] For example, such a steviol glycoside composition can have from 90-99% RebA
and an undetectable amount of stevia plant-derived contaminants, and be incorporated into
a food product at from 25-1600 mg/kg, e.g., 100-500 mg/kg, 25-100 mg/kg, 250-1000 mg/kg,
50-500 mg/kg or 500-1000 mg kg on a dry weight basis.
[00126] Such a steviol glycoside composition can be a RebB-enriched composition
having greater than 3% RebB and be incorporated into the food product such that the
amount of RebB in the product is from 25-1600 mg/kg, e.g., 100-500 mg/kg, 25-100 mg/kg,
250-1000 mg/kg, 50-500 mg/kg or 500-1000 mg/kg on a dry weight basis. Typically, the
RebB-enriched composition has an undetectable amount of stevia plant-derived
contaminants.
[00127] Such a steviol glycoside composition can be a RebD-enriched composition
having greater than 3% RebD and be incorporated into the food product such that the
amount of RebD in the product is from 25-1600 mg/kg, e.g., 100-500 mg/kg, 25-100 mg/kg,
250-1000 mg/kg, 50-500 mg/kg or 500-1000 mg/kg on a dry weight basis. Typically, the
RebD-enriched composition has an undetectable amount of stevia plant-derived
contaminants.
[00128] Such a steviol glycoside composition can be a RebE-enriched composition
having greater than 3% RebE and be incorporated into the food product such that the
amount of RebE in the product is from 25-1600 mg/kg, e.g., 100-500 mg/kg, 25-100 mg/kg,
250-1000 mg/kg, 50-500 mg/kg or 500-1000 mg/kg on a dry weight basis. Typically, the
RebE-enriched composition has an undetectable amount of stevia plant-derived
contaminants.
[00129] Such a steviol glycoside composition can be a RebM-enriched composition
having greater than 3% RebM and be incorporated into the food product such that the
amount of RebM in the product is from 25-1600 mg/kg, e.g., 100-500 mg/kg, 25-100 mg/kg,
250-1000 mg/kg, 50-500 mg/kg or 500-1000 mg/kg on a dry weight basis. Typically, the
RebM-enriched composition has an undetectable amount of stevia plant-derived
contaminants.
[00130] In some embodiments, a substantially pure steviol or steviol glycoside is
incorporated into a tabletop sweetener or "cup-for-cup" product. Such products typically are
diluted to the appropriate sweetness level with one or more bulking agents, e.g.,
maltodextrins, known to those skilled in the art. Steviol glycoside compositions enriched for
RebA, RebB, RebD, RebE, or RebM, can be package in a sachet, for example, at from
10,000 to 30,000 g steviol glycoside/kg product on a dry weight basis, for tabletop use.
[00131] The invention will be further described in the following examples, which do not
limit the scope of the invention described in the claims.
EXAMPLES
[00132] The Examples that follow are illustrative of specific embodiments of the invention,
and various uses thereof. They are set forth for explanatory purposes only, and are not to
be taken as limiting the invention.
Example 1. LC-MS Analytical Procedures
[00133] The LC-MS methods described here are oriented towards the separation, general
detection and potential identification of chemicals of particular masses (i.e. steviol
glycosides) in the presence of a mixture (i.e. culture media). LC-MS analyses were
performed on: (A) an UltiMate® 3000-TSQ (Thermo Fisher Scientific); (B) a 290 Infitity -
6130SQ (Agilent); or (C) an Acquity -XevoTQD (Waters) sytem. Specific methods used for
each system are described below.
[00134] Method A: LC-MS analyses were performed using an UltiMate® 3000 UPLC
system (Dionex) fitted with a waters ACQUITY UPLC® BEH shield RP18 column (2.1 x 50
mm, 1.7 m particles, 130 A pore size) connected to a TSQ Quantum® Access
(ThermoFisher Scientific) triple quadropole mass spectrometer with a heated electrospray
ion (HESI) source, unless otherwise indicated. Elution was carried out using a mobile phase
of eluent B (MeCN with 0.1% Formic acid) and eluent A (water with 0.1% Formic acid) by
increasing the gradient from 25% to 47 % B from min. 0.0 to 4.0, increasing 47% to 00% B
in min. 4.0 to 5.0, holding 00% B from min. 5.0 to 6.5 re-equilibration. The flow rate was
0.4 mlJmin and the column temperature 35°C. The steviol glycosides were detected using
SIM (Single Ion Monitoring) with the following m/z-traces.
Table 1. MS analytical information for Steviol Glycosides
[00135] The levels of steviol glycosides were quantified by comparing with calibration
curves obtained with authentic standards from LGC Standards. For example, standard
solutions of 0.5 to 100 µΜ RebA were typically utilized to construct a calibration curve.
[00136] Method B: A second analytical method was performed on the Agilent system
1290 Infinity fitted with a waters ACQUiTY UPLC® BEH shield RP18 column (2.1 x 50 mm,
1.7 µ η particles, 130 A pore size, Waters) was connected to a 6130 single quadrupol mass
detector (Agilent) with a APCI ion source. Elution was carried out using a mobile phase of
eiuent B (MeCN with 0.1% Formic acid) and eluent A (water with 0.1% Formic acid) by
increasing the gradient from 23% to 47 % B from min. 0.0 to 4.0, increasing 47% to 100% B
in min. 4.0 to 5.0, holding 100% B from min. 5.0 to 6.5 re-equilibration. The flow rate was
0.6 mL/min and the column temperature 50°C. The steviol glycosides were detected using
SIM (Single Ion Monitoring) with the following m/z-traces.
Table 2. MS analytical information for Steviol Glycosides
1289.5281 + 6 Glucose
1.51-1.90 687.3 [M+HCOOH-H]- Steviol Rubusoside
min 687.3217 + 2 Glucose
1.90-5.0 min 641.0 [M-H] Steviol 1.2-Stevioside (1.44)
641 .3168 + 2 Glucose 1.3-stevioside ( 1 .74)
2 0.0-1.0 min 1127.4 [M-H] Steviol RebD (0.81)
1127,4752 + 5 Glucose
1.0-5.0 min 525.3 [M-HCOOH-H]- Steviol 19SMG (2.49)
525.2689 + 1 Glucose 13SMG (2.65)
3 0.0-2.8 min 965.4 [M-H]- 965.4224 Steviol RebA (1.42)
+ 4 Glucose
4 0.0-3.2 min 803.4 [M-H] Steviol 1.2-Stevioside (2.16)
803.3696 + 2 Glucose 1.3-Stevioside (2.34)
RebB (2.13)
[00137] The levels of steviol glycosides were quantified by comparing with calibration
curves obtained with authentic standards from LGC Standards. For example, standard
solutions of 0.3 to 25 µΜ RebA were typically utilized to construct a calibration curve.
[00138] Method C: A third analytical method used was LC-MS analyses performed using
a Waters ACQUITY UPLC (Waters Corporation, Miiford, MA) with Waters ACQUITY UPLC®
BEH C18 column (2.1 x 50 mm, 1.7 µη particles, 130 A pore size) coupled to a Waters
ACQUITY TQD triple quadropoie mass spectrometer with electrospray ionization (ESI) in
negative mode. Compound separation was achieved by a gradient of the two mobile
phases A (water with 0.1% formic acid ) and B (MeCN with 0.1% formic acid) by increasing
from 20% to 50 % B between 0.3 to 2.0 min, increasing to 100% B at 2.01 min, holding
100% B for 0.6 min and re-equilibrate for another 0.6 min. The flow rate was 0.6 mL/min
and the column temperature 55°C. RebD (m/z 1127.5), RebM (m/z 1289.5), redaudioside A
(m/z 965.4) and RebB (m/z 803.4) were monitored using SIM (Single Ion Monitoring) and
quantified by comparing with authentic standards.
Example 2. Construction of a Steviol Glycoside-Producing Yeast Strain
[00139] Steviol glycoside-producing S. cerevisiae strains were constructed as described
in WO 201 1/153378, WO 2013/022989, WO 2014/122227, and WO 2014/122328, each of
which is incorporated by reference in its entirety. For example, a yeast strain comprising a
recombinant gene encoding a Synechococcus sp. GGPPS polypeptide (SEQ D NO:1, SEQ
ID NO: 149), a recombinant gene encoding a truncated Zea mays CDPS polypeptide (SEQ
ID NO:2, SEQ ID NO:150), a recombinant gene encoding an A. thaliana KS polypeptide
(SEQ ID NO:3, SEQ ID NO: 151), a recombinant gene encoding a recombinant S.
rebaudiana K01 polypeptide (SEQ ID NO:4, SEQ ID NO: 152), a recombinant gene encoding
an A. thaliana ATR2 polypeptide (SEQ ID NO:5, SEQ ID NO: 153), a recombinant gene
encoding an O. sativa EUGT1 1 polypeptide (SEQ ID NO: 12; SEQ ID NO: 148), a
recombinant gene encoding an SrKAHel polypeptide (SEQ ID NO:6, SEQ ID NO:154), a
recombinant gene encoding an S. rebaudiana CPR8 polypeptide (SEQ D NO:7, SEQ ID
NO:155), a recombinant gene encoding an S. rebaudiana UGT85C2 polypeptide (SEQ ID
NO:8, SEQ ID NO:156), a recombinant gene encoding an S. rebaudiana UGT74G1
polypeptide (SEQ ID NO:9, SEQ ID NO:157), a recombinant gene encoding an S.
rebaudiana UGT76G1 polypeptide (SEQ D NO: 10, SEQ D NO: 158), and a recombinant
gene encoding an S. rebaudiana UGT91D2 variant (or functional homolog), UGT91D2e-b
(SEQ ID NO:1 1, SEQ ID NO: 159) polypeptide produced steviol glycosides. As analyzed by
LC- S (Method C) following DMSO-extraction of total steviol glycosides from the whole cell
and broth mixture (total production), the strain produced between 18-21 g/mL or 1-1 .5
g/ LJODeoo RebM after growth for five days in 1 mL SC (Synthetic Complete) media at
30°C with 400 rpm shaking in deep-well plates. See Table 3 .
Table 3. Steviol glycoside production in a representative S. cerevisiae strain
comprising genes encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT11,
SrKAHel, CPR8, UGT85C2, UGT74G1, UGT76G1, and EUGT11 polypeptides.
[00140] A second strain, which comprised additional copies of the genes of the first strain,
was analyzed for steviol glycoside production. The second strain produced RebD and RebM
as primary steviol glycosides, although at higher levels than the first strain.
[00141] As analyzed by LC-MS (Method C) following DMSO-extraction of total steviol
glycosides from the whole cell and broth mixture (total production), the second strain
produced between 60-80 pg/mL or 4-6 g/mLJOD6oo RebM, after growth for five days in 1 m L
SC media at 30°C with 400 rpm shaking in deep-well plates. Production of RebA, RebB,
RebD and RebM by the second strain is shown in Table 4 .
Table 4. Steviol glycoside production i a S. cerevisiae strain comprising additional
copies of genes encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT11,
SrKAHe-l, CPR8, UGT85C2, UGT74G1, UGT76G1, and EUGT11 polypeptides.
Example 3. Knockout of Yeast Endogenous Transport Genes and Transport-Related
Genes
[00142] Observations from deep-well studies of Example 2 and similar strains indicated
that the fraction of RebA, RebB, RebD or RebM in the supernatant changes with time, and
the effect was determined not to be the result of cell lysis. To determine the effect of various
transporters on steviol glycoside excretion in S. cerevisiae, deletion cassettes for
homologous recombination were obtained by designing primers annealing approximately
200 bp upstream and downstream of the open reading frame (ORF) and then amplifying the
ORF-specific deletion cassette from the S. cerevisiae deletion collection. The candidate
genes selected include identified ORFs with relation to transport or comprising membrane
spanning domains, regardless of subcellular localization. In the resulting colonies, the
presence of the deletion cassette at the correct locus was verified by colony PGR. A
maximum of 6 clones of each deletion was frozen down as freezer stock. All samples for
analysis were initiated from the freezer stock and grown in SC medium for 5 days (30°C,
shaking 400 rpm) prior to harvest and extraction of samples for LC-MS. Samples were
analyzed for the presence of RebA, RebB, RebD and RebM in the culture broth lacking cells
(Supernatant) as well as in the whole cell and broth mixture (Total production).
[00143] Concentrations of total and supernatant RebA, RebB, RebD and RebM were
compared to the levels in a control steviol glycoside-producing strain. The amounts of
RebA, RebB, RebD and RebM in each sample were normalized to the control strain by
dividing the value of a particular steviol glycoside with the corresponding value for the control
strain, thereby calculating a percentage to the control strain, where 1 equals 100 percent.
The "ideal candidate" would exhibit a decrease in RebA, RebB, RebD and/or RebM levels in
the supernatant, as compared to the control steviol glycoside-producing strain, without
decreasing RebA, RebB, RebD, and/or RebM total production.
[00144] The effect of yeast gene knockouts on transport of higher molecular weight
steviol glycosides into the culture medium was tested in a strain that produces steviol
glycosides, such as the strains described in Example 2 . Disruption of each specific
transporter gene was performed by homologous recombination. After 5 days of growth in 1
L SC medium at 30°C and 400 rpm, cells were harvested. A 50 µ Ι aliquot of the culture
was mixed with an equal volume of 100% DMSO, vortexed, and heated to 80°C for 10 min.
The suspension was then centrifuged to remove cell debris. 60 L of the mixture were
analyzed by LC-MS as the "Total" sample. The remaining culture was then centrifuged to
pellet cells. An aliquot of 50 µ Ι_was removed from the supernatant (i.e., the culture medium)
and mixed with an equal volume of 100% DMSO. The suspension was heated to 80°C for
10 min and centrifuged. 60 pL of the the mixture were analysed by LC-MS as the
"Supernatant" sample. The amounts of higher molecular weight steviol glycosides (including
RebA, RebB, RebD, RebM) were measured by LC-MS (Method C), as described in Example
1.
[00145] The data demonstrate that disruption of a single endogenous yeast transporter
gene in a steviol glycoside-producing strain resulted in a decrease in the level of various
steviol glycosides in the supernatant of the culture media, as evaluated by the normalized
amount transported into the supernatant (see Tables 5-10). Tables 5-10 comprise lists of
transport related genes that were knocked out in a steviol glycoside-producing strain. More
specifically, Table 5 comprises a compiled list of genes by ordered locus name found to
affect steviol glycoside excretion in steviol glycoside-producing strains and are therefore
identified as having a role in steviol glycoside excretion. When the specified genes were
knocked out, a more than 40% decrease in either the supernatant alone or in the ratio of
supernatant/total production of RebA, RebB, RebD, and/or RebM was observed. This
corresponded approximately to more than 2 standard deviations removed from the mean of
a control steviol glycoside-producing strain (a value of 1 equals 100 percent of the control
strain, whereas a value of 0.5 indicates a 50% decrease).
[00146] Table 6 comprises a compiled list of genes by ordered locus name found to affect
steviol glycoside excretion in steviol glycoside-producing strains and are therefore identified
as having a role in steviol glycoside excretion. When knocked out, these genes caused a
mean of between 20-40% decrease in either the supernatant alone or in the ratio of
supernatant/total production. This corresponded to approximately between 1 and 2 standard
deviations removed from the mean of the control strain (a value of 1 equals 100 percent of
the control strain, whereas a value of 0.5 indicates a 50% decrease).
Table 5A. Transport related genes with over a 40% decrease in Reb A, RebB, RebD or
RebM levels compared to a control steviol glycoside-producing strain.
Table 5B. Continued list of Transport related genes with over a 40% decrease in Reb
A, RebB, RebD or RebM levels compared to a control steviol glycoside-producing
strain.
Table 6A. Transport related genes with a 20-40% decrease in Reb A, RebB, RebD or
RebM levels compared to a control steviol glycoside-producing strain.
Table 6B. Continued list of Transport related genes with a 20-40% decrease in Reb A,
RebB, RebD or RebM levels compared to a control steviol glycoside-producing strain.
[00147] Steviol glycoside exporter candidates were selected from the data based on two
selection criteria for each steviol glycoside measured (i.e., two methods of normalizing
expression).
[00148] Transporter selection criterion 1 corresponded to selection based on the level of
high molecular weight steviol glycosides (RebA, RebB, RebD, or RebM) available in the
supernatant, as well as the total production of the said steviol glycoside. Both values were
normalized to the value of the corresponding steviol glycoside-producing control strain. The
control level was set to 1, and the corresponding steviol glycoside level was calculated as a
percentage of the control. For Ordered Locus Names (i.e., genes) of interest, the steviol
glycoside available in the supernatant should be below 0.6 (below 60% of the control) or
between 0.8-0.6 (80-60% of the control). To avoid false positives or a bias towards
transporters that decrease the production in general, the calculation had an additional
requirement that the total production had to be similar to the control. In the current
calculation, production was set to be between 0.85 and 1.15 of the control, when the control
is set to 1. In this regard, steviol glycoside production levels did not affect results. Table 7
shows the supernatant/total ratio for each candidate that fulfills the selection criteria.
[00149] Transporter selection criterion 2 corresponded to selection based on the ratio of
high molecular weight steviol glycosides (RebA, RebB, RebD, or Reb ) in the supernatant
relative to total production of the said steviol glycoside. The supernatant-to-total production
ratio was normalized to the ratio of the corresponding steviol glycoside-producing strain
control. The control level was set to 1, and the corresponding steviol glycoside ratio was
calculated as a percentage of the control. For Ordered Locus Names (i.e., genes) of
interest, the supernatant-to-total production ratio for a given steviol glycoside should be
below 0.6 (below 60% of the control) or between 0.8-0.6 (80-60% of the control). To avoid
false positives or a bias towards transporters that decrease the production in general, the
calculation had an additional requirement that the total production had to be similar to the
control. In the current calculation, production was set to be between 0.85 and 1.15 of the
control, when the control is set to 1. In this regard, steviol glycoside production levels did not
affect results. Table 8 shows the supernatant/total ratio for each candidate that fulfills the
selection criteria.
[00150] The data demonstrate that disruption of a single endogenous yeast transporter
gene in a steviol glycoside-producing strain resulted in a decrease in the level of various
steviol glycosides in the supernatant of the culture media, as evaluated by the normalized
amount transported into the supernatant (see Tables 5-10), and are therefore identified as
having a role in steviol glycoside excretion.
[00151] For example, deletion in a steviol glycoside-producing strain of YDL128W (SEQ
ID NO:22), YDL194W (SEQ ID NO:24), YDL210W (SEQ ID NO:25), YFL01 1W (SEQ ID
NO:33), YGL006W (SEQ ID NO:34), YGL013C (SEQ ID NO:35), YGL255W (SEQ ID
NO:36), YGR181W (SEQ ID NO:38), YGR217W (SEQ ID NO:39), YIL088C (SEQ ID
NO:43), YJL094C (SEQ ID NO:45), YJR106W (SEQ ID NO:48), YNL065W (SEQ ID NO:59),
YNL083W (SEQ D NO:61), YNL121C (SEQ ID NO:63), YNL142W (SEQ ID NO:64),
YOR306C (SEQ ID NO:75), or YPR01 1C (SEQ D NO:82) led to a measurable decrease of
RebD excreted into the culture medium, indicating that each plays a role in RebD excretion.
This was confirmed by transporter selection criteria 1 and 2 (see Tables 7 and 8 , RebD
column).
[00152] Furthermore, for example, deletion in a steviol g!ycoside-producing strain of
YBR180W (SEQ ID NO:13), YBR241C (SEQ ID NO:17), YCL069W (SEQ ID NO:19),
YCR075C (SEQ ID NO:21), YDL128W (SEQ ID NO:22), YDL194W (SEQ ID NO:24),
YDR093W (SEQ D NO:27), YDR338C (SEQ ID NO:28), YER166W (SEQ D NO:32),
YFL01 W (SEQ ID NO:33), YGL006W (SEQ ID NO:34), YGL013C (SEQ D NO:35),
YGL255W (SEQ ID NO:36), YGR217W (SEQ ID NO:39), YJL094C (SEQ ID NO:45),
YJR106W (SEQ ID NO:48), YJR160C (SEQ ID NO:49), YKR106W (SEQ ID NO:53),
Y L116W (SEQ ID NO:55), YMR056C (SEQ ID NO:57), YNL070W (SEQ ID NO:60),
YNL083W (SEQ ID NO:61), YNL095C (SEQ ID NO:62), YNL121C (SEQ ID NO:63),
YOR087W (SEQ ID NO:70), YOR291W (SEQ ID NO:74), YOR306C (SEQ ID NO:75),
YPL274W (SEQ ID NO:80), or YPR01 C (SEQ ID NO:82) led to a measurable decrease of
RebM, indicating that each plays a role in RebM excretion. This was confirmed by
transporter selection criteria 1 and 2 (see Tables 7 and 8 , RebM column).
[00153] Table 7 represents the calculated ratio, normalized to a steviol glycoside-
producing strain comprising genes encoding GGPPS, truncated CDPS, KS, KO, ATR2,
EUGT1 1, SrKAHel, CPR8, UGT85C2, UGT74G1 , UGT76G1 , and EUGT1 polypeptides, of
supernatant/total production for each gene (by ordered locus name) deleted in the steviol
glycoside-producing strain. The supernatant or supernatant/total ratio of less than 0.6
represented a more than 40% decrease in either the supernatant alone or in the ratio of
supernatant/total production of RebA, RebB, RebD, or RebM, which corresponded
approximately to more than 2 standard deviations removed from the mean of the control
steviol glycoside-producing strain and indicates the gene as having a role in steviol glycoside
transportation (Table 7). The supernatant or ratio supernatant/total of between 0.6 and 0.8
represents a 40-20% decrease in either the supernatant alone or in the ratio of
supernatant/total production of RebA, RebB, RebD, or RebM, which corresponds to
approximately between 1 and 2 standard deviations removed from the mean of the control
steviol glycoside-producing strain, and indicates the gene as having a role in steviol
glycoside transportation and/or production (Table 8). Total production of each steviol
glycoside was between 0.85 and 1.15 compared to the steviol glycoside-producing strain.
Table 8 shows the supernatant/total ratio for each candidate that fulfills the selection criteria.
Table 7. Transport related genes with over a 40% decrease in RebA, RebB, RebD or
RebM compared to a control steviol glycoside-producing strain comprising genes
encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT11, SrKAHel, CPR8,
UGT85C2, UGT74G1, UGT76G1, and EUGT11 polypeptides.
Table 8. Transport related genes with a 20-40% decrease in Reb A, RebB, RebD or
RebM compared to a control steviol glycoside-producing strain comprising genes
encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT11, SrKAHel, CPR8,
UGT85C2, UGT74G1, UGT76G1, and EUGT polypeptides.
Transports cal 2; ratio sup/total vs
Transports cal total vs sup total
RebA RebB RebD RebM RebA RebB RebD RebM
YHL036W 0.798 0.798
YHR096C 0.879 0.798 0.798




YJL212C 0.817 0.682 0.682
YJR106W 0.719 0.719





YKR106W 0.785 0.738 0.785 0.738
YLR41 1W 0.852 0.782 0.782
YML038C 0.724 0.724
Y L116W 0.898 0.706
YMR056C 0.675 0.591 0.786 0.675
YMR279C 0.885
YNL065W 0.710 0.792 0.571 0.710 0.792
YNL070W 0.893 0.892 0.633
YNL083W 0.592





YOL158C 0.848 0.728 0.728
YOR087W 0.61
YOR100C 0.916
YOR271C 0.889 0.758 0.608 0.758 0.608




YPL036W 0.763 0.698 0.763 0.698
YPL078C 0.798 0.798
YPL270W 0.746 0.665 0.746
YPL274W 0.817 0.807 0.721 0.721
YPR01 1C 0.763 0.763 0.61
[00154] The effect of yeast gene knockouts on transport of higher molecular weight
steviol glycosides into the culture medium (i.e., supernatant) also was tested in a steviol
glycoside-producing strain comprising additional copies of genes encoding GGPPS,
truncated CDPS, KS, KO, ATR2, EUGT1 , SrKAHef , CPR8, UGT85C2, UGT74G1,
UGT76G1, and EUGT1 polypeptides, which was described in Example 2. The data
demonstrated that disruption of a single endogenous yeast transporter gene in the steviol
glycoside-producing strain resulted in a decrease in the level of various steviol glycosides in
the supernatant of the culture media, as evaluated by the normalized amount transported or
by the supernatant-to-total-production ratio (see Tables 9 and 10, RebD column). For
example, deletion in the steviol glycoside-producing strain of YDR536W (SEQ D NO:30),
YHL016C (SEQ D NO:42), YKR050W (SEQ D NO:51), YOR291W (SEQ D NO:74),
YOR334W (SEQ D NO:77), YPL270W (SEQ D NO:79), YPR058W (SEQ ID NO:83), or
YPR128C (SEQ ID NO:84) led to a measurable decrease of RebD transported into the
supernatant, indiciating that they play a role in RebD excretion. This was confirmed by
transporter selection criteria 1 and 2 (see Tables 9 and 10, RebD column).
[00155] Furthermore, for example, deletion of YAL067C (SEQ D NO: 14), YDR406W
(SEQ D NO:29), YHL016C (SEQ D NO:42), YJL212C (SEQ D NO:47), YKR050W (SEQ D
NO:51), YMR034C (SEQ D NO:56), YMR253C (SEQ D NO:58), YOL075C (SEQ D
NO:66), YOL122C (SEQ ID NO:68), YOR222W (SEQ D NO:73), YPR003C (SEQ D
NO:81), or YPR201W (SEQ D NO:85) led to a measurable decrease of Reb transported
into the supernatant, indicating that they play a role in RebM excretion. This was confirmed
by transporter selection criteria 1 and 2 (see Tables 9 and 10, RebM column).
[00156] Table 9 represents the calculated ratio, normalized to a steviol glycoside-
producing strain comprising additional copies of genes encoding GGPPS, truncated CDPS,
KS, KO, ATR2, EUGT1 1, SrKAHel, CPR8, UGT85C2, UGT74G1, UGT76G1, and EUGT1 1
polypeptides, of supernatant/total production for each gene (by ordered locus name) deleted
in the steviol glycoside-producing strain. The supernatant or ratio supernatant/total of less
than 0.6 represents a more than 40% decrease in either the supernatant alone or in the ratio
of supernatant/total production of RebA, RebB, RebD, or RebM, which corresponds
approximately to more than 2 standard deviations removed from the mean of a control
steviol glycoside-producing strain, and indicates the gene as having a role in steviol
glycoside transportation and/or production (Table 9). The supernatant or ratio
supernatant/total of between 0.6 and 0.8 represents a 40-20% decrease in either the
supernatant alone or in the ratio of supernatant/total production of RebA, RebB, RebD, or
RebM, which corresponds to approximately between 1 and 2 standard deviations removed
from the mean of the control strain, and indicates the gene as having a role in steviol
glycoside transportation and/or production, and indicates the gene as having a role in steviol
glycoside transportation and/or production (Table 10). Total production of each steviol
glycoside was between 0.85 and 1.15 compared to the control steviol glycoside-producing
strain. Table 10 shows the supernatant/total ratio for each candidate that fulfills the selection
criteria.
Table 9. Transport related genes with over a 40% decrease in Reb A, RebB, RebD or
RebM compared to a control steviol glycoside-producing strain comprising additional
copies of genes encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT11,
SrKAHel, CPR8, UGT85C2, UGT74G1, UGT76G1, and EUGT11 polypeptides.

Table 10. Transport related genes with a 20-40% decrease in Reb A, RebB, RebD or
RebM compared to a control steviol glycoside-producing strain comprising additional
copies of genes encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT11,
SrKAHel, CPR8, UGT85C2, UGT74G1, UGT76G1, and EUGT11 polypeptides.
[00157] Knockouts of YDL210W (SEQ D NO:25) and YPL270W (SEQ D NO:79)
resulted in decreased RebD excretion in the steviol glycoside-producing strain comprising
genes encoding GGPPS, truncated CDPS, KS, KO, ATR2, EUGT1 1, SrKAHel, CPR8,
UGT85C2, UGT74G1, UGT76G1, and EUGT1 1 polypeptides and the steviol glycoside-
producing strain comprising additional copies of genes encoding GGPPS, truncated CDPS,
KS, KO, ATR2, EUGT1 1, SrKAHel, CPR8, UGT85C2, UGT74G1, UGT76G1, and EUGT1 1
polypeptides. As well, knockouts of YJL212C (SEQ D NO:47) and YOL122C (SEQ ID
NO:68) resulted in decreased RebM transport in both strains.
Example 4. Confirmation of Knockout of Yeast Endogenous Transport Genes by
overexpression in a RebD/M-producing strain
[00158] Overexpression of a subset of the initial candidate transporters from Example 3
was performed using both plasmid-based expression and an integration cassette. First,
deep-well microtiter plate culture experiments were carried out. Two transport genes were
overexpressed using a plasmid in a RebD/M-producing strain in order to confirm the results
from the knockout experiements. YGR181W (SEQ ID NO:38), a TIM complex, helper
protein for insertion of mitochondrial inner membrane proteins, and YDR061W (SEQ D
NO:26) an ABC-like transporter were overexpressed. The data shown in Figure 2
demonstrate that the phenotype based on the knockout studies was confirmed with a
plasmid based overexpression phenotype for YGR181W (SEQ ID NO:38) and YDR061W
(SEQ ID NO:26) in deep-well plates.
[00159] Next, confirmation of the phenotype in fermenters was performed in additional
steviol glycoside-producing strains, which were characterized by intergration of YGR181W
(SEQ ID NO:38) or YDR061W (SEQ ID NO:26) on chromosome XII. The steviol glycoside-
producing strains were grown on defined media at 30°C in a fed-batch fermentation for about
5 days under glucose-limited conditions, and the levels of RebA, RebB, RebD, and RebM
were measured using LC-MS (Method B, Example 1). The graphs shown in Figure 3
illustrate an approximate 2-fold increase in RebD and RebM transported in the culture
medium for the new integration constructs, and little change in RebA and RebB transport.
Overexpression of YGR181W (SEQ ID NO:38) or YDR061W (SEQ D NO:26) resulted in
improved (~2-fold) RebD and RebM transport into the culture medium (-400-500 mg/L of
supernatant RebD and RebM in YGR181W (SEQ ID NO:38) and YDR061W (SEQ ID
NO:26) overexpression strains versus -250 mg/L of supernatant RebD and RebM in a
control steviol glycoside-producing strain). See Figure 3A. The ratio of transported RebD as
compared to the total RebD increased from 0.158 in the control strain to 0.21-0.25 with the
candidate genes overexpressed. RebM transport into the culture medium was also
simultaneously improved. See Figure 3 .
Example 5. Overexpression of Selected Yeast Endogenous Transport Genes
[00160] Overexpression in a steviol glycoside-producing strain (as described in Example
2) using a plasmid with a constitutive promoter of the transporter genes shown in Table 1
resulted in greater than a 20% increase in excretion of RebA, RebB, RebD, and/or RebM.
Results were analyzed using criterion 2 described in Example 3 . Additionally,
overexpression of the transporter genes shown in Table 12 resulted in greater than a 40%
improvement in production of RebA, RebB, RebD, and/or RebM. Table 11 shows the
supernatant/total ratio for each candidate that fulfills the selection criteria.
Table 11. Transport related genes with over a 20% increase in RebA, RebB, RebD or
RebM excretion, compared to a control stevtol glycoside-producing strain.
Table 12. Transport related genes with over a 40% increase in RebA, RebB, RebD or
RebM production, compared to a control stevioi glycoside-producing strain.
Example 6. Genomic Integration of Transporter Genes
[00161] DNA of the transporter genes selected for integration into the genome of a
RebD/M-producing S. cerevisiae strain (see Example 2) was amplified from an S288C
background by PGR and cloned into a plasmid with homology regions for the integration site
and a PGK1 promoter for overexpression, using the USER cloning system. See, e.g., Nour-
Eidin et a/., 2010, Methods Mol Biol. 643:185-200. The USER cloning construct including
the homology regions and the transporter was cut out from the plasmid using restriction
enzymes, and the linear piece of DNA was integrated into the genome of the receiving
RebD/M-producing strain by standard LiAc method. The genomically integrated transporters
were tested in plates that release glucose from a polymer after addition of a growth medium.
A polymer that releases 20 g/L glucose over 3 days was used to mimic the feed profile
during fermentation. Steviol glycoside levels were measured by LC-MS (see Example 1) ,
and OD600 was measured on a Perkin Elmer 2104 Multilabel reader. YBR043C (SEQ ID
NO:88), YEL027W (SEQ ID NO: 102), YJL093C (SEQ ID NO:44), YJR106W (SEQ ID
NO:48), YKL120W (SEQ ID NO: 126), and YMR166C (SEQ ID NO: 132) showed improved
excretion of 13-SMG. (Figure 4A). YBR043C (SEQ ID NO:88), YEL027W (SEQ ID
NO.102), and YMR166C (SEQ ID NO:132) showed improved excretion of RebA (Figure 4B).
YBR043C (SEQ ID NO:88), YEL027W (SEQ D NO:102), and YMR166C (SEQ ID NO: 132)
showed improved excretion of RebB (Figure 4C). YBR043C of SEQ ID NO:88, YEL027W of
SEQ ID NO: 102, YJL093C of SEQ ID NO:44, YJR106W of SEQ ID NO:48, and YMR166C of
SEQ ID NO: 132 showed improved production of RebD, and YBR043C of SEQ ID NO:88,
YEL027W of SEQ ID NO: 102, YIL166C (SEQ ID NO: 121), YJL093C of SEQ D NO:44,
YJR106W of SEQ ID NO:48, and YMR166C of SEQ ID NO: 132 showed improved
production of RebM, as measured by an increase in RebD and RebM levels in the
supernatant compared to a control steviol glycoside-producing strain. See Figures 4D and
4E. Controls with a URA marker are also shown in Figure 4 .
[00162] Figure 5A shows supernatant levels of RebA, RebB, RebD, and Reb of an
additional steviol glycoside-producing strain overexpressing YMR166C (SEQ ID NO: 132),
YEL027W (SEQ ID NO: 102), YKL120W (SEQ ID NO: 126), YJR106W (SEQ ID NO:48),
YJL093C (SEQ ID NO:44), and YBR043C (SEQ ID NO:88) by the USER cloning system.
The strain of Figure 5 comprised a recombinant gene encoding a Synechococcus sp.
GGPPS polypeptide (SEQ D NO:1 , SEQ ID NO: 149), a recombinant gene encoding a
truncated Zea mays CDPS polypeptide (SEQ ID NO:2, SEQ ID NO: 150), a recombinant
gene encoding an A. thaliana KS polypeptide (SEQ ID NO:3, SEQ D NO: 151 ) , a
recombinant gene encoding a recombinant S. rebaudiana K01 polypeptide (SEQ ID NO:4,
SEQ ID NO:152), a recombinant gene encoding a KO polypeptide (SEQ ID NO:XX, SEQ ID
NO:XX), a recombinant gene encoding an A. thaliana ATR2 polypeptide (SEQ D NO:5,
SEQ ID NO:153), a recombinant gene encoding an O. sativa EUGT1 1 polypeptide (SEQ ID
NO:12; SEQ ID NO: 148), a recombinant gene encoding an SrKAHel polypeptide (SEQ ID
NO:6, SEQ D NO: 154), a recombinant gene encoding an S. rebaudiana CPR8 polypeptide
(SEQ ID NO:7, SEQ D NO: 155), a recombinant gene encoding an S. rebaudiana UGT85C2
polypeptide (SEQ ID NO:8, SEQ ID NO: 156), a recombinant gene encoding an S.
rebaudiana UGT74G1 polypeptide (SEQ ID NO:9, SEQ D NO:157), a recombinant gene
encoding an S. rebaudiana UGT76G1 polypeptide (SEQ ID NO:10, SEQ ID NO:158), and a
recombinant gene encoding an S. rebaudiana UGT91D2 variant (or functional homolog),
UGT91D2e-b (SEQ ID NO:1 1, SEQ ID NO: 159) polypeptide. Figure 5B shows total levels of
RebA, RebB, RebD, and RebM of the above described steviol glycoside-producing strain
overexpressing YMR166C (SEQ ID NO:132), YEL027W (SEQ ID NO:102), YKL120W (SEQ
ID NO: 126), YIL166C (SEQ ID NO: 132), YJR106W (SEQ ID NO:48), YJL093C (SEQ ID
NO:44), and YBR043C (SEQ ID NO:88) by the USER cloning system.
Example 7. Production of RebD and RebM by Fermentation of Steviol Glycoside-
Producing S. cerevisiae strains overexpressing YJL093C or YBR043C
[00163] YJL093C (SEQ D NO:44) and YBR043C (SEQ ID NO:88) were individually
overexpressed in the steviol glycoside-producing strain described in Example 3 . The strains
were cultivated by fermentation (fed-batch, minimum medium, glucose-limiting) for
approximately 130 h. Production of RebD and RebM was measured by LC-MS. As shown in
Table 13, the strains overexpressing YJL093C or YBR043C produced higher levels of RebD
and RebD + RebM, as compared to a control steviol glycoside-producing strain.
Tab!e 13. Production of RebD and RebM in S. cerevisiae strains overexpressing
YJL093C and YBR043C.
Table 14. Sequences disclosed herein.
SEQ ID NO: 1
Synechococcus sp. GGPPS (GenBank ABC98596.1)
atggtcgcac aaactttcaa cctggatacc tacttatccc aaagacaaca acaagttgaa 60
gaggccctaa gtgctgctct tgtgccagct tatcctgaga gaatatacga agctatgaga 120
tactccctcc tggcaggtgg caaaagatta agacctatct tatgtttagc tgcttgcgaa 180
ttggcaggtg gttctgttga acaagccatg ccaactgcgt gtgcacttga aatgatccat 240
acaatgtcac taattcatga tgacctgcca gccatggata acgatgattt cagaagagga 300
aagccaacta atcacaaggt gttcggggaa gatatagcca tcttagcggg tgatgcgctt 360
ttagcttacg cttttgaaca tattgcttct caaacaagag gagtaccacc tcaattggtg 420
ctacaagtta ttgctagaat cggacacgcc gttgctgcaa caggcctcgt tggaggccaa 480
gtcgtagacc ttgaatctga aggtaaagct atttccttag aaacattgga gtatattcac 540
tcacataaga ctggagcctt gctggaagca tcagttgtct caggcggtat tctcgcaggg 600
gcagatgaag agcttttggc cagattgtct cattacgcta gagatatagg cttggctttt 660
caaatcgtcg atgatatcct ggatgttact gctacatctg aacagttggg gaaaaccgct 720
ggtaaagacc aggcagccgc aaaggcaact tatccaagtc tattgggttt agaagcctct 780
agacagaaag cggaagagtt gattcaatct gctaaggaag ccttaagacc ttacggttca 840
caagcagagc cactcctagc gctggcagac ttcatcacac gtcgtcagca ttaa 894
SEQ ID NO: 2
Zea mays truncated CDPS
atggcacagcaca catcagaatc cgcagctgtc gcaaagggca gcagtttgac ccctatagtg 60
agaactgacg ctgagtcaag gagaacaaga tggccaaccg atgacgatga cgccgaacct 120
ttagtggatg agatcagggc aatgcttact tccatgtctg atggtgacat ttccgtgagc 180
gcacacgata cagcctgggt cggattggtt ccaagattag acggcggtga aggtcctcaa 240
tttccagcag ctgtgagatg gataagaaat aaccagttgc ctgacggaag ttggggcgat 300
gccgcattat tctctgccta tgacaggctt atcaataccc ttgcctgcgt tgtaactttg 360
acaaggtggt ccctagaacc agagatgaga ggtagaggac tatctttttt gggtaggaac 420
atgtggaaat tagcaactga agatgaagag tcaatgccta ttggcttcga attagcattt 480
ccatctttga tagagcttgc taagagccta ggtgtccatg acttccctta tgatcaccag 540
gccctacaag gaatctactc ttcaagagag atcaaaatga agaggattcc aaaagaagtg 600
atgcataccg ttccaacatc aatattgcac agtttggagg gtatgcctgg cctagattgg 660
gctaaactac ttaaactaca gagcagcgac ggaagttttt tgttctcacc agctgccact 720
gcatatgctt taatgaatac cggagatgac aggtgtttta gctacatcga. tagaacagta 780
aagaaattca acggcggcgt ccctaatgtt tatccagtgg atctatttga acatatttgg 840
gccgttgata gacttgaaag attaggaatc tccaggtact tccaaaagga gatcgaacaa 900
tgcatggatt atgtaaacag gcattggact gaggacggta tttgttgggc aaggaactct 960
gatgtcaaag aggtggacga cacagctatg gcctttagac ttcttaggtt gcacggctac 1020
agcgtcagtc ctgatgtgtt taaaaacttc gaaaaggacg gtgaattttt cgcatttgtc 1080
ggacagtcta atcaagctgt taccggtatg tacaacttaa acagagcaag ccagatatcc 1140
ttcccaggcg aggatgtgct tcatagagct ggtgccttct catatgagtt cttgaggaga 1200
aaagaagcag agggagcttt gagggacaag tggatcattt ctaaagatct acctggtgaa 12 60
gttgtgtata ctttggattt tccatggtac ggcaacttac ctagagtcga ggccagagac 1320
tacctagagc aatacggagg tggtgatgac gtttggattg gcaagacatt gtataggatg 1380
ccacttgtaa acaatgatgt atatttggaa ttggcaagaa tggatttcaa ccactgccag 1440
gctttgcatc agttagagtg gcaaggacta aaaagatggt atactgaaaa taggttgatg 1500
gactttggtg tcgcccaaga agatgccctt agagcttatt ttcttgcagc cgcatctgtt 1560
tacgagcctt gtagagctgc cgagaggctt gcatgggcta gagccgcaat actagctaac 1620
gccgtgagca cccacttaag aaatagccca tcattcagag aaaggttaga gcattctctt 1680
aggtgtagac ctagtgaaga gacagatggc tcctggttta actcctcaag tggctctgat 1740
gcagttttag taaaggctgt cttaagactt actgattcat tagccaggga agcacagcca 1800
atccatggag gtgacccaga agatattata cacaagttgt taagatctgc ttgggccgag 1860
tgggttaggg aaaaggcaga cgctgccgat agcgtgtgca atggtagttc tgcagtagaa 1920
caagagggat caagaatggt ccatgataaa cagacctgtc tattattggc tagaatgatc 1980
gaaatttctg ccggtagggc agctggtgaa gcagccagtg aggacggcga tagaagaata 2040
attcaattaa caggctccat ctgcgacagt cttaagcaaa aaatgctagt ttcacaggac 2100
cctgaaaaaa atgaagagat gatgtctcac gtggatgacg aattgaagtt gaggattaga 2160
gagttcgttc aatatttgct tagactaggt gaaaaaaaga ctggatctag cgaaaccagg 2220
caaacatttt taagtatagt gaaatcatgt tactatgctg ctcattgccc acctcatgtc 2280
gttgatagac acattagtag agtgattttc gagccagtaa gtgccgcaaa gtaaccgcgg 2340
SEQ ID NO: 3
Arabidopsis thaliana KS (similar to GenBank AEE36246. 1 )
atgtctatta atttgagatc ttccggttgt agctccccaa taagcgcaac tttggaaagg 60
ggtctagact ctgaagttca aacaagagca aacaatgtat cttttgagca gaccaaagag 120
aagatcagga aaatgcttga gaaggtcgag ttgagcgtga gtgcctatga cactagttgg 180
gtagctatgg tcccatcacc atccagtcaa aacgcacctc ttttcccaca gtgcgtcaaa 240
tggctacttg ataatcaaca tgaggacggc tcttggggat tggataacca cgaccatcag 300
agcttaaaga aagatgtgtt gtcatccaca ttagcctcta tcctagctct taagaaatgg 360
ggaataggcg aaagacagat caataagggt ctacagttca ttgaattaaa ctctgcacta 420
gttaccgatg aaactataca aaaacctaca ggtttcgaca tcatttttcc aggaatgatt 480
aagtacgcca gggaccttaa tttgaccata cctcttggct cagaagtagt cgacgatatg 540
atcaggaaaa gagatctaga cttaaagtgt gatagcgaga aattcagcaa aggtagagag 600
gcttatcttg cctatgttct tgaaggaact aggaacttga aggactggga cttaattgtg 660
aaatatcaga gaaagaacgg tagtctattt gatagtccag ctacaaccgc cgcagctttc 720
actcaatttg gcaatgacgg ttgcttgagg tacttatgtt cacttttaca gaaattcgag 780
gccgcagtgc ctagtgtata tccatttgat caatacgcta gattaagcat aatcgtcact 840
ttagaatcat tgggaattga cagagatttc aagactgaga taaaaagcat attggatgag 900
acctataggt actggcttag aggtgacgaa gaaatttgcc tagatttggc cacatgtgca 960
cttgctttta ggttgctttt agcccacggc tatgacgtgt catacgatcc tctaaagcca 1020
tttgcagagg aatctggttt cagcgatacc cttgagggat atgttaaaaa caccttttcc 1080
gtattagagc ttttcaaggc tgcccaaagt taccctcatg agagtgcttt gaaaaagcag 1140
tgttgctgga caaaacaata tctagaaatg gaactaagtt catgggttaa aacaagcgtt 1200
agggacaagt acttgaaaaa ggaagtggag gatgctttgg catttccatc atatgcctct 12 60
ttagaaagaa gtgaccacag aaggaaaatt cttaatggct cagcagttga aaacacaaga 1320
gtaaccaaga cctcttacag gttgcataat atatgtacat cagatatctt aaaacttgct 1380
gtcgacgatt tcaacttttg ccaatctatt catagagagg aaatggaaag attggataga 1440
tggatagtgg agaatagact acaggaatta aagttcgcca gacaaaaatt ggcttactgt 1500
tactttagtg gcgctgccac actattctct ccagaattgt ctgacgcaag gatctcatgg 1560
gctaagggag gtgttctaac cacagtagtc gatgactttt ttgatgttgg cggtagtaaa 1620
gaagagcttg agaacttaat tcacttggtg gaaaagtggg atcttaatgg agttcctgaa 1680
tactcttcag agcatgtaga aataattttc tctgtcctaa gagacactat cttagaaacc 1740
ggtgataaag cctttacata tcagggcaga aacgttactc accatattgt gaaaatatgg 1800
ttggacttac ttaagagcat gctaagggag gctgaatggt ccagtgacaa atcaacccca 1860
tctttggaag attacatgga gaatgcctat atcagcttcg cattaggtcc tattgtattg 1920
ccagctacat accttatagg acctccacta cctgaaaaga ctgtcgactc ccaccaatat 1980
aatcaattat acaaattggt tagtaccatg ggtagactat taaacgatat ccagggcttt 2040
aagagggaat cagccgaggg aaaacttaat gcagtgtctc tacatatgaa gcatgaaaga 2100
gacaacagaa gcaaagaggt tattatagaa tccatgaaag gattggctga aaggaaaaga 2160
gaggaattac acaaacttgt actagaagag aaaggtagtg tcgttccaag agaatgcaag 2220
gaagccttct taaaaatgtc aaaagtgttg aacctttttt ataggaagga tgatggcttc 2280
acatctaacg acttgatgag ccttgtgaaa tccgtcatct acgagcctgt ttcacttcaa 234 0
aaggagagtc taacttga 2358
SEQ ID NO;
S . rebaudiana KOI (codon optimized)
atggatgctg tgacgggttt gttaactgtc ccagcaaccg ctataactat tggtggaact 60
gctgtagcat tggcggtagc gctaatcttt tggtacctga aatcctacac atcagctaga 120
agatcccaat caaatcatct tccaagagtg cctgaagtcc caggtgttcc attgttagga 180
aatctgttac aattgaagga gaaaaagcca tacatgactt ttacgagatg ggcagcgaca 240
tatggaccta tctatagtat caaaactggg gctacaagta tggttgtggt atcatctaat 300
gagatagcca aggaggcatt ggtgaccaga ttccaatcca tatctacaag gaacttatct 360
aaagccctga aagtacttac agcagataag acaatggtcg caatgtcaga ttatgatgat 420
tatcataaaa cagttaagag acacatactg accgccgtct tgggtcctaa tgcacagaaa 480
aagcatagaa ttcacagaga tatcatgatg gataacatat ctactcaact tcatgaattc 540
gtgaaaaaca acccagaaca ggaagaggta gaccttagaa aaatctttca atctgagtta 600
ttcggcttag ctatgagaca agccttagga aaggatgttg aaagtttgta cgttgaagac 660
ctgaaaatca ctatgaatag agacgaaatc tttcaagtcc ttgttgttga tccaatgatg 720
ggagcaatcg atgttgattg gagagacttc tttccatacc taaagtgggt cccaaacaaa 730
aagttcgaaa atactattca acaaatgtac atcagaagag aagctgttat gaaatcttta 840
atcaaagagc acaaaaagag aatagcgtca ggcgaaaagc taaatagtta tatcgattac 900
cttttatctg aagctcaaac tttaaccgat cagcaactat tgatgtcctt gtgggaacca 960
atcattgaat cttcagatac aacaatggtc acaacagaat gggcaatgta cgaattagct 1020
aaaaacccta aattgcaaga taggttgtac agagacatta agtccgtctg tggatctgaa 1080
aagataaccg aagagcatct atcacagctg ccttacatta cagctatttt ccacgaaaca 11 0
ctgagaagac actcaccagt tcctatcatt cctctaagac atgtacatga agataccgtt 1200
ctaggcggct accatgttcc tgctggcaca gaacttgccg ttaacatcta cggttgcaac 1260
atggacaaaa acgtttggga aaatccagag gaatggaacc cagaaagatt catgaaagag 1320
aatgagacaa ttgattttca aaagacgatg gccttcggtg gtggtaagag agtttgtgct 1380
ggttccttgc aagccctttt aactgcatct attgggattg ggagaatggt tcaagagttc 1440
gaatggaaac tgaaggatat gactcaagag gaagtgaaca cgataggcct aactacacaa 1500
atgttaagac cattgagagc tattatcaaa cctaggatct aa 1542
SEQ ID NO: 5
A . thaliana ATR2 (codon optimized)
atgtcttcct cttcctcttc cagtacctct atgattgatt tgatggctgc tattattaaa 60
ggtgaaccag ttatcgtctc cgacccagca aatgcctctg cttatgaatc agttgctgca 120
gaattgtctt caatgttgat cgaaaacaga caattcgcca tgatcgtaac tacatcaatc 180
gctgttttga tcggttgtat tgtcatgttg gtatggagaa gatccggtag tggtaattct 240
aaaagagtcg aacctttgaa accattagta attaagccaa gagaagaaga aatagatgac 300
ggtagaaaga aagttacaat atttttcggt acccaaactg gtacagctga aggttttgca 360
aaagccttag gtgaagaagc taaggcaaga tacgaaaaga ctagattcaa gatagtcgat. 420
ttggatgact atgccgctga tgacgatgaa tacgaagaaa agttgaagaa agaagatgtt 480
gcatttttct ttttggcaac ctatggtgac ggtgaaccaa ctgacaatgc agccagattc 540
tacaaatggt ttacagaggg taatgatcgt ggtgaatggt tgaaaaactt aaagtacggt 600
gttttcggtt tgggtaacag acaatacgaa catttcaaca aagttgcaaa ggttgtcgac 660
gatattttgg tcgaacaagg tgctcaaaga ttagtccaag taggtttggg tgacgatgac 720
caatgtatag aagatgactt tactgcctgg agagaagctt tgtggcctga attagacaca 780
atcttgagag aagaaggtga caccgccgtt gctaccccat atactgctgc agtattagaa 840
tacagagttt ccatccatga tagtgaagac gcaaagttta atgatatcac tttggccaat 900
ggtaacggtt atacagtttt cgatgcacaa cacccttaca aagctaacgt tgcagtcaag 960
agagaattac atacaccaga atccgacaga agttgtatac acttggaatt tgatatcgct 1020
ggttccggtt taaccatgaa gttgggtgac catgtaggtg ttttatgcga caatttgtct 1080
gaaactgttg atgaagcatt gagattgttg gatatgtccc ctgacactta ttttagtttg 114 0
cacgctgaaa aagaagatgg tacaccaatt tccagttctt taccacctcc attccctcca 1200
tgtaacttaa gaacagcctt gaccagatac gcttgcttgt tatcatcccc taaaaagtcc 1260
gccttggttg ctttagccgc tcatgctagt gatcctactg aagcagaaag attgaaacac 1320
ttagcatctc cagccggtaa agatgaatat tcaaagtggg tagttgaatc tcaaagatca 1380
ttgttagaag ttatggcaga atttccatct gccaagcctc cattaggtgt cttctttgct 1440
ggtgtagcac ctagattgca accaagattc tactcaatca gttcttcacc taagatcgct 1500
gaaactagaa ttcatgttac atgtgcatta gtctacgaaa agatgccaac cggtagaatt 1560
cacaagggtg tatgctctac ttggatgaaa aatgctgttc cttacgaaaa atcagaaaag 1620
ttgttcttag gtagaccaat cttcgtaaga caatcaaact tcaagttgcc ttctgattca 1680
aaggttccaa taatcatgat aggtcctggt acaggtttag ccccattcag aggtttcttg 1740
caagaaagat tggctttagt tgaatctggt gtcgaattag gtccttcagt tttgttcttt 1800
ggttgtagaa acagaagaat ggatttcatc tatgaagaag aattgcaaag attcgtcgaa 1860
tctggtgcat tggccgaatt atctgtagct ttttcaagag aaggtccaac taaggaatac 1920
gttcaacata agatgatgga taaggcatcc gacatatgga acatgatcag tcaaggtgct 1980
tatttgtacg tttgcggtga cgcaaagggt atggccagag atgtccatag atctttgcac 2040
acaattgctc aagaacaagg ttccatggat agtaccaaag ctgaaggttt cgtaaagaac 2100
ttacaaactt ccggtagata cttgagagat gtctggtga 2139
SEQ ID NO: 6
Stevia rebaudiana KAHel (codon-optimized)
atggaagcct cttacctata catttctatt ttgcttttac tggcatcata cctgttcacc 60
actcaactta gaaggaagag cgctaatcta ccaccaaccg tgtttccatc aataccaatc 120
attggacact tatacttact caaaaagcct ctttatagaa ctttagcaaa aattgccgct 180
aagtacggac caatactgca attacaactc ggctacagac gtgttctggt gatttcctca 240
ccatcagcag cagaagagtg ctttaccaat aacgatgtaa tcttcgcaaa tagacctaag 300
acattgtttg gcaaaatagt gggtggaaca tcccttggca gtttatccta cggcgatcaa 360
tggcgtaatc taaggagagt agcttctatc gaaatcctat cagttcatag gttgaacgaa 420
tttcatgata tcagagtgga tgagaacaga ttgttaatta gaaaacttag aagttcatct 480
tctcctgtta ctcttataac agtcttttat gctctaacat tgaacgtcat tatgagaatg 540
atctctggca aaagatattt cgacagtggg gatagagaat tggaggagga aggtaagaga 600
tttcgagaaa tcttagacga aacgttgctt ctagccggtg cttctaatgt tggcgactac 660
ttaccaatat tgaactggtt gggagttaag tctcttgaaa agaaattgat cgctttgcag 720
aaaaagagag atgacttttt ccagggtttg attgaacagg ttagaaaatc tcgtggtgct 780
aaagtaggca aaggtagaaa aacgatgatc gaactcttat tatctttgca agagtcagaa 840
cctgagtact atacagatgc tatgataaga tcttttgtcc taggtctgct ggctgcaggt 900
agtgatactt cagcgggcac tatggaatgg gccatgagct tactggtcaa tcacccacat 960
gtattgaaga aagctcaagc tgaaatcgat agagttatcg gtaataacag attgattgac 1020
gagtcagaca ttggaaatat cccttacatc gggtgtatta tcaatgaaac tctaagactc 1080
tatccagcag ggccattgtt gttcccacat gaaagttctg ccgactgcgt tatttccggt 1140
tacaatatac ctagaggtac aatgttaatc gtaaaccaat gggcgattca tcacgatcct 1200
aaagtctggg atgatcctga aacctttaaa cctgaaagat ttcaaggatt agaaggaact 1260
agagatggtt tcaaacttat gccattcggt tctgggagaa gaggatgtcc aggtgaaggt 1320
ttggcaataa ggctgttagg gatgacacta ggctcagtga tccaatgttt tgattgggag 1380
agagtaggag atgagatggt tgacatgaca gaaggtttgg gtgtcacact tcctaaggcc 1440
gttccattag ttgccaaatg taagccacgt tccgaaatga ctaatctcct atccgaactt 1500
taa 1503


































SEQ ID NO: 8
Stevia rebaudiana UGT85C2 (codon optimized)
atggatgcaa tggcaactac tgagaaaaag cctcatgtga tcttcattcc atttcctgca 60
caatctcaca taaaggcaat gctaaagtta gcacaactat tacaccataa gggattacag 120
ataactttcg tgaataccga cttcatccat aatcaatttc tggaatctag tggccctcat 180
tgtttggacg gagccccagg gtttagattc gaaacaattc ctgacggtgt ttcacattcc 240
ccagaggcct ccatcccaat aagagagagt ttactgaggt caatagaaac caactttttg 300
gatcgtttca ttgacttggt cacaaaactt ccagacccac caacttgcat aatctctgat 360
ggctttctgt cagtgtttac tatcgacgct gccaaaaagt tgggtatccc agttatgatg 420
tactggactc ttgctgcatg cggtttcatg ggtttctatc acatccattc tcttatcgaa 480
aagggttttg ctccactgaa agatgcatca tacttaacca acggctacct ggatactgtt 540
attgactggg taccaggtat ggaaggtata agacttaaag attttccttt ggattggtct 600
acagacctta atgataaagt attgatgttt actacagaag ctccacaaag atctcataag 660
gtttcacatc atatctttca cacctttgat gaattggaac catcaatcat caaaaccttg 720
tctctaagat acaatcatat ctacactatt ggtccattac aattacttct agatcaaatt 780
cctgaagaga aaaagcaaac tggtattaca tccttacacg gctactcttt agtgaaagag 840
gaaccagaat gttttcaatg gctacaaagt aaagagccta attctgtggt ctacgtcaac 900
ttcggaagta caacagtcat gtccttggaa gatatgactg aatttggttg gggccttgct 960
aattcaaatc attactttct atggattatc aggtccaatt tggtaatagg ggaaaacgcc 1020
gtattacctc cagaattgga ggaacacatc aaaaagagag gtttcattgc ttcctggtgt 1080
tctcaggaaa aggtattgaa acatccttct gttggtggtt tccttactca ttgcggttgg 114 0
ggctctacaa tcgaatcact aagtgcagga gttccaatga tttgttggcc atattcatgg 1200
gaccaactta caaattgtag gtatatctgt aaagagtggg aagttggatt agaaatggga 12 60
acaaaggtta aacgtgatga agtgaaaaga ttggttcagg agttgatggg ggaaggtggc 1320
cacaagatga gaaacaaggc caaagattgg aaggaaaaag ccagaattgc tattgctcct 138 0
aacgggtcat cctctctaaa cattgataag tggtcaaag agattacagt cttagccaga 1440
aactaa 1446
SEQ ID NO: 9
S , rebaudiana UGT74G1 {GenBank AAR06920.1)
atggcggaac aacaaaagat caagaaatca ccacacgttc tactcatccc attcccttta 60
caaggccata taaacccttt catccagttt ggcaaacgat taatctccaa aggtgtcaaa 120
acaacacttg ttaccaccat ccacacctta aactcaaccc taaaccacag taacaccacc 180
accacctcca tcgaaatcca agcaatttcc gatggttgtg atgaaggcgg ttttatgagt 240
gcaggagaat catatttgga aacattcaaa caagttgggt ctaaatcact agctgactta 300
atcaagaagc ttcaaagtga aggaaccaca attgatgcaa tcatttatga ttctatgact 360
gaatgggttt tagatgttgc aattgagttt ggaatcgatg gtggttcgtt tttcactcaa 420
gcttgtgttg taaacagctt atattatcat gttcataagg gtttgatttc tttgccattg 480
ggtgaaactg tttcggttcc tggatttcca gtgcttcaac ggtgggagac accgttaatt 540
ttgcagaatc atgagcaaat acagagccct tggtctcaga tgttgtttgg tcagtttgct 600
aatattgatc aagcacgttg ggtcttcaca aatagttttt acaagctcga ggaagaggta 660
atagagtgga cgagaaagat atggaacttg aaggtaatcg ggccaacact tccatccatg 720
taccttgaca aacgacttga tgatgataaa gataacggat ttaatctcta caaagcaaac 780
catcatgagt gcatgaactg gttagacgat aagccaaagg aatcagttgt ttacgtagca 840
tttggtagcc tggtgaaaca tggacccgaa caagtggaag aaatcacacg ggctttaata 900
gatagtgatg tcaacttctt gtgggttatc aaacataaag aagagggaaa gctcccagaa 960
aatctttcgg aagtaataaa aaccggaaag ggtttgattg tagcatggtg caaacaattg 1020
gatgtgttag cacacgaatc agtaggatgc tttgttacac attgtgggtt caactcaact 108 0
cttgaagcaa taagtcttgg agtccccgtt gttgcaatgc ctcaattttc ggatcaaact 1140
acaaatgcca agcttctaga tgaaattttg ggtgttggag ttagagttaa ggctgatgag 1200
aatgggatag tgagaagagg aaatcttgcg tcatgtatta agatgattat ggaggaggaa 1260
agaggagtaa taatccgaaa gaatgcggta aaatggaagg atttggctaa agtagccgtt 1320
catgaaggtg gtagctcaga caatgatatt gtcgaatttg taagtgagct aattaaggct 138 0
taaatttttg ttgctttgta ttttatgtgt tatggttttt tgatttagat gtattcaatt 1440
aatattgaat cataactaaa ttcaagatta ttgtttgtaa tattctttgt cctaaaattt 1500
tgcgacttaa. aacctttagt ttataaaaag aaattagaaa atactattgc acgga 1555
SEQ ID NO: 10
S , rebaudiana UGT7 6G1 (codon optimized)
atggaaaaca agaccgaaac aacagttaga cgtaggcgta gaatcattct gtttccagta 60
ccttttcaag ggcacatcaa tccaatacta caactagcca acgttttgta ctctaaaggt 120
ttttctatta caatctttca caccaatttc aacaaaccaa aaacatccaa ttacccacat 180
ttcacattca gattcatact tgataatgat ccacaagatg aacgtatttc aaacttacct 240
acccacggtc ctttagctgg aatgagaatt ccaatcatca atgaacatgg tgccgatgag 300
cttagaagag aattagagtt acttatgttg gcatccgaag aggacgagga agtctcttgt 360
ctgattactg acgctctatg gtactttgcc caatctgtgg ctgatagttt gaatttgagg 420
agattggtac taatgacatc cagtctgttt aactttcacg ctcatgttag tttaccacaa 480
tttgacgaat tgggatactt ggaccctgat gacaagacta ggttagagga acaggcctct 540
ggttttccta tgttgaaagt caaagatatc aagtctgcct attctaattg gcaaatcttg 600
aaagagatct taggaaagat gatcaaacag acaaaggctt catctggagt gatttggaac 660
agtttcaaag agttagaaga gtctgaattg gagactgtaa tcagagaaat tccagcacct 720
tcattcctga taccattacc aaaacatttg actgcttcct cttcctcttt gttggatcat 780
gacagaacag tttttcaatg gttggaccaa caaccaccta gttctgtttt gtacgtgtca 840
tttggtagta cttctgaagt cgatgaaaag gacttccttg aaatcgcaag aggcttagtc 900
gatagtaagc agtcattcct ttgggtcgtg cgtccaggtt tcgtgaaagg ctcaacatgg 960
gtcgaaccac ttccagatgg ttttctaggc gaaagaggta gaatagtcaa atgggttcct 1020
caacaggaag ttttagctca tggcgctatt ggggcattct ggactcattc cggatggaat 1080
tcaactttag aatcagtatg cgaaggggta cctatgatct tttcagattt tggtcttgat 1140
caaccactga acgcaagata catgtctgat gttttgaaag tgggtgtata tctagaaaat 1200
ggctgggaaa ggggtgaaat agctaatgca ataagacgtg ttatggttga tgaagagggg 1260
gagtatatca gacaaaacgc aagagtgctg aagcaaaagg ccgacgtttc tctaatgaag 1320
ggaggctctt catacgaatc cttagaatct cttgtttcct acatttcatc actgtaa 1377
SEQ ID NO: 11
S . rebaudiana UGT91D2e-b (codon optimized)
atggctactt ctgattccat cgttgacgat agaaagcaat tgcatgttgc tacttttcca 60
tggttggctt tcggtcatat tttgccatac ttgcaattgt ccaagttgat tgctgaaaag 120
ggtcacaagg tttcattctt gtctaccacc agaaacatcc aaagattgtc ctctcatatc 180
tccccattga tcaacgttgt tcaattgact ttgccaagag tccaagaatt gccagaagat 240
gctgaagcta ctactgatgt tcatccagaa gatatccctt acttgaaaaa ggcttccgat 300
ggtttacaac cagaagttac tagattcttg gaacaacatt ccccagattg gatcatctac 360
gattatactc attactggtt gccatccatt gctgcttcat tgggtatttc tagagcccat 420
ttctctgtta ctactccatg ggctattgct ratatgggtc catctgctga tgctatgatt 480
aacggttctg atggtagaac taccgttgaa gatttgacta ctccaccaaa gtggtttcca 540
tttccaacaa aagtctgttg gagaaaacac gatttggcta gattggttcc atacaaagct 600
ccaggtattt ctgatggtta cagaatgggt atggttttga aaggttccga ttgcttgttg 660
tctaagtgct atcatgaatt cggtactcaa tggttgcctt tgttggaaac attgcatcaa 720
gttccagttg ttccagtagg tttgttgcca ccagaaattc caggtgacga aaaagacgaa 780
acttgggttt ccatcaaaaa gtggttggat ggtaagcaaa agggttctgt tgtttatgtt 840
gctttgggtt ccgaagcttt ggtttctcaa accgaagttg ttgaattggc tttgggtttg 900
gaattgtctg gtttgccatt tgtttgggct tacagaaaac ctaaaggtcc agctaagtct 960
gattctgttg aattgccaga tggtttcgtt gaaagaacta gagatagagg tttggtttgg 1020
acttcttggg ctccacaatt gagaattttg tctcatgaat ccgtctgtgg tttcttgact 1080
cattgtggtt ctggttctat cgttgaaggt ttgatgtttg gtcacccatt gattatgttg 1140
ccaatctttg gtgaccaacc attgaacgct agattattgg aagataagca agtcggtatc 1200
gaaatcccaa gaaatgaaga agatggttgc ttgaccaaag aatctgttgc tagatctttg 1260
agatccgttg tcgttgaaaa agaaggtgaa atctacaagg ctaacgctag agaattgtcc 1320
aagatctaca acgataccaa ggtcgaaaaa gaatacgttt cccaattcgt tgactacttg 1380
gaaaagaatg ctagagctgt tgccattgat catgaatctt ga 1422
SEQ ID NO: 12
Oryza sativa sequence encoding EUGT11 (codon optimized)
atggatagtg gctactcctc atcttatgct gctgccgctg gtatgcacgt tgtgatctgc 60
ccttggttgg cctttggtca cctgttacca tgtctggatt tagcccaaag actggcctca 120
agaggccata gagtatcatt tgtgtctact cctagaaata tctctcgttt accaccagtc 180
agacctgctc tagctcctct agttgcattc gttgctcttc cacttccaag agtagaagga 240
ttgccagacg gcgctgaatc tactaatgac gtaccacatg atagacctga catggtcgaa 300
ttgcatagaa gagcctttga tggattggca gctccatttt ctgagttcct gggcacagca 360
tgtgcagact gggttatagt cgatgtattt catcactggg ctgctgcagc cgcattggaa 420
cataaggtgc cttgtgctat gatgttgtta gggtcagcac acatgatcgc atccatagct 480
gatagaagat tggaaagagc tgaaacagaa tccccagccg cagcaggaca aggtaggcca 540
gctgccgccc caacctttga agtggctaga atgaaattga ttcgtactaa aggtagttca 600
gggatgagtc ttgctgaaag gttttctctg acattatcta gatcatcatt agttgtaggt 660
agatcctgcg tcgagttcga acctgaaaca gtacctttac tatctacttt gagaggcaaa 720
cctattactt tccttggtct aatgcctcca ttacatgaag gaaggagaga agatggtgaa 780
gatgctactg ttaggtggtt agatgcccaa cctgctaagt ctgttgttta cgttgcattg 840
ggttctgagg taccactagg ggtggaaaag gtgcatgaat tagcattagg acttgagctg 900
gccggaacaa gattcctttg ggctttgaga aaaccaaccg gtgtttctga cgccgacttg 960
ctaccagctg ggttcgaaga gagaacaaga ggccgtggtg tcgttgctac tagatgggtc 1020
ccacaaatga gtattctagc tcatgcagct gtaggggcct ttctaaccca ttgcggttgg 1080
aactcaacaa tagaaggact gatgtttggt catccactta ttatgttacc aatctttggc 1140
gatcagggac ctaacgcaag attgattgag gcaaagaacg caggtctgca ggttgcacgt 1200
aatgatggtg atggttcctt tgatagagaa ggcgttgcag ctgccatcag agcagtcgcc 1260
gttgaggaag agtcatctaa agttttccaa gctaaggcca aaaaattaca agagattgtg 1320
gctgacatgg cttgtcacga aagatacatc gatggtttca tccaacaatt gagaagttat 1380
aaagactaa 1389
SEQ ID NO: 13
YBR180W
>sp P38125 DTR1_YEAST Dityrosine transporter 1 OS=Saccharomyces











SEQ ID NO: 14
YAL067C
>sp P39709 SE01_YEAST Probable transporter SEOl OS=Saccharomyces








GMVYLMLTGI IADKLHSRWFAI IFTQVFNI IGNS ILAAWDVAEGAKWFAFMLQCFGWAMA
PVLYSWQNDICRRDAQTRAITLVTMNIMAQSSTAWISVLVWKTEEAPRYLKGFTFTACSA
FCLSIWTFVVLYFYKRDERNNAKKNGIVLYNSKHGVEKPTSKDVETLSVSDEK
SEQ ID NO: 15
YBL089W
>sp| P3817 V 5 YEAST Vacuolar amino acid transporter 5








C L FSYL ISITSLAKVLAIVGATGSTS SFTLPGLFGY GSEFTGT E
RVPTSIKIFKYLSLSLFIWGIAVMVASLSAIVFLGTSSH
SEQ ID NO: 16
YBL099W
>sp| P07251 ATPA__YEAST ATP synthase subunit alpha, mitochondrial
OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=ATP1
PE=1 SV=5
MLARTAAIRSLSRTLINSTKAARPAAAALASTRRLASTKAQPTEVSSILEERIKGVSDEA
NLNETGRVLAVGDGIARVFGLNNIQAEELVE FSSGVKGMALNLE PGQVGIVLFGS DRLVK
EGELVKRTGNIVDVPVGPGLLGRVVDALGNPIDGKGPIDAAGRSRAQVKAPGILPRRSVH







SEQ ID NO: 17
YBR241C
>sp| P38142 YB91_YEAST Probable metabolite transport protein YBR2 C








LLLASTTV TA SLLISVGLTLSVSFLLV FVYIAAFAIGLGPIPFLI IGELSYPQDA
ATAQSFGTVCNWLATFIVGYLFPIGHGLMGGYVFAIFAAIAAMFATYVYKRVPETKGKTT
YSEVWAGY
SEQ ID NO: 18
YBR2 94
>sp P38359 SUL1_YEAST Sulfate permease 1 OS=Saccharomyces cerevisiae
(strain ATCC 204508 / S288c) GN=SUL1 PE=1 SV=2
MSRKSSTEYVHNQEDADIEVFESEYRTYRESEAAENRDGLHNGDEENWKVNSSKQKFGVT
KNELSDVLYDS IPAYEESTVTLKEYYDHS IKNNLTAKSAGS YLVSLFPI IKWFPHYNFTW
GYADLVAGITVGCVLVPQSMSYAQIASLSPEYGLYSSFIGAFIYSLFATSKDVCIGPVAV
MSLQTAKVIAEVLKKYPEDQTEVTAPIIATTLCLLCGIVATGLGILRLGFLVELISLNAV











SEQ ID NO: 19
YCL069W
>s P25594 |¥BA3_YEAST Vacuolar basic amino acid transporter 3










SEQ ID NO: 20
YCR028C
>s P25621 FEN2__YEAST Pantothenate transporter FEN2 OS=Saccharomyces










SEQ ID NO: 21
YCR075C
>sp| P17261 ERS1__YEAST Cystine transporter OS=Saccharomyces








>sp Q99385 VCX1__YEAST Vacuolar calcium ion transporter











>sp| P1 255 ¥AT A Y E A S V-type proton ATPase catalytic subunit A




















SEQ ID NO: 24
YDL194W
>sp P10870 SNF3__YEAST High-affinity glucose transporter SNF3

















SEQ ID NO: 25
YDL210W
>s P32837 |UGA4_YEAST GABA-spccif ic permease OS=Saccharomyces











SEQ ID NO: 26
YDR061W
>sp| Q12298 |YD061__YEAST Uncharacterized ABC transporter ATP-binding
protein YDR061W OS=Saccharomyces cerevisiae (strain ATCC 204508 /










SEQ ID NO: 27
YDR093W
>sp I Q12675 IATC4_YEAST Phospholipid-transporting ATPase DNF2































>sp| Q05497 |YD338__YEAST Uncharacterized transporter YDR338C














SEQ ID NO: 29
YDR40 6
>s Q04182 PDR15_YEAST ATP-dependent permease PDR15 OS=Saccharomyces



























SEQ I D NO: 30
YDR536W
>s P39932 |STL1_YEAST Sugar transporter STLl OS=Saccharomyces











SEQ ID NO: 31
YEL031W
>s P3998 6 ATC6_ YEAST Manganese-transporting ATPase 1























SEQ ID NO: 32
YER166W
>spi P32 0 !A?C5_YEAST Phospholipid- ranspo ng ATPase DNF1





























SEQ ID NO: 33
YFL011W
>sp| P43581 IHXT10JYEAST Kexcse transporter HXT10 OS=Saccharomyces











SEQ ID NO: 34
YGL006W
>s P38929 |ATC2__YEAST Calcium-transporting ATPase 2 OS=Saccharomyces
cerevisiae (strain ATCC 204508 / S288c) GN=PMC1 PE=1 SV=1
MSRQDENSALLANNENNKPSYTGNENGVYDNFKLSKSQLSDLHNPKSIRSFVRLFGYESN



















SEQ ID NO: 35
YGL013C
>sp P12383 PDR1___YEAST Transcription factor PDRl OS=Saccharomyces



















SEQ ID NO: 36
YGL255W
>sp| P32804 ZRT1__YEAST Zinc-regulated transporter 1 0S=Saccha ny ces







CTLFGAG I ALIGK A
SEQ ID NO: 37
YGR125W
>sp P53273 YG35__YEAST Uncharacterized vacuolar membrane protein




















SEQ ID NO: 38
YGR181W
>sp P53299 TIM13__YEAST Mitochondrial import inner membrane
translocase subunit TIM13 OS=Saccharomyces cerevisiae (strain ATCC
204508 / 5288c) GN=TIM13 PE=1 S¥=l
MGLSSI FGGGAPSQQKEAATTAKTTPNPIAKELKNQIAQELA¥ANATEL¥NKISENCFEK
CLTSPYATRNDACIDQCLAKYMRSWN¥ISKAYISRIQNASASGEI
SEQ ID NO: 39
YGR217W
>s P50077 CCH1___YEAST Calcium-channel protein CCHl OS=Saccharomyces



































SEQ ID NO: 0
YGR224W
>sp| P50080 AZR1_YEAST Azole resistance protein 1 OS=Saccharomyces












SEQ ID NO: 41
YGR281W
>s P53049 IYORl__YEAST Oligomycin resistance ATP-dependent permease



























SEQ ID NO: 2
YHL016C
>s P33413 DUR3_YEAST Urea active transporter OS=Saccharomyces











QLQNELDEEQRELARGLKIAYFLCVFFALAFLVVWPMPMYGSKYI FSKKFF G VVV I
WLFFSAFAVCIYPLWEGRHGIYTTLRGLYWDLSGQTYKLREWQNSNPQDLHVVTSQISAR
AHRQSSHFGQVDEII
SEQ ID NO: 3
YIL088C
>sp| P40501 AVT7__YEAST Vacuolar amino acid transporter 7











SEQ ID NO: 4
YJL093C
>sp| P40310 IT0K1__YEAST Outward-rectifier potassium channel TOKl





GGMLLVDVIVCSLNDMPSIYSKTIGFWFACISSGLYLVCTI L HFIGYKLGKYPP N
LLPNERSIMAYTVLLSLWLIWGAGMFSGLLHITYGNALYFCTVSLLTVGLGDILPKSVGA







SEQ ID NO: 5
YJL094C
>sp IP40309 IKHA1_YEAST K (+ )/H (+ } an.tiporter 1 OS=S ccha crry c e s
cerevisiae (strain ATCC 204508 / S288c) GN=KHA1 PE=1 SV=1
MANTVGGILSGVNPFHYNSSSPLTLFLFQACLILLVCNLIHIPFSMMRQPKVISEVISGV
GP FGQ PNYTNTIFPTSSI PGLNLVANLGI ILFMFFLGLEVDIAFIKKHLKKALVI
GIVTLAVPFGFGCLLAIPLFHTYANKTEGERHIKFSVFMVFIAVSISVTAFPVLCRILNE
LRLIKDRAGIVVLAAGIINDIMGWILLALSIILSSAEGSPVNTVYILLITFAWFLIYFFP
LKYLLRWVLIRTHELDRSKPS PLATMC F M F SAY D GVH GA F AGLVVPRD










SEQ ID NO: 46
YJL108C
>s P42946 |PRM10_YEAST Pheromone-regulated membrane protein 10









SEQ ID NO: 7
YJL212C
>sp P40897 0PT1__YEAST Oligopeptide transporter 1 OS=Saccharoir.yces












L WFFL GLLFPLAVYAVQWKFPKFKFAK I TPVFFTGPG PSTPYNYSLFFAMSFC
LNLIRKRWRAWFNKYNF¥MGAGVEAG¥AISV¥IIFLC¥QYPGGKLSWWGNNVWKRTYDND
YKKFYTLKKGETFGYDKWW
SEQ ID NO: 8
YJR106
>sp| P4714 ECM27_YEAST Protein ECM27 OS=Saccharomyces cerevisiae
(strain ATCC 204508 / 5288c) GN=ECM27 PE=1 SV=2
MDWAINVAHPRLLYKDPKLS¥TFI¥PSLFHIIIAF¥LLGICASDFLCPNVAHISDPNSLR
SNGSL¥SKTASHASHTGALMA¥LLSWCNSSPDLFSNLMSWATSTRETRSTS¥SLSIGE¥L




THGHFGAQEMRRFSKRSLGWI IKI FI HLS SQKSISDAI FSI IT¥PFFI I LSC QP






SEQ ID NO : 9
YJR160C
>s POCEOO MPH3_YEAST Alpha-giucosides permease MPH3













SEQ ID NO: 50
YKL064W
>sp| P35724 |MNR2_YEAST Manganese resistance protein MNR2



















SEQ ID NO: 51
YKR050W
>sp P28584 TRK2___YEAST Low-affinity potassium transport protein

















SEQ ID NO: 2
YKR105C
>s IP36172 IVBA5_YEAST Vacuolar basic amino acid transporter 5












SEQ ID NO: 53
YKR106W
>s IP36173 IGEX2__YEAST Glutathione exchanger 2 OS=Saccharomyces












SEQ ID NO: 54
YLR447C
>s IP32366 IVA0DJYEAST V-type proton ATPase subunit d








SEQ ID NO: 55
YML116W
>s IP13090 ATR1_YEAST Aminotriazole resistance protein










GATVETQVNS DGKHLLKGYRGAQYLGI GLA AC SGLYMVES FIKGRRARAAAE YDCT
VA
SEQ ID NO: 56
YMR034C
>sp IQ05131 IYMS4___YEAST Uncharacteri zed membrane protein YMR034C










SEQ ID NO: 57
YMR056C
>sp 1P04710 ADT1__YEAST ADP, ATP carrier protein 1 OS=Saccharomyces







SEQ ID NO: 58
YMR253C
>sp| Q04835 |YM87_YEAST Oncharacterized membrane protein YMR2 53C








I S G I ISATLWVIRIRAANNETTAKDLTPIIDDEENSIPLTEFDLSDSK
SEQ ID NO: 9
YNL065
>sp P53943 AQR1_YEAST Probable transporter AQRl OS=Saccharomyces









STTLLVDL PTKS STAS SCFNFVRCSLST F GCFAKMKAAMT GGTFTFLCALVFFFN F
LMFI PMKYGMKWREDRLLKQQRQSWLNTLAVKAKKGTKRDQNDNHN
SEQ ID NO: 60
YNL070W
>sp P53507 ITOM7_YEAST Mitochondrial import receptor subunit TOM7
OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=TOM7
PE=1 SV=2
MSFLPSFILSDESKERISKILTLTHNVAHYGWIPFVLYLGWAHTSNRPNFLNLLSPLPSV
SEQ ID NO: 1
YNL083W
>sp D6W196 CMC1__YEAST Truncated non-functional calcium-binding
mitochondrial carrier SALl-1 OS=Saccharomyces cerevisiae (strain










SEQ ID NO: 2
YNL095C
>s 53932 YNJ5_YEAST Uncharacter i ed transporter YNL095C
OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YNL095C
PE=1 SV=1











SEQ ID NO: 63
YNL121C
>sp P07213 TOM70__YEAST Mitochondrial import receptor subunit TOM70













SEQ ID NO: 64
YNL142W
>s P41948 MEP2_YEAST Ammonium transporter MEP2 OS=Saccharomyces
cerevisiae (strain ATCC 204508 / S288c) GN=MEP2 PE=1 SV=1
MSYNFTGTPTGEGTGGNSLTTDLNTQFDLANMGWIGVASAGVWIMVPGIGLLYSGLSRKK
HALSLLWASMMASAVCIFQWFFWGYSLAFSHNTRGNGFIGTLEFFGFRNVLGAPSSVSSL







SEQ ID NO: 65
YOL020W
>sp P38967 |TAT2___YEAST Tryptophan permease OS=Saccharomyces










TGKWWGVKALKDI ETDRK D E K EKK Y S P YVRQF C
SEQ ID NO: 66
YOL075C
>sp Q08234 |YO075___YEAST Uncharacteri zed ABC transporter ATP-binding
protein/permease YOL075C OS=Saccharomyces cerevisiae (strain ATCC






VDS RSDKE AATQS RLN SLIDHWHDYERTHLQLQAE SY SNAT E QNMTTRLP FWXQ V
















SEQ ID NO: 67
YOL077W-A
>sp[ P814 51 ATP19_YEAST ATP synthase subunit K , mitochondrial




SEQ ID NO: 68
YOL122C
>sp P38925 iSMF1__ YEAST Manganese transporter SMFl 05=Saccharomyces








SEGH I WKL PWQRRLATRC S1 CLVIS C IGREALS KALNASQVVLS I LPFLVAPL
IFFTCKKSIMKTEITVDHTEEDSHNHQNNNDRSAGSVIEQDGSSGMEIENGKDVKIVYMA
NN II VIA IIVWLFLSLLNVYAIVQLGMSHGDIS
SEQ ID NO: 9
YOR079C
>s Q12067 ATX2_YEAST Metal homeostasis factor AT OS=Saccharomyces




NDSLLI VL A HK PAVLSLTSLMVSRQNLMKWEVICNVFLFASSTPIGYIVLSLLN
LSHSPTMDWISGNLLLMSGGSLLYASFTAFVGGDSHDHDLSVEQEVVLPHDESVYVLIGV
CIPLVISYCISEE
SEQ ID NO: 70
YOR087W
>s Q12324 |YVC1__YEAST Calcium channel YVC1 OS=Saccharomyces













SEQ ID NO: 71
YOR092W
>s Q99252 |ECM3_YEAST Protein EC 3 OS=Saccharomyces cerevisiae
(strain ATCC 204508 / S288c) GN=ECM3 PE=1 SV=1











SEQ ID NO: 72
YOR130C
>sp Q12375 ORTl__YEAST Mitochondrial ornithine transporter 1







SEQ ID NO: 73
YOR222W
>s Q99297 |ODC2_YEAST Mitochondrial 2-oxodicarboxylate carrier 2








SEQ ID NO; 74
YOR2 91W
>sp Q12697 |YPK9_YEAST Vacuolar cation-transporting ATPase YPK9



























SEQ ID NO: 75
YOR306C
>sp Q08777 MCH5_YEAST Riboflavin transporter MCH5 OS=Saccharomyces










SEQ ID NO: 76
YOR316C
>sp| P32798 |COTl__YEAST Cobalt uptake protein COTl OS=Saccharomyces









SEQ ID NO: 7
YOR334W
>sp Q01926 MRS2__YEAST Magnesium transporter MRS 2 , mitochondrial










SEQ ID NO: 8
YPL078C
>sp P05626 IAT _YEAS ATP synthase subunit 4 , mitochondrial
OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=ATP4
PE=1 SV=2
MSMSMGVRGLALRSVSKTLFSQGVRCPSMVIGARYMSSTPEKQTDPKAKANSIINAIPGN




SEQ ID NO: 79
YPL270W
>s P33311 IMDL2_YEAST ATP-dependent permease MDL2 , mitochondrial












KP L LDEATSAL DVESEGA TFGQLMKS KSMT IVS AHRLST RRSENVI VLGH
DGSVVEMGKFKELYANPTSALSQLLNEKAAPGPSDQQLQIEKVIEKEDLNESKEHDDQKK
DDNDDNDNNHDNDSNNQSPETKDNNSDDIEKSVEHLLKDAAKEANPIKITPQP
SEQ ID NO: 80
YPL274W
>s Q08986 ISAM3_YEAST S-adenosylmethionine permease S 3












SEQ ID NO: 81
YPR003C
>sp I 5339 |SULX_YEAST Putative sulfate transporter YPR003C















SEQ ID NO: 2
YPR011C
>sp Q12251 YP01 1___YEAST Uncharacteri zed mitochondrial carrier YPR011C








SEQ ID NO: 83
YPR058W
>sp| P32331 Y C1_YEAST Carrier protein YMC1, mitochondrial








SEQ ID NO: 84
YPR128C
>s I Q06497 |ANT1__YEAST Peroxisomal adenine nucleotide transporter 1
O5=5accharomyces cerevisiae (strain ATCC 204508 / S288c) GN=ANTl
PE=1 SV=1
MLTLESALTGAVASAMANI AVYPLDLSKTI IQSQVSPSSSEDSNEGKVLPNRRYKNVVDC





SEQ ID NO: 85
YPR201W
>s Q06598 ARR3_YEAST Arsenical-resistance protein 3
OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=ARR3
PE=1 SV=1







SEQ ID NO: 86
YBR008C
>sp| P38124 FLR1_YEAST Fluconazole resistance protein 1












SEQ ID NO: 87
YBR021W
>s P05316 FUR4__YEAST Uracil permease OS=Saccharomyces cerevisiae












SEQ ID NO: 88
YBR043C
>sp P38227 QDR3__YEAST Quinidine resistance protein 3














SEQ ID NO: 89
YBR287W
>s P38355 |YB8B_YEAST Uncharacteri zed transporter YBR287W










SEQ ID NO: 90
YBR295W
>sp P38360 IATU1__YEAST P-type cation-transporting ATPase























SEQ ID NO: 91
YBR296C
>sp P38361 IPH089_YEAST Phosphate permease PH089 OS=Saccharomyces








NDVANATGPLSAVYV KTN GAKSE PVWVLAYGGVAL GC TYGY IIKNLGNKMI
LQSPSRGFSIELAVAITTVMATQLGIPTSTTQIAVGGIVAVGLCNKDLKSVNWRMVAWCY
SGWFLTLPIAGLIAGI INGI ILNAPRFGVEYQMT
SEQ ID NO: 92
YCL038C
>s P25568 |ATG22_YEAST Autophagy-related protein 22 OS=Saccharomyces










SEQ ID NO: 3
YCR011C
>sp P25371 ADP1__YEAST Probable ATP-dependent permease




















SEQ ID NO: 94
YDL054C
>sp Q07376 MCH1_YEAST Probable transporter MCHl OS=Saccharomyces










SEQ ID NO: 5
YDL100C
>sp Q12154 GET3_YEAST ATPase GET3 OS=Saccharomyces cerevisiae
(strain ATCC 204508 / S288c) GN=GET3 PE=1 SV=1
MDLTVEPNLHSLITSTTHKWIFVGGKGGVGKTTSSCSIAIQMALSQPNKQFLLISTDPAH
NLSDAFGEKFGKDARKVTGMNNLSCMEIDPSAALKDMNDMAVSRANNNGSDGQGDDLGSL




SEQ ID NO; 96
YDL245C
>s P54854 |HXT15__YEAST Hexose transporter HXT15 OS=Saccharomyces











SEQ ID NO: 97
YDL2 7
>sp P0CD99 MPH2__YEAST Alpha-glucosides permease MPH2













SEQ ID NO: 8
YDR011W
>sp IP32568 SNQ2_YEAST Protein SNQ2 0S=Saccha om ces cerevisiae
(strain ATCC 204508 / S288c) GN=SNQ2 PE=1 SV=2
MSNIKSTQDSSHNAVARSSSASFAASEESFTGITHDKDEQSDTPADKLTKMLTGPARDTA
SQISATVSEMAPDVVSKVESFADALSRHTTRSGAFNMDSDSDDGFDAHAIFESFVRDADE
G IHIRKAGVT E DV'SAKG VDAS ALEGAT FG ILCLPLT FKG KA KRHQK R 1 S V
ALAEAGEMILVLGRPGAGCSSFLKVTAGEIDQFAGGVSGEVAYDGIPQEEMMKRYKADVI
YNGELDVHFPYLTVKQTLDFAIACKTPALRVNNVSKKEYIASRRDLYATIFGLRHTYNTK
VG DFVRGVSGGERKR S I EALAA KGS C DNATRGLD STALE MTNLLKS
TAFVTIYQASENI YETFDKVTVLYSGKQI YFGLIHEAKPYFAKMGYLCPPRQATAEFLTA
LTDPNGFHLIKPGYENKVPRTAEEFETYWLNSPEFAQMKKDIAAYKEKVNTEKTKEVYDE
















LTH ISSKYSYL R G F Y F 1 AMVCVYYLFHVRQ3 SFLSPVS IL K K RKKK
Q
SEQ ID NO: 99
YDR2 92C
>s P32916 SRPR_YEAST Signal recognition particle receptor subunit
a ha homolog S=Sacchar yces cerevisiae (strain ATCC 204508 /










GEALVGTDSVQQAKN FNDAFGKGRNL DFFI ISKCDTVGEMLGTMVNMVYATGI L FVGV
GQTYTDLRTLSVKWAVNTLMS
SEQ ID NO: 100
YDR497C
>sp IP30605 ITRl__YEAST Myo-inositol transporter 1 OS=Saccharomyces











SEQ ID NO: 101
YEL006W
>sp P39953 |YEA6__YEAST Mitochondrial nicotinamide adenine
dinucleotide transporter 2 OS=Saccharomyces cerevisiae (strain ATCC
204508 / S288c) GN=YEA6 PE=1 SV=1
MNNGDNKTTLENSKNASLANGNYAIPTKLNRLKKNADPRVAAIS GALS GALSAMLVCPFD
VAKTRLQAQGLQNMTHQSQHYKGFFGTFATI FKDEGAAGLYKGLQPTVLGYI TLM YFS
VYDFCRKYSVDIFPHSPFLSNASSAITAGAISTVATNPIWVVKTRLMLQTGIGKYSTHYK
G ID RK IQQEGAKALYAGLVPALLGMLNVAIQFPLYENLKIRFGYSESTDVSTDVTS
SNFQKLILASMLSKMVASTVTYPHEILRTRMQLKSDLPNTVQRHLLPLIKITYRQEGFAG
FYSGFATNLVRTVPAAVVTLVSFEYSKKYLTTFFQ
SEQ ID NO: 102
YEL027W
>sp P2551 5 VATL1_YEAST V-type proton ATPase subunit c





SEQ ID NO: 103
YEL065W
>sp IP39980 ISIT1JYEAST Siderophore iron transporter 1




VGQIFFARLSDI FGRFSIMIVSI IFYSMGTI IESQAVNITRFAVGGCFYQLGLTGIILIL
EVIASDFSNLNWRLLALFIPALPFIINTWISGNVTSAIDANWKWGIGMWAFILPLACIPL
GICMLHMRYLARKHAKDRLKPEFEALNKLKWKSFCIDIAFWKLDIIGMLLITVFFGCVLV






SEQ ID NO: 104
YER019C-A
>sp ί P528 1 SC6B2__ YEAST Protein transport protein SBH2




SEQ ID NO: 105
YER053C
>sp P40035 PIC2_YEAST Mitochondrial phosphate carrier protein 2







SEQ ID NO: 106
YER119C
>sp P40074 IAVT6_YEAST Vacuolar amino acid transporter 6










SEQ ID NO: 107
YFL028C
>sp P43569 CAF16_YEAST CCR4-associated factor 16 OS=Saccharomyces






SEQ ID NO: 108
YFR04 5
>sp P43617 YFL5_YEAST Uncharacteri zed mitochondrial carrier YFR04 5





FVQG7 TTFRQ I TS QFTAYTAFKRL LQARN DKAS S I G SF LVA TQ D
VVKTRMMSQNAKTEYKNTLNCMYRI FVQE G ATF KGSIFRFMKVGI SGGLTFTVYEQVS
LLLGFSSRS
SEQ ID NO: 109
YGL084C
>sp P53154 GUP1___YEAST Glycerol uptake protein 1 OS=Saccharomyces











SEQ ID NO: 110
YGL104C
>sp P53142 VPS73_YEAST Vacuolar protein sorting-associated protein








HSLPRKPLLMTSTVLVSVTAFIMGIAMNHNKMNLLIVFSFI GVFT GLNPL FII RE
VSKPQDMVLAQRYGTICNWVGTFI AYTFPI IHDVLSGYVFI IFAI IACSISAFIWKKVP
ETKRSG
SEQ ID NO: 111
YGL114W
>s P53134 YGL4_YEAST Putative oligopeptide transporter YGL114W















SEQ ID NO: 112
YGL167C
>sp| P13586 |ATC1_YEAST Calcium-transporting ATPase 1 OS=Saccharomyces

















SEQ ID NO: 113
YGR257C
>sp| P53320 MTM1___YEAST Mitochondrial carrier protein MTM1









SEQ ID NO: 114
YHL035C
>sp P38735 VMR1__YEAST ABC transporter ATP-binding protein/permease





























SEQ ID NO: 115
YHL036W
>sp P38734 !MUP3__YEAST Low-affinity methionine permease












SEQ ID NO: 116
YHR002W
>sp P38702 LEU5__YEAST Mitochondrial carrier protein LEU5







TMYDHKFQS ISEIAH 11FKERGVRGFFVGLSI GYIKV PMVACS FFVYERMKWNFGI
SEQ ID NO: 117
YHR096C
>s IP38 695 HXT5_YEAST Probable glucose transporter HXT5









CYVVYAS GVTRL NGQDQ SS GAGNC FACF IFCFATTWAPVAYVLI SESYPLR
VRGKA S ASACNWIWGFLISFFTPFITSAINFYYGYVFMGCMVFAYFYVFFFVPETKGL
TLEEVNEMYEENVLPWKSTKWIPPSRRTTDYDLDATRNDPRPFYKRMFTKEK
SEQ ID NO: 118
YIL006W
>sp P40556 YIA6__YEAST Mitochondrial nicotinamide adenine
di uc eo de transporter 1 OS=Saccharomyces cerevisiae (strain ATCC






LRTRMQLKS D PDS IQRRLFPLI KATYAQEGLKGFYSGFTTNLVRT IPASAITLVS FEY
FRNRLENISTMVI
SEQ ID NO: 119
YIL120W
>sp P40475 I QDR1___YEAST Quinidine resistance protein 1












SEQ ID NO: 120
YIL121W
>sp P40474 I QDR2___YEAST Quinidine resistance protein 2












SEQ ID NO: 121
YIL166C
>sp P40445 IYIQ6___YEAST Uncharacterized transporter YIL166C












SEQ ID NO: 122
YJL133W
>sp P10566 MRS3_YEAST Mitochondrial RNA-splicing protein MRS 3





AFYYSYPTTLVMNI PFAAF FV YESSTKFLNPSNEYNPLIHCLCGSISGSTCAAITTPL
DCIKTVLQIRGSQTVSLEIMRKADTFSKAASAIYQVYGWKGFWRGWKPRIVANMPATAIS
WTAYECAKHFLMTY
SEQ ID NO: 123
YJL219W
>sp| P40885 IHXT9_YEAST Hexose transporter HXT9 OS=Saccha o yces
cerevisiae (strain ATCC 204508 / S288c) GN=HXT9 PE=1 SV=1
MSGVNNTSANDLSTTESNSNSVANAPSVKTEHNDSKNSLNLDATEPPIDLPQKPLSAYTT









SEQ ID NO: 124
YKL016C
>sp iP30902 ATP7_YEAST ATP synthase subunit d , mitochondrial





SEQ ID NO: 125
YKL0 50C
>s P35736 YKF0_YEAST Uncharacteri zed protein YKL050C


















SEQ ID NO: 126
YKL120W
>sp P32332 OACl_YEAST Mitochondrial oxaloacetate transport protein








SEQ ID NO: 127
YKL14 6
>sp| P36062 [AVT3__YEAST Vacuolar amino acid transporter 3













SRARLLLDLI VFGVAVMAYTSWQT M SQ
SEQ ID NO: 128
YKL209C
>sp| P12866 ISTE6___YEAST Alpha-factor-transporting ATPase
























SEQ ID NO: 129
YKR039W
>sp| PI91 5 GAP1__YEAST General amino-acid permease GAP1













SEQ ID NO; 130
YLR411W
>sp Q06686 CTR3_YEAST Copper transport protein CTR3 OS=Saccharomyces




SYIIMLLFMYYNGYI SCLIGAI VGRFI FCYEPLGSLGANGSAQGTVSYDKESDDRKCC
L
SEQ ID NO: 131
YML038C
>s Q03697 |YMD8_YEAST Putative nucleotide-sugar transporter YMD8










SEQ ID NO: 132
YMR166C
>sp| Q03829 YM39__YEAST Uncharacterized mitochondrial carrier YMR166C









SEQ ID NO: 133
YMR27 9C
>sp Q03263 IYM8M__YEAST Uncharacterized transporter YMR279C











SEQ ID NO: 134
YNL003C
>sp! P38 921 PET8_YEAST Putative mitochondrial carrier protein PETS







SEQ ID NO: 135
YNL2 68W
>s !P32487 jLYP1__YEAST Lysine -specific permease OS=Saccharomyces












SEQ ID NO: 136
YNR055C
>sp| P53389 IHOLl_YEAST Protein HOL1 OS=Saccharomyces cerevisiae
(strain ATCC 204508 / S288c) GN=HOLl PE=1 SV=1
MDKYTNRDHPDYIPGTFNIYSSQNLENGI IYESKLKKTSSGVVLIPQPSYSPNDPLNWSS









SEQ ID NO: 137
YOL158C
>sp Q08299 ENB1_YEAST Siderophore iron transporter ENB1




R SD G I C I ALVLYT GE ISAATPTFSGLFAGI VIQQFGYSGFRLLATALTGDL
SGLRDRTFAMNIFLIPVI INTWVSGNIVSSVAGNVAPYKWRWGYGIFCIIVPISTLILVL
PYVYAQYISWRSGKLPPLKLKEKGQTLRQTLWKFADDINLIGVILFTAFLVLVLLPLTIA
GGATSKWREGHIIAMI VVGGCLGFI FLIWELKFAKNPFI PRVYLGDPTI YVALLMEFVWR
LGLQIELEYLVTVLMVAFGESTLSAQRIAQLYNFLQSCTNIVVGIMLHFYPHPKVFVVAG
SLLGVIGMGLLYKYRVVYDGISGLIGAEIVVGIAGGMIRFPMWTLVHASTTHNEMATVTG
LLMSVYQ IGDAVGASI AG TQRLAKELIQRLGSSLGMAI YKSPLNYLKKYPIGSEVRV
QMIESYSKIQRLLIIVSISFAAFNAVLCFFLRGFTVNKKQSLSAEEREKEKLKIKQQSWL
RRVIGY
SEQ ID NO: 138
YOR100C
>sp| Q12289 |CRC1_YEAST Mitochondrial carnitine carrier








SEQ ID NO: 139
YOR153W
>sp P33302 PDR5_YEAST Pleiotropic ABC efflux transporter of multiple
















SDRKMLQESSEEESDTYGEIGLSKSEAI H R LCYE KAETRRI VDG V GTL
TALMGASGAGKTTLLDCLAERVTMGVITGDILVNGIPRDKSFPRSIGYCQQQDLHLKTAT
VRESLRFSAYLRQPAEVSIEEKNRYVEEVIKILEMEKYADAVVGVAGEGLNVEQRKRLTI









SEQ ID NO: 140
YOR271C
>sp Q12029 FSF1_YEAST Probable mitochondrial transport protein FSFl








SEQ ID NO: 141
YOR273C
>s IQ12256 ITP04_YEAST Polyamine transporter 4 OS=Saccharomyces












SEQ ID NO: 142
YOR307C
>s P22215 SLY41_YEAST Uncharacteri zed transporter SLY4I










SEQ ID NO: 143
YOR332W
>sp P2220 VATE_YEAST V-type proton ATPase subunit E






SEQ ID NO: 44
YOR34 8C
>s P 5380 PUT4_YEAST Proline-specif ic permease OS=Saccharomyces












SEQ ID NO: 145
YPL036W
>sp| P19657 IPMA2_YEAST Plasma membrane ATPase 2 OS=Saccharomyces

















SEQ ID NO: 46
YDL198C
MPHTDKKQSG LARLLGSASA GIMEIAVFHP VDTISKRLMS NHTKITSGQE LNRVIFRDHF
SEPLGKRLFT LFPGLGYAAS YKVLQRVYKY GGQPFANEFL NKHYKKDFDN LFGEKTGKAM
RSAAAGSLIG IGEIVLLPLD VLKIKRQTNP ESFKGRGFIK ILRDEGLFNL YRGWGWTAAR
NAPGSFALFG GNAFAKEYIL GLKDYSQATW SQNFISSIVG ACSSLIVSAP LDVIKTRIQN
RNFDNPESGL RIVKNTLKNE GVTAFFKGLT PKLLTTGPKL VFSFALAQSL IPRFDNLLSK
SEQ ID NO: 147
YFL054C
MSYESGRSSS SSESTRPPTL KEEPNGKIAW EESVKKSREN NENDSTLLRR KLGETRKAIE
TGGSSRNKLS ALTPLKKVVD ERKDSVQPQV PSMGFTYSLP NLKTLNSFSD AEQARIMQDY
LSRGVNQGNS NNYVDPLYRQ LNPTMGSSRN RPVWSLNQPL PHVLDRGLAA KMIQKNMDAR
SRASSRRGST DISRGGSTTS VKDWKRLLRG AAPGKKLGDI EAQTQRDNTV GADVKPTKLE
PENPQKPSNT HIENVSRKKK RTSHNVNFSL GDESYASSIA DAESRKLKNM QTLDGSTPVY
TKLPEELIEE ENKSTSALDG NEIGASEDED ADIMTFPNFW AKIRYHMREP FAEFLGT L
VIFGVGGNLQ ATVTKGSGGS YESLSFAWGF GCMLGVYVAG GISGGH.TNPA VTISMAIFRK
FPWKKVPVYI VAQIIGAYFG GAMAYGYFWS SITEFEGGPH IRTTATGACL FTDPKSYVTW
RNAFFDEFIG ASILVGCLMA LLDDSNAPPG NGMTALIIGF LVAAIGMALG YQTSFTINPA
RDLGPRIFAS MIGYGPHAFH LTHWWWTWGA WGGPIAGGIA GALIYDIFIF TGCESPVNYP
DNGYIENRVG KLLHAEFHQN DGTVSDESGV NSNSNTGSKK SVPTSS
SEQ ID NO: 148
O yza sativa sequence encoding EUGT11
MDSGYSSSYA AAAGMHVVIC PWLAFGHLLP CLDLAQRLAS RGHRVSFVST PRNISRLPPV
RPALAPLVAF VALPLPRVEG LPDGAESTND VPHDRPDMVE LHRRAFDGLA APFSEFLGTA
CADWVIVDVF HHWAAAAALE HKVPCAMMLL GSAH I S DRRLERAETE SPAAAGQGRP
AAAPTFEVAR MKLIRTKGSS GMSLAERFSL TLSRSSLVVG RSCVEFEPET VPLLSTLRGK
PITFLGLMPP LHEGRREDGE DA VR LDAQ PAKSVVYVAL GSEVPLGVEK VHELALGLEL
AGTRFLWALR KPTGVSDADL LPAGFEERTR GRGVVATRWV PQMSILAHAA VGAFLTHCGW
NSTIEGLMFG HPLIMLPIFG DQGPNARLIE AKNAGLQVAR NDGDGSFDRE GVAAAIRAVA
VEEESSKVFQ AKAKKLQEI V ADMACHERYI DGFIQQLRSY KD
SEQ ID NO: 149
Synechococcus sp . GGPPS
MVAQTFNLDT YLSQRQQQVE EALSAALVPA YPERI EA R YSLLAGGKRL RPILCLAACE
LAGGSVEQAM PTACALEMIH TMSLIHDDLP AMDNDDFRRG KPTNHKVFGE DIAILAGDAL
LAYAFEHI.A3 QTRGVPPQLV LQVIARIGHA VAATGLVGGQ VVDLESEGKA ISLETLEYIH
SHKTGALLEA SVVSGGILAG ADEELLARLS HYARDIGLAF QIVDDILDVT ATSEQLGKTA
GKDQAAAKAT YPSLLGLEAS RQKAEELIQS AKEALRPYGS QAEPLLALAD FITRRQH
SEQ ID NO: 150
Zea mays truncated CD
MAQHTSESAA VAKGSSLTPI VRTDAESRRT RWPTDDDDAE PLVDEIRAML TSMSDGDISV
SAYDTAWVGL VPRLDGGEGP QFPAAVRWIR NNQLPDGSWG DAALFSAYDR LINTLACVVT
LTRWSLEPEM RGRGLSFLGR NMWKLATEDE ESMPIGFELA FPSLIELAKS LGVHDFPYDH
QALQGIYSSR EIKMKRIPKE VMHTVPTSIL HSLEGMPGLD WAKLLKLQSS DGSFLFSPAA
TAYALMNTGD DRCFSYIDRT VKKFNGGVPN VYPVDLFEHI WAVDRLERLG ISRYFQKEIE
QCMDYVNRHW TEDGICWARN SDVKEVDDTA MAFRLLRLHG YSVSPDVFKN FEKDGEFFAF
VGQSNQAVTG MYNLNRASQI SFPGEDVLHR AGAFSYEFLR RKEAEGALRD KWIISKDLPG
EVVYTLDFPW YGNLPRVEAR DYLEQYGGGD DVWIGKTLYR MPLVNNDVYL ELARMDFNHC
QALHQLEWQG LKRWYTENRL KDFGVAQEDA LRAYFLAAAS VYEPCRAAER LAWARAAILA
NAVSTHLRNS PSFRERLEHS LRCRPSEETD GSWFNSSSGS DAVLVKAVLR LTDSLAREAQ
PIHGGDPEDI IHKLLRSAWA EWVREKADAA DSVCNGSSAV EQEGSRMVHD KQTCLLLARM
lEISAGRAAG EAASEDGDRR IIQLTGSICD SLKQKMLVSQ DPEKNEEMMS HVDDELKLRI
REFVQYLLRL GEKKTGSSET RQTFLSIVKS CYYAAHCPPH VVDRHISRVI FEPVSAAK
SEQ ID NO: 151
Arabidopsis haliana S (similar to GenBank AEE36246.1)
MSINLRSSGC SSPISATLER GLDSEVQTRA NNVSFEQTKE KIRKMLEKVE LSVSAYDTSW
VAMVPSPSSQ NAPLFPQCVK WLLDNQHEDG SWGLDNHDHQ SLKKDVLSST LAS LALKKW
GIGERQINKG LQFIELNSAL VTDETIQKPT GFDIIFPGMI KYARDLNLTI PLGSEVVDDM
IRKRDLDLKC DSEKFSKGRE AYLAYVLEGT RNLKDWDLI KYQRKNGSLF DSPATTAAAF
TQFGNDGCLR YLCSLLQKFE AAVPSVYPFD QYARLSI IVT LESLGIDRDF KTEIKSILDE
TYRYWLRGDE EICLDLATCA LAFRLLLAHG YDVSYDPLKP FAEESGFSDT LEGYVKNTFS
VLELFKAAQS YPHESALKKQ CCWTKQYLEM ELSSWVKTSV RDKYLKKEVE DALAFPSYAS
LERSDHRRKI LNGSAVENTR VTKTSYRLHN ICTSDILKLA VDDFNFCQSI HREEMERLDR
WIVENRLQEL KFARQKLAYC YFSGAATLFS PELSDARISW AKGGVLTTVV DDFFDVGGSK
EELENLIHLV EKWDLNGVPE YSSEHVEIIF SVLRDTILET GDKAFTYQGR NVTHHIVKIW
LDLLKSMLRE AEWSSDKSTP SLEDYMENAY ISFALGPIVL PATYLIGPPL PEKTVDSHQY
NQLYKLVSTM GRLLNDIQGF KRESAEGKLN AVSLHMKHER DNRSKEVIIE SMKGLAERKR
EELHKLVLEE KGSVVPRECK EAFLKMSKVL NLFYRKDDGF TSNDLMSLVK SVIYEPVSLQ
KESLT
SEQ ID NO: 152
S . rebaudiana KOI
MDAVTGLLTV PATAITIGGT AVALAVALIF WYLKSYTSAR RSQSNHLPRV PEVPGVPLLG
NLLQLKEKKP YMTFTRWAAT YGPIYSIKTG ATSMVVVSSN EIAKEALVTR FQSISTRNLS
KALKVLTADK TMVAMSDYDD YHKTVKRHIL TAVLGPNAQK KHRIHRDIMM DNISTQLHEF
VKNNPEQEEV DLRKIFQSEL FGLAMRQALG KDVESLYVED LKITMNRDEI FQVLVVDPMM
GAIDVDWRDF FPYLKWVPNK KFENTIQQMY I REAV KSL IKEHKKRIAS GEKLNSYIDY
LLSEAQTLTD QQLLMSLWEP IIESSDTTMV TTEWAMYELA KNPKLQDRLY RDIKSVCGSE
KITEEHLSQL PYITAIFHET LRRHSPVPII PLRHVHEDTV LGGYHVPAGT ELAVNIYGCN
DKNV ENPE EWNPERFMKE NETIDFQKTM AFGGGKRVCA GSLQALLTAS IGIGRMVQEF
EWKLKDMTQE EVNTIGLTTQ MLRPLRAIIK PRI
SEQ ID NO: 153
A . thaliana ATR2
MSSSSSSSTS MIDLMAAIIK GEPVIVSDPA NA5AYE5VAA ELSSMLIENR QFAMIVTTSI
AVLIGCIVML VWRRSGSGNS KRVEPLKPLV IKPREEEIDD GRKKVTIFFG TQTGTAEGFA
KALGEEAKAR YEKTRFKIVD LDDYAADDDE YEEKLKKEDV AFFFLATYGD GEPTDNAARF
YKWFTEGNDR GEWLKNLKYG VFGLGNRQYE HFNKVAKVVD DILVEQGAQR LVQVGLGDDD
QCIEDDFTAW REALWPELDT ILREEGDTAV ATPYTAAVLE YRVSIHDSED AKFNDITLAN
GNGYTVFDAQ HPYKANVAVK RELHTPESDR SCIHLEFDIA GSGLTMKLGD HVGVLCDNLS
ETVDEALRLL DMSPDTYFSL HAEKEDGTPI SSSLPPPFPP CNLRTALTRY ACLLSSPKKS
ALVALAAHAS DPTEAERLKH LASPAGKDEY SKWVVESQRS LLEVMAEFPS AKPPLGVFFA
GVAPRLQPRF YSISSSPKIA ETRIHVTCAL VYEKMPTGRI HKGVCSTWMK NAVPYEKSEK
LFLGRPIFVR QSNFKLPSDS KVPIIMIGPG TGLAPFRGFL QERLALVESG VELGPSVLFF
GCRNRRMDFI YEEELQRFVE SGALAELSVA FSREGPTKEY VQHKMMDKAS DIWNMISQGA
YLYVCGDAKG MARDVHRSLH TIAQEQGSMD STKAEGFVKN LQTSGRYLRD V
SEQ ID NO: 154
Stevia rebaudiana KAHel
MEASYLYISI LLLLASYLFT TQLRRKSANL PPTVFPSIPI IGHLYLLKKP LYRTLA A
KYGPILQLQL GYRRVLVISS PSAAEECFTN NDVIFANRPK TLFGKIVGGT SLGSLSYGDQ
WRNLRRVASI EILSVHRLNE FHDIRVDENR LLIRKLRSSS SPVTLITVFY ALTLNVIMRM
ISGKRYFDSG DRELEEEGKR FREILDETLL LAGASNVGDY LPILNWLGVK SLEKKLIALQ
KKRDDFFQGL IEQVRKSRGA KVGKGRKTMI ELLLSLQESE PEYYTDAMIR SFVLGLLAAG
SDTSAGTMEW AMSLLVNHPH VLKKAQAEID RVIGNNRLID ESDIGNIPYI GCIINETLRL
YPAGPLLFPH ESSADCVISG YNIPRGTMLI VNQWAIHHDP KVWDDPETFK PERFQGLEGT
RDGFKLMPFG SGRRGCPGEG LAIRLLGMTL GSVIQCFDWE RVGDEMVDMT EGLGVTLPKA
VPLVAKCKPR SEMTNLLSEL
SEQ ID NO: 155
Stevia rebaudiana CPR8
MQSNSVKISP LDLVTALFSG KVLDTSNASE SGESAMLPTI AMIMENRELL MILTTSVAVL
IGCVVVLVWR RSSTKKSALE PPVIVVPKRV QEEEVDDGKK KVTVFFGTQT GTAEGFAKAL
VEEAKARYEK AVFKVIDLDD YAADDDEYEE KLKKESLAFF FLATYGDGEP TDNAARFYKW
FTEGCAKGEW LNKLQYGVFG LGNRQYEHFN KIAKVVDDGL VEQGAKRLVP VGLGDDDQCI
EDDFTAWKEL VWPELDQLLR DEDDTTVATP YTAAVAEYRV VFHEKPDALS EDYSYTNGHA
VHDAQHPCRS NVAVKKELHS PESDRSCTHL EFDISNTGLS YETGDHVGVY CENLSEVVND
AERLVGLPPD TYSSIHTDSE DGSPLGGASL PPPFPPCTLR KALTCYADVL SSPKKSALLA
LAAHATDPSE ADRLKFLASP AGKDEYSQWI VASQRSLLEV MEAFPSAKPS LGVFFASVAP
RLQPRYYSIS SSPKMAPDRI HVTCALVYEK TPAGRIHKGV CSTWMKNAVP MTESQDCSWA
PIYVRTSNFR LPSDPKVPVI MIGPGTGLAP FRGFLQERLA LKEAGTDLGL SILFFGCRNR
KVDFI YENEL NNFVETGALS ELIVAFSREG PTKEYVQHKM SEKASDIWNL LSEGAYLYVC
GDAKGMAKDV HRTLHTIVQE QGSLDSSKAE LYVKNLQMSG RYLRDVW
SEQ ID NO: 156
Stevia rebaudiana UGT85C2
MDAMATTEKK PHVIFIPFPA QSHIKAMLKL AQLLHHKGLQ ITFVNTDFIH NQFLESSGPH
CLDGAPGFRF ETIPDGVSHS PEAS IP ES LLRSIETNFL DRFIDLVTKL PDPPTCIISD
GFLSVFTIDA AKKLGIPVMM YWTLAACGFM GFYHIHSLIE KGFAPLKDAS YLTNGYLDTV
IDWVPGMEGI RLKDFPLDWS TDLNDKVLMF TTEAPQRSHK VSHHIFHTFD ELEPSIIKTL
SLRYNHIYTI GPLQLLLDQI PEEKKQTGIT SLHGYSLVKE EPECFQWLQS KEPNSVVYVN
FGSTTVMSLE DMTEFGWGLA NSNHYFLWI I RSNLVIGENA VLPPELEEHI KKRGFIASWC
SQEKVLKHPS VGGFLTHCGW GSTIESLSAG VPMICWPYSW DQLTNCRYIC KEWEVGLEMG
TKVKRDEVKR LVQELMGEGG HKMRNKAKDW KEKARIAIAP NGSSSLNIDK MVKEITVLAR
N
SEQ ID NO: 57
S. rebaudi na UGT74G1 (GenBank A .LR0 6 9 2 0 . 1)
MAEQQKIKKS PHVLLIPFPL QGHINPFIQF GKRLISKGVK TTLVTTIHTL NSTLNHSNTT
TTSIEIQAIS DGCDEGGFMS AGESYLETFK QVGSKSLADL IKKLQSEGTT IDAIIYDSMT
EWVLDVAIEF GIDGGSFFTQ ACVVNSLYYH VHKGLISLPL GETVSVPGFP VLQRWETPLI
LQNHEQIQSP WSQMLFGQFA NIDQARWVFT NSFYKLEEEV lEWTRKIWNL KVIGPTLPSM
YLDKRLDDDK DNGFNLYKAN HHECMNWLDD KPKESVVYVA FGSLVKHGPE QVEEITRALI
DSDVNFLWVI KHKEEGKLPE NLSEVIKTGK GLIVAWCKQL DVLAHESVGC FVTHCGFNST
LEAISLGVPV VAMPQFSDQT TNAKLLDEIL GVGVRVKADE NGIVRRGNLA SCIKMIMEEE
RGVI IRKNAV KWKDLAKVAV HEGGSSDNDI VEFVSELIKA
SEQ ID NO: 158
S . rebaudiana UGT76G1
MENKTETTVR RRRRI ILFPV PFQGHINPIL QLANVLYSKG FSITIFHTNF NKPKTSNYPH
FTFRFILDND PQDERISNLP THGPLAGMRI PIINEHGADE LRRELELLML ASEEDEEVSC
LITDALWYFA QSVADSLNLR RLVLMTSSLF NFHAHVSLPQ FDELGYLDPD DKTRLEEQAS
GFPMLKVKDI KSAYSNWQIL KEILGKMIKQ TKASSGVIWN SFKELEESEL ETVIREIPAP
SFLIPLPKHL TASSSSLLDH DRTVFQWLDQ QPPSSVLYVS FGSTSEVDEK DFLEIARGLV
DSKQSFLWVV RPGFVKGSTW VEPLPDGFLG ERGRIVKWVP QQEVLAHGAI GAFWTHSGWN
STLESVCEGV PMIFSDFGLD QPLNARYMSD VLKVGVYLEN GWERGEIANA IRRVMVDEEG
EYIRQNARVL KQKADVSLMK GGSSYESLES LVSYISSL
SEQ ID NO: 159
S . rebaudiana UGI91D2e-b
MATSDSIVDD RKQLHVATFP WLAFGHILPY LQLSKLIAEK GHKVSFLSTT RNIQRLSSHI
S L VVQLT LPRVQELPED AEATTDVHPE DIPYLKKASD GLQPEVTRFL EQHSPDWIIY
DYTHYWLPSI AASLGISRAH FSVTTPWAIA YMGPSADAMI NGSDGRTTVE DLTTPPKWFP
FPTKVCWRKH DLARLVPYKA PGISDGYRMG MVLKGSDCLL SKCYHEFGTQ WLPLLETLHQ
VPVVPVGLLP PEIPGDEKDE TWVSIKKWLD GKQKGSVVYV ALGSEALVSQ TEVVELALGL
ELSGLPFVWA YRKPKGPAKS DSVELPDGFV ERTRDRGLVW S QLR SHESVCGFLT
HCGSGSIVEG LMFGHPLIML PIFGDQPLMA RLLEDKQVGI EIPRNEEDGC LTKESVARSL
RS¥WEKEGE IYKANARELS KIYNDTKVEK EYVSQFVDYL EKNARAVAi HES
SEQ ID NO: 160
atggctacct tgttggaaca ttttcaagct atgccattcg ctattccaat tgcttt ggc
gctttgtctt ggttgttttt gttctacatc aaggtttctt tcttctccaa caaatccgct
caagctaaat tgccaccagt tccagttgtt ccaggtttgc cagttattgg taatttgttg
caattgaaag aaaagaagcc ataccaaacc ttcactagat gggctgaaga atatggtcca
atctactcta ttagaactgg tgcttctact atggttgtct tgaacactac tcaagttgcc
aaagaagcta tggttaccag atacttgtct atctctacca gaaagttgtc caacgccttg
aaaattttga ccgctgataa gtgcatggtt gccatttctg attacaacga tttccacaag
atgatcaaga gatatatctt gtctaacgtt ttgggtccat ctgcccaaaa aagacataga
tctaacagag ataccttgag agccaacgtt tgttctagat tgcattccca agttaagaac
tctccaagag aagctgtcaa ctttagaaga gttttcgaat gggaattatt cggtatcgct
ttgaaacaag ccttcggtaa ggatattgaa aagccaatct acgtcgaaga attgggtact
actttgtcca gagatgaaat cttcaaggtt ttggtcttgg acattatgga aggtgccatt
gaagttgatt ggagagattt tttcccatac ttgcgttgga ttccaaacac cagaatggaa
actaagatcc aaagattata ctttagaaga aaggccgtta tgaccgcctt gattaacgaa
caaaagaaaa gaattgcctc cggtgaagaa atcaactgct acatcgattt cttgttgaaa
gaaggtaaga ccttgaccat ggaccaaatc tctatgttgt tgtgggaaac cgttattgaa
actgctgata ccacaatggt tactactgaa tgggctatgt acgaagttgc taaggattct
aaaagacaag acagattata ccaagaaatc caaaaggtct gcggttctga aatggttaca
gaagaatact tgtcccaatt gccatacttg aatgctgttt tccacgaaac tttgagaaaa
cattctccag ctgctttggt tccattgaga tatgctcatg aagatactca attgggtggt
tattacattc cagccggtac tgaaattgcc attaacatct acggttgcaa catggacaaa
caccaatggg aatctccaga agaatggaag ccagaaagat ttttggatcc taagtttgac
ccaatggact tgtacaaaac tatggctttt ggtgctggta aaagagtttg cgctggttct
ttacaagcta tgttgattgc ttgtccaacc atcggtagat tggttcaaga atttgaatgg
aagttgagag atggtgaaga agaaaacgtt gatactgttg gtttgaccac ccataagaga
tatccaatgc atgctatttt gaagccaaga tcttaa
SEQ ID NO: 161
MATLLEHFQA MPFAIPIALA ALSWLFLFYI KVSFFSNKSA QAKLPPVPVV PGLPVIGNLL
QLKEKKPYQT FTRWAEEYGP IYSIRTGAST MVVLNTTQVA KEAMVTRYLS ISTRKLSNAL
KILTADKCMV AISDYNDFHK MIKRYILSNV LGPSAQKRHR SNRDTLRANV CSRLHSQVKN
SPREAVNFRR VFEWELFGIA LKQAFGKDIE KPI YVEELGT TLSRDEIFKV LVLDIMEGAI
EVDWRDFFPY LRWIPNTRME TKIQRLYFRR KAVMT LI E QKKRIASGEE INCYIDFLLK
EGKTLTMDQI SMLLWETVIE TADTTMVTTE WAMYEVAKDS KRQDRLYQEI QKVCGSEMVT
EEYLSQLPYL NAVFHETLRK HSPAALVPLR YAHEDTQLGG YYIPAGTEIA INIYGCNMDK
HQWESPEEWK PERFLDPKFD PMDLYKTMAF GAGKRVCAGS LQAMLIACPT IGRLVQEFEW
KLRDGEEENV DTVGLTTHKR YPMHAILKPR S
[00164] Having described the invention in detail and by reference to specific
embodiments thereof, it will be apparent that modifications and variations are possible
without departing from the scope of the invention defined in the appended claims. More
specifically, although some aspects of the present invention are identified herein as
particularly advantageous, it is contemplated that the present invention is not necessarily
limited to these particular aspects of the invention.
WHAT IS CLAIMED IS:
1. A recombinant host capable of synthesizing a steviol glycoside, comprising a gene
encoding a transporter polypeptide and/or a gene encoding a transcription factor
polypeptide that regulates expression of at least one transporter gene;
wherein expression of the gene encoding the transporter polypeptide and/or
the gene encoding the transcription factor polypeptide that regulates expression of at
least one transporter gene is modified and the recombinant host transports at least a
portion of the synthesized steviol glycoside from the host into a culture medium.
2 . The recombinant host of claim 1, wherein the gene encoding the transporter
polypeptide is an endogenous gene.
3 . The recombinant host of any one of claims 1 or 2 , wherein the transporter
polypeptide comprises an ATP-binding cassette (ABC) transporter, a major facilitator
superfamily (MFS) transporter, an amino acid/auxin permease (AAAP) family
transporter, an ATPase transporter, a sulfate permease (SulP) family transporter, a
lysosomal cystine transporter (LCT) family transporter, a Ca2+:cation antiporter
(CaCA) family transporter, an amino acid-polyamine-organocation (APC) superfamily
transporter, a multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) transporter, a
Z T/ RT-li e protein (ZIP) metal transporter family transporter, a mitochondrial
protein translocase (MPT) family transporter, a voltage-gated ion channel (VIC)
family transporter, a monovalent cation.proton antiporter-2 (CPA2) family transporter,
a ThrE family of putative transmembrane amino acid efflux transporter, an
oligopeptide transporter (OPT) family transporter, a K+ transporter (Trk) family
transporter, a bile acid:Na symporter (BASS) family transporter, a drug/metabolite
transporter (DMT) superfamily transporter, a mitochondrial carrier (MC) family
transporter, an auxin efflux carrier (AEC) family transporter, an ammonia channel
transporter (Ami) family transporter, a metal ion (Mn2+-iron) transporter (Nramp)
family transporter, a transient receptor potential Ca2+ channel (TRP-CC) family
transporter, an arsenical resistance-3 (ACR3) family transporter, a nucleobase.cation
symporter-1 (NCS1) family transporter, an inorganic phosphate transporter (PiT)
family transporter, an arsenite-antimonite (ArsAB) efflux family transporter, an MSP
family of transporter, a glycerol uptake (GUP) family transporter, a metal ion transport
(MIT) family transporter, a copper transport (Ctr) family transporter, or a cation
diffusion facilitator (CDF) family transporter.
The recombinant host of any one of claims 1-3, wherein modified expression
comprises:
(a) overexpressing the gene encoding the transporter polypeptide and/or
the gene encoding the transcription factor polypeptide; or
(b) deleting the gene encoding the transporter polypeptide and/or the
gene encoding the transcription factor polypeptide.
The recombinant host of any one of claims 1-4, wherein the gene encoding the
transporter polypeptide and/or the gene encoding the transcription factor polypeptide
has an activity that is increased.
The recombinant host of any one of claims 1-5, wherein one or more of the genes
encoding the transporter polypeptide and/or one or more of the gene encoding the
transcription factor polypeptide is overexpressed.
The recombinant host of claim 6 , wherein the transporter polypeptide and/or
transcription polypeptide comprise YAL067C set forth in SEQ ID NO: 14, YBL089W
set forth in SEQ ID NO:15, YBL099W set forth in SEQ ID NO:16, YBR008C set forth
in SEQ ID NO:86, YBR021W set forth in SEQ ID NO:87, YBR043C set forth in SEQ
ID NO:88, YBR180W set forth in SEQ D NO:13, YBR241C set forth in SEQ ID
NO: 17, YBR287W set forth in SEQ D NO:89, YBR294W set forth in SEQ D NO: 18,
YBR295W set forth in SEQ ID NO:90, YBR296C set forth in SEQ ID NO:91 ,
YCL038C set forth in SEQ ID NO:92, YCL069W set forth in SEQ ID NO: 19,
YCR01 1C set forth in SEQ ID NO:93, YCR028C set forth in SEQ ID NO:20,
YCR075C set forth in SEQ ID NO:21, YDL054C set forth in SEQ ID NO:94,
YDL100C set forth in SEQ ID NO:95, YDL128W set forth in SEQ D NO:22,
YDL185W set forth in SEQ ID NO:23, YDL194W set forth in SEQ ID NO:24,
YDL210W set forth in SEQ ID NO:25, YDL245C set forth in SEQ ID NO:96,
YDL247W set forth in SEQ ID NO:97, YDR01 1W set forth in SEQ ID NO:98,
YDR061W set forth in SEQ D NO:26, YDR093W set forth in SEQ ID NO:27,
YDR292C set forth in SEQ ID NO:99, YDR338C set forth in SEQ ID NO:28,
YDR406W set forth in SEQ ID NO:29, YDR497C set forth in SEQ ID NO: 100,
YDR536W set forth in SEQ ID NO:30, YEL006W set forth in SEQ D NO: 101,
YEL027W set forth in SEQ ID NO:102, YEL031W set forth in SEQ D NO:31,
YEL065W set forth in SEQ D NO: 103, YER019C-A set forth in SEQ ID NO: 104,
YER053C set forth in SEQ ID NO:105, YER1 19C set forth in SEQ ID NO:106,
YER166W set forth in SEQ ID NO:32, YFL01 1W set forth in SEQ ID NO:33,
YFL028C set forth in SEQ ID NO:107, YFR045W set forth in SEQ D NO:108,
YGL006W set forth in SEQ ID NO:34, YGL013C set forth in SEQ ID NO:35,
YGL084C set forth in SEQ ID NO: 109, YGL104C set forth in SEQ ID NO: 110,
YGL1 14W set forth in SEQ ID NO:1 11, YGL167C set forth in SEQ D NO: 1 2 ,
YGL255W set forth in SEQ ID NO:36, YGR125W set forth in SEQ ID NO:37,
YGR181W set forth in SEQ ID NO:38, YGR217W set forth in SEQ ID NO:39,
YGR224W set forth in SEQ ID NO:40, YGR257C set forth in SEQ D NO: 113,
YGR281W set forth in SEQ ID NO:41, YHL016C set forth in SEQ ID NO:42,
YHL035C set forth in SEQ ID NO:1 14, YHL036W set forth in SEQ ID NO:1 15,
YHR002W set forth in SEQ ID NO: 116, YHR096C set forth in SEQ ID NO: 11 ,
YIL006W set forth in SEQ ID NO:1 18, YIL088C set forth in SEQ ID NO:43, YIL120W
set forth in SEQ ID NO:1 19, YIL1 2 1 set forth in SEQ ID NO:120, YIL166C set forth
in SEQ D NO: 121, YJL093C set forth in SEQ D NO:44, YJL094C set forth in SEQ
ID NO:45, YJL108C set forth in SEQ ID NO:46, YJL133W set forth in SEQ ID
NO: 122, YJL212C set forth in SEQ ID NO:47, YJL219W set forth in SEQ ID NO: 123,
YJR106W set forth in SEQ ID NO:48, YJR160C set forth in SEQ ID NO:49, YKL016C
set forth in SEQ ID NO: 124, YKL050C set forth in SEQ ID NO: 125, YKL064W set
forth in SEQ ID NO:50, YKL120W set forth in SEQ ID NO:126, YKL146W set forth in
SEQ ID NO: 127, YKL209C set forth in SEQ ID NO: 128, YKR039W set forth in SEQ
D NO: 129, YKR050W set forth in SEQ ID NO:51, YKR105C set forth in SEQ ID
NO:52, YKR1 06W set forth in SEQ ID NO:53, YLR41 set forth in SEQ ID NO: 130,
YLR447C set forth in SEQ ID NO:54, YML038C set forth in SEQ ID NO: 131,
YML1 16W set forth in SEQ ID NO:55, YMR034C set forth in SEQ ID NO:56,
YMR056C set forth in SEQ ID NO:57, YMR166C set forth in SEQ ID NO:132,
YMR253C set forth in SEQ ID NO:58, YMR279C set forth in SEQ ID NO: 133,
YNL003C set forth in SEQ ID NO: 134, YNL065W set forth in SEQ ID NO:59,
YNL070W set forth in SEQ ID NO:60, YNL083W set forth in SEQ ID NO:61,
YNL095C set forth in SEQ ID NO:62, YNL121C set forth in SEQ ID NO:63,
YNL142W set forth in SEQ ID NO:64, YNL268W set forth in SEQ ID NO: 135,
YNR055C set forth in SEQ ID NO: 136, YOL020W set forth in SEQ ID NO:65,
YOL075C set forth in SEQ ID NO:66, YOL077W-A set forth in SEQ ID NO:67,
YOL122C set forth in SEQ D NO:68, YOL158C set forth in SEQ ID NO: 137,
YOR079C set forth in SEQ ID NO:69, YOR087W set forth in SEQ ID NO: 70,
YOR092W set forth in SEQ ID NO:71 , YOR100C set forth in SEQ D NO:138,
YOR130C set forth in SEQ ID NO:72, YOR153W set forth in SEQ ID NO: 139,
YOR222W set forth in SEQ ID NO:73, YOR271C set forth in SEQ ID NO: 140,
YOR273C set forth in SEQ ID NO:141, YOR291W set forth in SEQ ID NO:74,
YOR306C set forth in SEQ ID NO:75, YOR307C set forth in SEQ D NO: 142,
YOR316C set forth in SEQ ID NO:76, YOR332W set forth in SEQ ID NO: 143,
YOR334W set forth in SEQ ID NO:77, YOR348C set forth in SEQ ID NO: 144,
YPL036W set forth in SEQ ID NO: 145, YPL078C set forth in SEQ ID NO:78,
YPL270W set forth in SEQ D NO:79, YPL274W set forth in SEQ ID NO:80,
YPR003C set forth in SEQ ID NO:81, YPR01 1C set forth in SEQ ID NO:82,
YPR058W set forth in SEQ ID NO:83, YPR128C set forth in SEQ ID NO:84, or
YPR201W set forth in SEQ ID NO:85.
8. The recombinant host of any one of claims 1-7, wherein YBR043C set forth in SEQ
ID NO:88, YDL100C set forth in SEQ ID NO:95, YDL054C set forth in SEQ D
NO:94, YDL128W set forth in SEQ ID NO:22, YDL198C set forth in SEQ ID NO:146,
YDR061W set forth in SEQ ID NO:26, YDR536W set forth in SEQ D NO:30,
YEL027W set forth in SEQ ID NO: 102, YFL054C set forth in SEQ ID NO: 147,
YGL167C set forth in SEQ ID NO:1 12, YGR181W set forth in SEQ D NO:38,
YHL016C set forth in SEQ D NO:42, YIL166C set forth in SEQ ID NO:121 , YJL093C
set forth in SEQ ID NO:44, YJR106W set forth in SEQ ID NO:48, YKL120W set forth
in SEQ ID NO: 126, YKL146W set forth in SEQ ID NO: 127, YKR039W set forth in
SEQ ID NO: 129, YMR034C set forth in SEQ ID NO:56, YMR166C set forth in SEQ
ID NO: 132, YOL122C set forth in SEQ ID NO:68, YOR079C set forth in SEQ ID
NO:69, YPL270W set forth in SEQ ID NO:79, and/or YPR01 1C set forth in SEQ ID
NO:82 are overexpressed.
9 . The recombinant host of any one of claims 1-8, further comprising:
(a) one or more genes encoding a sucrose transporter and a sucrose
synthase;
(b) a gene encoding a geranylgeranyl diphosphate synthase (GGPPS)
polypeptide;
(c) a gene encoding an ent-copalyl diphosphate synthase (CDPS)
polypeptide;
(d) a gene encoding a kaurene synthase (KS) polypeptide;
(e) a gene encoding a kaurene oxidase (KO) polypeptide;
(f) a gene encoding a steviol synthase (KAH) polypeptide;
(g) a gene encoding a cytochrome P450 reductase (CPR)
polypeptide;
(h) a gene encoding a UGT85C2 polypeptide;
(i) a gene encoding a UGT76G1 polypeptide;
0) a gene encoding a UGT74G1 polypeptide;
(k) a gene encoding a UGT91D2 functional homolog; and/or
(I) a gene encoding a EUGT1 1 polypeptide;
wherein at Ieast one of the genes is a recombinant gene; and
wherein the host is capable of producing one or more of RebA, RebB, RebD
and/or RebM.
10. The recombinant host of claim 9, wherein at Ieast one of the genes is codon
optimized for expression in the host.
11. The recombinant host of claim 10, wherein at Ieast one of the genes is codon
optimized for expression in Saccharomyces cerevisiae.
The recombinant host of claim 9, wherein:
(a) the GGPPS polypeptide comprises a polypeptide having at Ieast 70%
identity to an amino acid sequence set forth in SEQ D NO: 149;
(b) the CDPS polypeptide comprises a polypeptide having at Ieast 70%
identity to an amino acid sequence set forth in SEQ ID NO:150;
(c) the KO polypeptide comprises a polypeptide having at least 70%
identity to an amino acid sequence set forth in SEQ D NO: 152;
(d) the KS polypeptide comprises a polypeptide having at least 40%
identity to an amino acid sequence set forth in SEQ ID NO: 151;
(e) the KAH polypeptide comprises a polypeptide having at least 60%
identity to an amino acid sequence set forth in SEQ ID NO: 154;
(f) the CPR polypeptide comprises a polypeptide having at least 70%
identity to an amino acid sequence set forth in SEQ ID NO: 153 and/or
a polypeptide having at least 65% identity to an amino acid sequence
set forth in SEQ ID NO:155;
(g) the UGT85C2 polypeptide comprises a polypeptide having at least
55% identity to an amino acid sequence set forth in SEQ ID NO: 156;
(h) the UGT76G1 polypeptide comprises a polypeptide having at least
50% identity to an amino acid sequence set forth in SEQ ID NO: 158;
(i) the UGT74G1 polypeptide comprises a polypeptide having at least
55% identity to an amino acid sequence set forth in SEQ D NO: 157;
(j) the a UGT91 D2 functional homolog comprises a UGT91D2e-b
polypeptide having at least 90% identity to the amino acid sequence
set forth in SEQ ID NO: 159; and
(k) the EUGT1 1 polypeptide comprises a polypeptide having at least 65%
identity to an amino acid sequence set forth in SEQ ID NO: 148.
13. The recombinant host of any one of claims 1-12, wherein the recombinant host
comprises a microorganism that is a plant cell, a mammalian cell, an insect cell, a
fungal cell, or a bacterial cell.
14. The recombinant host of claim 13, wherein the bacterial cell comprises Escherichia
bacteria cells, Lactobacillus bacteria cells, Lactococcus bacteria cells,
Cornebacterium bacteria cells, Acetobacter bacteria cells, Acinetobacter bacteria
cells, or Pseudomonas bacterial cells.
15. The recombinant host of claim 13, wherein the fungal cell is a yeast cell.
16. The recombinant host of claim 15, wherein the yeast cell is a cell from
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Yarrowia lipolytica,
Candida glabrata, Ashbya gossypii, Cyberlindnera jadinii, Pichia pastohs,
Kluyveromyces lactis, Hansenula polymorpha, Candida boidinii, Arxula
adeninivorans, Xanthophyllomyces dendrorhous, or Candida albicans species.
17. The recombinant host of claim 16, wherein the yeast cell is a Saccharomycete.
18. The recombinant host of claim 17, wherein the yeast cell is a cell from the
Saccharomyces cerevisiae species.
19. A method of producing a steviol glycoside, comprising:
(a) growing the recombinant host of any one of claims 1-18 in a culture
medium, under conditions in which the genes discussed in any one of
claims 1 to 18 are expressed,
wherein the steviol glycoside is synthesized by the host; and
(b) optionally isolating the stevioi glycoside.
20. The method of claim 19, wherein the steviol glycoside is RebA, RebB, RebD, and/or
RebM, and wherein:
(a) RebA is capable of being synthesized in the recombinant host of any
one of claims 1-18 expressing UGT85C2, UGT76G1, UGT74G1, and
UGT91D2;
(b) RebB is capable of being synthesized in the recombinant host of any
one of claims 1-18 expressing UGT85C2, UGT76G1, and UGT91D2;
(c) RebD is capable of being synthesized in the recombinant host of any
one of claims 1-18 expressing UGT85C2, UGT76G1, UGT74G1, and
UGT91 D2 and/or EUGT1 1; and
(d) RebM is capable of being synthesized in the recombinant host of any
one of claims 1-18 expressing UGT85C2, UGT76G1 , UGT74G1, and
UGT91D2 and/or EUGT1 1.
21. The method of claims 19 or 20, wherein a gene encoding YBR043C set forth in SEQ
D NO:88, YDL100C set forth in SEQ ID NO:95, YDL054C set forth in SEQ ID
NO:94, YDL128W set forth in SEQ ID NO:22, YDL198C set forth in SEQ ID NO: 146,
YDR061W set forth in SEQ ID NO:26, YDR536W set forth in SEQ ID NO:30,
YEL027W set forth in SEQ ID NO: 102, YFL054C set forth in SEQ ID NO: 147,
YGL167C set forth in SEQ ID NO:1 12, YGR181W set forth in SEQ ID NO:38,
YHL016C set forth in SEQ ID NO:42, YIL166C set forth in SEQ ID NO: 121, YJL093C
set forth in SEQ ID NO:44, YJR106W set forth in SEQ ID NO:48, YKL120W set forth
in SEQ ID NO: 126, YKL146W set forth in SEQ ID NO: 127, YKR039W set forth in
SEQ ID NO: 129, YMR034C set forth in SEQ ID NO:56, YMR166C set forth in SEQ
ID NO: 132, YOL122C set forth in SEQ ID NO:68, YOR079C set forth in SEQ D
NO:69, YPL270W set forth in SEQ ID NO:79, and/or YPR01 1C set forth in SEQ ID
NO:82 is overexpressed.
22. The method of any one of claims 19-21, wherein the steviol glycoside is produced at
a concentration of between about 500 mg/L to about 10,000 mg/L.
23. A method of increasing production or transport of a steviol glycoside into a culture
medium, comprising:
(a) growing the recombinant host of any one of claims 1-18 in a culture
medium, under conditions in which the genes discussed in any one of
claims 1 to 18 are expressed,
wherein the steviol glycoside is synthesized by the host; and
(b) optionally isolating the steviol glycoside.
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